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ABSTRACT 
WHITNEY E. HEAVNER: Using the Mouse Retina to Model the Role of SOX2 in 
Neural Induction 
(Under the direction of Dr. Larysa Pevny) 
 
Neural competence is the ability of a progenitor cell to generate a neuron. The eye 
is one of the few tissues derived from the neural ectoderm that contains both neurogenic 
and non-neurogenic cells, all of which arise from a common progenitor pool. Therefore, 
the eye is a particularly useful model to study the molecular mechanisms that confer 
neural competence. Moreover, this cell fate dichotomy is highly reminiscent of the earlier 
process of neural induction, or the decision of an ectoderm precursor cell to become 
neural plate or epidermis. The HMG-box transcription factor SOX2 is crucial for both of 
these processes. Little is known about the role of SOX2 in neural induction, and what is 
known has been worked out primarily in lower vertebrates. Humans and mice with 
mutations in SOX2 exhibit a range of neural defects; therefore, from the perspective of 
human health, it is important to understand SOX2’s function in mammalian 
neuroepithelium. This project takes advantage of the accessibility of the embryonic 
mouse eye to identify pathways that SOX2 regulates to maintain neural competence.  
Chapter I gives an overview of neural induction from an historical perspective, 
with particular attention to the role of SOXB1 factors. A detailed description of 
   iv 
mammalian eye development and the similarities between optic cup regionalization and 
neural induction are described. 
Chapter II investigates one potential mechanism of how SOX2 specifies neural 
fate: antagonism of Pax6. Using mouse genetics, we show that ablation of Sox2 in the OC 
leads to increased Pax6 expression and loss of neural competence. This phenotype is 
partially rescued by lowering Pax6 in Sox2
cond/cond
; P0CreiresGFP cells. Chapter III 
investigates the increased WNT signaling activity observed upon SOX2 ablation. Using 
mouse genetics, we show that removal of -Catenin from Sox2-negative cells rescues 
some aspects of the Sox2-mutant phenotype. 
Chapter IV offers some ideas of how these studies potentially relate to the 
treatment of degenerative eye disease, focusing on identifying candidate genes that could 
rescue neurogenesis in a Sox2-depleted background. To put these ideas into context, an 
overview of the current state of gene therapy for the treatment of eye disease is offered.  
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This work is dedicated to my beloved advisor, Larysa, who taught me to revere mouse 
genetics and adore the developing embryo. 
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CHAPTER I: INTRODUCTION 
Overview 
This chapter summarizes what is known about eye development in mammals and 
describes the classical studies that inform the current questions surrounding neural induction. 
The role of the SOXB1 family of transcription factors in these processes is referenced 
throughout. The function of the SOXB1 family member SOX2 as a transcriptional activator, and 
sometimes a transcriptional repressor, is described in terms of neural development. Finally, the 
usefulness of the optic cup as a model of neural induction is explained.  
Eye Development in Mammals 
For generations of biologists, the eye has offered an accessible model for investigating 
the mechanisms that coordinate the development and morphogenesis of diverse cell types. At 
the beginning of the twentieth century, embryologists studying eye development in amphibians 
described the concept of induction for the first time after discovering that tissues of different 
origins must interact in order to generate a lens (Spemann, 1901). A century later, with 
significant advances in molecular biology, the eye has provided a system for studying gene 
interactions. Because vision is not essential for life, eye malformations have revealed that a 
single mutation can lead to disease. Currently, the ability to profile gene expression in single 
retinal cells, which has revealed extensive heterogeneity among retinal progenitors, enables the 
study of eye development at the systems level (Byerly and Blackshaw, 2009; Kim et al., 2008; 
Roesch et al., 2008; Trimarchi et al., 2008). Genes that coordinate eye development are highly 
conserved across species, so while this section focuses principally on mammalian eye 
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development, the underlying cellular and molecular paradigms can be applied to lower 
vertebrates as well. Indeed, the eye development field thrives on a rich history of 
developmental biologists working in organisms from flies to humans. 
Briefly, the visible stages of mouse eye development, which are described in detail 
below, include optic sulci (E8.0), optic vesicle evagination (E9.0), optic cup invagination (E10.0), 
and retinal neurogenesis (E11.0 – P7). 
The eye field: establishing the optic primordia 
Shortly after gastrulation, the eye primordium, or eye field, is specified in the medial 
anterior neural plate and contains all the progenitors of the neural-derived eye structures (Li et 
al., 1997; Wilson and Houart, 2004; Zaghloul et al., 2005). In mice, the first morphological sign of 
the eye field is the formation of bilateral indentations in the prospective forebrain termed the 
optic sulci, or optic pits, at embryonic (E) day 8.0 (Adelmann, 1929; Li et al., 1997; Wilson and 
Houart, 2004) (Figure 1-1A). Molecularly, the eye field can be identified by the overlapping 
expression domains of a set of highly conserved genes termed the eye field transcription factors 
(EFTFs) (Lee et al., 2006; Moore et al., 2004; Zaghloul et al., 2005) (Byerly and Blackshaw, 2009; 
Zuber et al., 2003). In mammals, the EFTFs, which include Pax6, Rax, Six3 and Lhx2, constitute a 
regulatory network required for eye development (Byerly and Blackshaw, 2009; Zuber et al., 
2003). The identification of the upstream signaling pathways that specify the eye field is 
challenging given that these genes also play a role in forebrain development (Hagglund et al., 
2011). 
A recent study identified an 11kb genomic region in the Lhx2 promoter that specifically 
directs Lhx2 expression to the eye field, thus defining a distinct eye-committed progenitor cell 
population in the forebrain (Hagglund et al., 2011). The identification of factors controlling the 
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activity of this Lhx2 regulatory element may reveal specific pathways required for eye field 
specification. In fact, the conditional inactivation of Lhx2 in this cell population has no effect on 
the activity of the Lhx2 eye field enhancer, suggesting that Lhx2 itself is not essential for eye 
field priming (Hagglund et al., 2011). However, the finding that eye development is arrested in 
mice lacking Lhx2 corroborates a study in which ectopic expression of eye field transcription 
factors can generate eyes in Xenopus only when endogenous Lhx2 expression is induced. 
(Cavodeassi et al., 2005; Fuhrmann, 2008; Rasmussen et al., 2001; Zuber et al., 2003). Moreover, 
this study demonstrated that OTX2, a transcription factor essential for forebrain development, 
and Noggin, a BMP antagonist, potentiate EFTF expression in the anterior neural plate (Zuber et 
al., 2003). Similarly, in vitro data suggest that OTX2 cooperates with SOX2 to activate Rax 
expression, even though Otx2 becomes down-regulated in the Rax expression domain of the 
early eye field (Andreazzoli et al., 1999; Danno et al., 2008; Zuber et al., 2003). SOX2 in 
coordination with a POU-factor may directly antagonize OTX2 in this region (see Discussion). 
These data demonstrate that SOX2 plays an integral role in the earliest stages of eye 
development and support a model of “progressive induction” (Zuber et al., 2003). This model 
predicts that the anterior forebrain must be primed for eye field formation such that SOX2 and 
OTX2 activate EFTF expression, and EFTFs then work in a feedback network to maintain the eye 
field (Figure 1-2). 
Heterozygous mutations in human OTX2 can cause a range of ocular phenotypes from 
bilateral anophthalmia to retinal dystrophy (Ragge et al., 2005a). In contrast to SOX2 mutations 
(discussed below), OTX2 mutations are commonly associated with impaired retinal function, 
perhaps owing to the role of OTX2 in RPE development (Chase, 1944; Grindley et al., 1995; 
Hanson et al., 1993; Martinez-Morales et al., 2003; Mathers et al., 1997; Medina-Martinez et al., 
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2009; Ragge et al., 2005a; Tabata et al., 2004; Tucker et al., 2001; Voronina et al., 2004; 
Wawersik and Maas, 2000; Zhang et al., 2000) 
Eye field transcription factors 
Genetic studies in flies (Wawersik and Maas, 2000), mice and humans illustrate that the 
EFTFs are essential for proper eye development and function in a conserved network to regulate 
eye formation. 
a. Pax6 and Lhx2 
An initial genetic demonstration of EFTF function was the identification of heterozygous 
mutations in the Pax6 locus that cause the mouse small eye (Sey) haploinsufficient phenotype 
(Hill et al., 1991; Hogan et al., 1988). Pax6 is a member of the evolutionarily conserved family of 
paired domain-containing transcription factors (further discussed in Chaper II) (Walther and 
Gruss, 1991). Humans with mutations in one copy of PAX6 often have aniridia, a severe ocular 
malformation characterized by abnormal iris development and, more rarely, microphthalmia, 
corneal cataracts and macular and foveal hypoplasia (Glaser et al., 1994; Glaser et al., 1992; 
Hever et al., 2006). Mice with one copy of the Sey allele exhibit reduced eye size and variable 
abnormal development of the retina, iris, lens and/or cornea (Hever et al., 2006; Hill et al., 
1991). Homozygous loss of Pax6 function in humans and mice causes anophthalmia, or the 
complete lack of eyes (Glaser et al., 1994; Hill et al., 1991).  
Like Pax6Sey/Sey mouse mutants, Lhx2-/- embryos generate optic vesicles but never form 
optic cups (Porter et al., 1997). Conditional inactivation of Lhx2 in the eye field leads to 
developmental arrest of the optic vesicle just prior to optic cup formation, but the expression of 
Pax6, Rax and Six3 persists in the optic vesicle (Hagglund et al., 2011) (Tetreault et al., 2009). 
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The maintenance of Pax6 in Lhx2-/- mutants, and the maintenance of Lhx2 in Pax6Sey/Sey mutants, 
suggests that these two EFTFs are independently essential but separately insufficient for proper 
eye development (Porter et al., 1997). Moreover, Pax6 may cooperate with Lhx2 to induce the 
expression of Six6, a retinal determinant gene, in the optic vesicle (Tetreault et al., 2009).  
b. Rax 
Like the Sey mouse line, the spontaneous mutant mouse strain eyeless, first discovered 
in the 1940s, carries a hypomorphic mutation in the Rax (retina and anterior neural fold 
homeobox) locus (Chase, 1944; Tucker et al., 2001). Mutations in human RAX are associated 
with anophthalmia (Hanson et al., 1993; Voronina et al., 2004).  The role of RAX has been 
further elucidated using mouse model systems where it was shown that Rax-/- mice fail to 
upregulate EFTF expression in the presumptive eye field and do not develop optic vesicles 
(Grindley et al., 1995; Mathers et al., 1997; Zhang et al., 2000). In chimeric mice containing wild-
type and Rax-/- cells, the Rax-negative cells segregate together and are never found in eye field-
derived tissues. This result suggests that RAX is involved in the sorting of cells to form a distinct 
eye territory, perhaps through the action of cell surface molecules (Medina-Martinez et al., 
2009). Conversely, overexpression of Rax in mouse embryonic stem cells co-cultured with a host 
retina promotes retinal cell fates (Tabata et al., 2004).  
c. Six3 
Six3 encodes a homeobox-containing transcription factor homologous to the Drosophila 
sine oculis gene (Oliver et al., 1995). Genetic inactivation of Six3 in presumptive eye tissue has 
demonstrated that it is essential for eye development in mammals (Liu et al., 2010; Marquardt 
et al., 2001). Conditional inactivation of Six3 in the eye field abrogates neural retina 
development, while misexpression of Six3 in the midbrain-hindbrain region of mouse embryos 
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causes ectopic optic vesicles (Lagutin et al., 2001; Liu et al., 2010). Mutations in human SIX3 are 
associated with holoprosencephaly, or a failure of the cerebral hemispheres to separate 
(described below) (Geng et al., 2008).  
These studies collectively illustrate the importance of the EFTFs in regulating the 
network of events that control early eye development, from the specification of the eye field to 
the maintenance of progenitor multipotency. 
Division of the eye field 
Developmental biologists working in the 1920s observed that both eyes arise from a 
single eye field that is divided into bilateral hemispheres (Adelmann, 1929; Li et al., 1997; 
Mangold, 1931). At least two molecules have been clearly demonstrated to be involved in this 
morphogenetic process. The first is sonic hedgehog (Shh), which is expressed in the ventral 
forebrain and prechordal mesoderm (Echelard et al., 1993). Targeted disruption of Shh in mice 
results in the failure of the eye field to split, resulting in cyclopia and a single Pax6-positive optic 
vesicle (Chiang et al., 1996). The second player is Six3, which is expressed throughout the 
anterior neural ectoderm before becoming restricted to the ventral forebrain and eye field 
(Oliver et al., 1995). In humans, loss-of-function mutations in either SHH or SIX3 result in midline 
defects that frequently include cyclopia (Belloni et al., 1996; Muenke and Cohen, 2000; Roessler 
et al., 1996). In fact, SIX3 was shown to regulate Shh expression in the ventral midline of the 
rostral diencephalon via an upstream enhancer element (Geng et al., 2008; Jeong et al., 2008).  
Establishing boundaries in the optic vesicle 
Ocular development begins with the formation of the optic vesicles. From E8.5-9.0 of 
mouse development, the walls of the diencephalon evaginate (the optic vesicles) and come into 
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close contact with the surface ectoderm (Figure 1-1D) where the lens placode is formed. Each 
optic vesicle (OV) consists of the retinal stem cells (RSCs) that give rise to all neuroectoderm-
derived cells of the eye. RSC patterning occurs along the dorso-distal/proximal-ventral axis of 
the OV prior optic cup formation. Regions along this axis correspond to the presumptive neural 
retina (NR -- distal OV), retinal pigment epithelium (RPE -- dorsal/proximal OV) and optic stalk 
(OS -- ventral/proximal OV) (Figure 1-3, Figure 1-4A).  
Several cell-intrinsic signaling pathways are involved in patterning the OV. Each 
compartment of the OV expresses a specific set of transcription factors that are important for 
the development of the cell type in which they are expressed. The presumptive neural retina 
specifically expresses the homeodomain protein Vsx2 (formerly Chx10), the future RPE 
expresses the basic helix-loop-helix transcription factor Mitf and the prospective OS expresses 
the paired domain protein Pax2 (Hodgkinson et al., 1993; Liu et al., 1994; Nornes et al., 1990). 
SOX2 is maintained in the prospective NR and OS but is down-regulated in the prospective RPE. 
There is evidence to suggest that OTX2 directly represses SOX2 in the RPE (Nishihara et al., 
2012). Many studies have revealed that Vsx2, Mitf and Pax2, in combination with the EFTFs, 
have cell intrinsic roles in compartmentalizing the future optic cup, often through reciprocal 
transcriptional repression of one another (Figure 1-3). Collectively, these studies also suggest 
that the RSCs of the OV are competent to become NR, RPE or OS when provided with the 
appropriate combination of signals.  
Neural retina versus retinal pigment epithelium versus optic stalk 
Mutual antagonism between Vsx2 and Mitf serves to establish the boundary between 
the future NR and RPE (Horsford et al., 2005; Nguyen and Arnheiter, 2000). Mitf is initially 
expressed throughout the dorsal OV but becomes down-regulated distally upon the expression 
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of Vsx2 (Nguyen and Arnheiter, 2000). The function of Mitf in boundary formation is supported 
by the observation that mice with loss of function mutations in Mitf exhibit a conversion of RPE 
to NR (Bumsted and Barnstable, 2000; Nguyen and Arnheiter, 2000). A similar RPE-to-NR 
conversion phenotype occurs in mice that are deficient in both Otx1 and Otx2, transcription 
factors that are normally expressed in the dorsal OV/presumptive RPE (Martinez-Morales et al., 
2001).  Conversely, mice with loss-of-function mutations in Vsx2, termed orJ or ocular 
retardation mice, exhibit ectopic expression of Mitf and Mitf target genes in the NR. Fate 
mapping analyses suggest that this phenotype is a direct transdifferentiation of the neural retina 
to RPE (Horsford et al., 2005; Rowan et al., 2004).  
A similar antagonistic relationship exists between Pax2 and Pax6. Pax2-/- mice exhibit 
ventral expansion of the Pax6 expression domain and subsequent expansion of the NR and RPE 
at the expense of the OS (Schwarz et al., 2000). Conversely, Pax6-deficient mice exhibit a dorsal 
expansion of the Pax2 expression domain and fail to develop a neural retina or RPE, maintaining 
only the Pax2-positive optic stalk. This reciprocally repressive relationship appears to involve a 
direct molecular interaction, as PAX2 can bind the Pax6 retina-specific enhancer, , (Figure 1-
4A), and PAX6 can bind the Pax2 OS-specific enhancer (Schwarz et al., 2000). Similarly, humans 
with PAX2 mutations have optic nerve coloboma caused by the failure of the ventral optic 
fissure to properly close during development (Torres et al., 1996). Therefore, Pax2 and Pax6 
likely establish the boundary between the optic stalk and the neural retina through mutual 
repression of one another. 
The EFTF Lhx2 appears to act upstream of the above described genetic interactions. In 
Lhx2 loss-of-function mutants, the OV fails to become regionalized, exhibiting ventral expansion 
of Pax6 but lacking Vsx2, Mitf and Pax2 (Yun et al., 2009). However, in embryos with specific 
   9 
ablation of Lhx2 in the eye field, Pax2 expression persists in the ventral optic vesicle, but Mitf is 
downregulated, and Vsx2 is absent (Hagglund et al., 2011).  
Signaling networks in the optic vesicle 
Adding complexity to the system of early eye development is the understanding that 
these cell intrinsic transcription factors modulate extrinsic signals to functionally 
compartmentalize the OV. The extrinsic pathways involved in OV patterning include BMP, FGF, 
Wnt and Sonic Hedgehog signaling. Early Lhx2 activity, for instance, is required to transduce 
BMP7 to activate Pax2 expression in the ventral OV, while later in development, Lhx2 is required 
to maintain BMP4 expression in the OV (Yun et al., 2009). Similarly, FGF1 or FGF2 from the 
surface ectoderm activates Vsx2 in the presumptive NR, which in turn represses Mitf (Horsford 
et al., 2005; Nguyen and Arnheiter, 2000).  
FGF9, which is normally confined to the distal OV, promotes NR fate when ectopically 
expressed in the presumptive RPE, and mice with targeted deletion of Fgf9 exhibit expansion of 
the RPE into the NR domain (Zhao et al., 2001). Moreover, OV-specific deletion of the protein 
phospatase Shp2, which mediates the FGF signaling cascade via sustained activation of Ras, 
causes a cell fate conversion from NR to RPE (Cai et al., 2010). Conversely, inactivation of 
canonical Wnt signaling in the presumptive RPE causes it to transdifferentiate to NR 
(Westenskow et al., 2009). Lastly, in addition to its role in splitting the eye field, midline-
secreted Shh plays an additional role in ventralizing the OV.  The optic vesicle of Shh mutant 
mice shows expanded Pax6 expression at the expense of Pax2, while Otx2, a presumptive RPE 
(dorsal) marker, persists in the cyclopic Shh mutant eye (Chiang et al., 1996).  
Humans with mutations in some of these genes exhibit ocular malformations. Mutations 
in BMP4, for instance, have been described in patients with anophthalmia/microphthalmia, 
   10 
coloboma and retinal dystrophy (Hayashi et al., 2008). Similarly, mutations in VSX2 are 
associated with microphthalmia, iris abnormalities, coloboma and retinal dystrophy (Ferda 
Percin et al., 2000; Iseri et al., 2010). Although rare in comparison to cyclopia, 
anopthalmia/microphthalmia and coloboma can result from mutations in human SHH (Bakrania 
et al., 2010). 
Optic cup morphogenesis 
After the formation of the OV, a coordinated invagination of the lens placode and the 
OV forms the lens vesicle and the bi-layered optic cup (OC) (Figure 1-1B, C, E, F). The OV folds 
into itself creating two nested cups; the distal OV becomes the inner layer of the OC -- the 
presumptive NR -- while the proximal OV becomes the outer layer of the OC -- the presumptive 
RPE (Figure 1-1F, Figure 4B). An additional invagination occurs in the ventral OV where the optic 
stalk meets the ventral retina to generate the optic or choroidal fissure (Figure 1-4B). The optic 
fissure provides an exit for retinal axons and an entrance for the hyaloid artery, which supplies 
blood to the retina (Saint-Geniez and D'Amore, 2004). The OC grows circumferentially until it 
closes over the optic fissure (Figure 1-4C).  
Crosstalk between the presumptive lens and retina may be necessary for the proper 
invagination of these tissues in vivo (Ashery-Padan et al., 2000; Bassett et al., 2010; Grindley et 
al., 1995; Smith et al., 2009). SOX2 is expressed in both of these tissues and is necessary for their 
specification (discussed further in Chapter 3). The optic vesicle and lens placode are tightly 
apposed at the initiation of OV invagination. However, the necessity of the presence of the lens 
placode for the formation of the two-walled optic cup remains unclear. A recent study used 
three-dimensional culture of mouse embryonic stem cell aggregates to derive hollowed spheres 
of neuroepithelium containing Rax-positive domains. Many of these regions spontaneously 
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invaginated, in the absence of a lens or ectodermal tissues, to form the optic cup (Eiraku et al., 
2011). This autonomous morphogenetic process appeared to be driven by forces within the 
retinal anlage, suggesting that, at least in vitro, the OV can form the OC without instruction from 
other structures (Eiraku et al., 2011). This finding is relevant to the cell-autonomous role of 
SOX2 in patterning the OC independently of lens-derived signals (discussed in Chapter II). 
Conversely, the apposition of the lens placode and the OV appears to be important for 
placode invagination. The LP arises from the preplacodal region (PPR), an ectoderm-derived 
bilateral structure that forms discrete thickenings called placodes, the precursors to various 
vertebrate sensory structures (Streit, 2007).  The LP is identified as the group of thickened 
columnar cells in the head surface ectoderm that arises in response to OV proximity. The LP and 
OV become physically tethered through cytoplasmic processes, or filopodia, originating from the 
base of the lens (Chauhan et al., 2009).The LP invaginates to form the lens cup or lens pit which 
eventually separates from the surface ectoderm to form the lens vesicle (Graw, 2010).  
Placode thickening is associated with local changes in cell shape without associated 
changes in cell volume. LP formation appears to be mediated by adhesion between the optic 
vesicle and the surface ectoderm, where lens precursors continue to proliferate but cannot 
expand beyond the region of adhesion (Hendrix and Zwaan, 1975; Huang et al., 2011). The 
increase in cell number in this fixed area is sufficient to account for the increase in cell length 
observed during placode formation (Hendrix and Zwaan, 1975). Adhesion between the optic 
vesicle and the surface ectoderm is mediated by the extracellular matrix protein fibronectin1 
(fn1) (Huang et al., 2011). Indeed, fn1 expression is lost when Pax6, a master regulator of lens 
development, is deleted in the surface ectoderm (Huang et al., 2011) (Figure 1-5). 
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Lens and cornea 
In addition to Pax6, several other transcriptional regulators are important for lens 
specification. Six3 and Sox2, for example, are both essential for proper lens development. Six3 
expression precedes that of Pax6 in the presumptive lens ectoderm and activates Pax6 
transcription (Liu et al., 2006b). While Sox2 expression in the LP is induced by signals from the 
OV, it may also be mediated by SIX3 in the surface ectoderm (Furuta and Hogan, 1998; Kamachi 
et al., 1998). Thus, much like the cell-intrinsic regulation of OV patterning, transcription factors 
involved in lens induction transduce signaling cascades to activate downstream targets. One 
such signal is BMP4 from the OV, which may activate Sox2 but not Pax6 expression in the LP. 
Another is BMP7 in the head ectoderm, which may activate Pax6 expression in the LP (Furuta 
and Hogan, 1998; Wawersik et al., 1999).  
SOX2 and PAX6 also function in cross- and self- regulatory feedback loops in lens 
development. Sustained Sox2 expression appears to depend on PAX6 only after lens placode 
stages (Ashery-Padan et al., 2000; Smith et al., 2009). Moreover, SOX2 cooperates with PAX6 in 
its own upregulation in lens precursor cells via the N3 enhancer upstream of the Sox2 coding 
sequence (Inoue et al., 2007). Likewise, PAX6 and SOX2 synergistically activate Pax6 expression 
via the head surface ectoderm enhancer element LE9 (Aota et al., 2003). SOX2 and PAX6 may 
also co-regulate other genes important for lens development, such as those encoding lens 
crystallins (Kamachi et al., 1998; Kamachi et al., 2001). The relationship between SOX2 and PAX6 
in lens development is consistent with a strong genetic interaction in optic cup development, as 
described in detail in Chapter II. 
The lens vesicle remains transiently attached to the surface ectoderm via the lens stalk. 
Once detached from the lens, the surface ectoderm proliferates to restore the exterior, 
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eventually giving rise to the corneal epithelium. The corneal endothelium is composed of 
migrated forebrain and midbrain neural crest-derived mesenchymal cells (Kanakubo et al., 2006; 
Trainor and Tam, 1995). These cells invade the newly formed space between the lens vesicle 
and the surface ectoderm and condense into a multilayered structure connected by a loose 
extracellular matrix. The cells between the corneal epithelium and endothelium differentiate 
into karatocytes and make up the corneal stroma (Cvekl and Tamm, 2004). The space between 
the future cornea and lens, called the anterior chamber, becomes fluid filled. A second group of 
mesenchymal cells migrates into the angle between the presumptive cornea and peripheral 
edge of the optic cup to become the stroma of the iris and ciliary body (described below). 
Around the same time that mesenchymal cells migrate into the future cornea (E11.5), other 
POM cells invade the space between the lens and the retina, called the hyaloid, giving rise to the 
hyaloid vasculature (Gage et al., 2005) 
Axes in the neural retina 
The inner layer of the OC, which gives rise to the neural retina, is patterned along its 
dorsal-ventral (D-V) and nasal-temporal (N-T) axes (Figure 1-6). By E10.5, the optic stalk (ventral) 
has begun to elongate and will eventually give rise to the optic nerve. The axons of retinal 
ganglion cells from the innermost layer of the NR begin to enter the optic stalk around E11.5 
and intersperse with the PAX2-positive optic stalk cells, the glial precursors that will develop 
into the astrocytes that make up the mature optic nerve (Torres et al., 1996).   
Proper optic nerve placement depends on signals that pattern the OC along the D-V axis. 
These signals are mediated in part by members of the VAX family of homeodomain transcription 
factors. At E13.5, Vax1 is expressed in the optic stalk, while Vax2 exhibits a steep ventralhigh-to-
dorsallow gradient of expression (Mui et al., 2002; Mui et al., 2005). Both Vax1 and Vax2 are 
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expressed in the optic stalk and ventral retina from E9.5 to E11.5, which may explain why Vax1-/; 
Vax2-/- double mutant mice exhibit severe ventral eye defects. The optic stalk of these mice 
becomes dorsalized, developing into RPE and NR instead of optic nerve (Mui et al., 2005). In 
vitro and in vivo data suggest that VAX1 and VAX2 cooperatively specify the ventral optic cup 
and optic stalk by directly repressing Pax6 expression via the Pax6 retina-specific 
enhancer(Mui et al., 2005). Conversely, the T-box transcription factor Tbx5, a BMP4 target, is 
normally expressed in the dorsal NR (Behesti et al., 2006). Its expression is lost when Pax6 is 
ablated from the developing NR, further demonstrating Pax6’s role in specifying the dorsal OC 
(Baumer et al., 2002; Behesti et al., 2006). These genetic studies illustrate the precise regulation 
of PAX6 localization in the OC, which in turn helps to establish the dorsal-ventral axis.  
N-T patterning of the optic cup ensures that the axons of retinal ganglion cells will 
correctly map to their targets in the superior colliculus (SC) and the dorsal lateral geniculate 
nucleus (dLGN). In mammals, axons from the nasal retina project to the caudal SC, and axons 
from the temporal retina project to the rostral SC. The earliest transcriptional regulators of N-T 
identity in the OC are the forkhead transcription factors FOXD1 (BF-2) and FOXG1 (BF-1). Foxg1 
is expressed in the nasal retina, but appears to play an additional role in D-V patterning, as 
Foxg1-/- mutants lose Shh signaling and have dorsalized optic vesicles (Huh et al., 1999). 
However, Foxd1 functions in N-T patterning to specify the retinal ganglion cells (RGCs) of the 
temporal retina (Carreres et al., 2011). Indeed, RGCs of Foxd1-/- mutants lose topographic 
specificity, mapping indiscriminately to the entire extent of the SC (Carreres et al., 2011). 
Expression of both Foxd1 and Foxg1 is lost in Pax6-/- mutants, demonstrating an additional role 
for PAX6 in establishing the naso-temporal region of the retina (Baumer et al., 2002).   
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Ciliary body and iris 
A third axis along which the OC is patterned is the central-peripheral axis (Figure 1-4D, 
Figure 1-6). The distal tip of the OC, where the presumptive NR meets the RPE, is termed the 
“ciliary margin” in mice and contains non-neurogenic progenitors that give rise to the epithelia 
of the ciliary body (CB) and iris (Beebe, 1986; Davis-Silberman and Ashery-Padan, 2008). The CB 
epithelia are continuous with the RPE and NR, while the iris epithelia are distal to the CB. The 
outer layer of the ciliary margin gives rise to the pigmented epithelium of the CB and the 
anterior pigmented layer of the iris, whereas the inner layer gives rise to the non-pigmented 
epithelium of the CB (herein referred to as the ciliary epithelium or CE) and the posterior 
pigmented layer of the iris. Non-neurogenic progenitor cells of the optic cup margin can be 
identified as early as E12.5 by their specific expression of transcription factors, including Msx1 
and Otx1, lack of expression of neuronal markers and a slower proliferation rate relative to the 
NR (Beebe, 1986; Cho and Cepko, 2006; Martinez-Morales et al., 2001; Monaghan et al., 1991; 
Trimarchi et al., 2009). Indeed, CB development is absent in mice that lack Otx1 (Acampora et 
al., 1996).  
Several cell-intrinsic and extrinsic pathways have been identified to play a role in 
specifying the ciliary margin in mammals. CE-specific genes can be induced in embryonic mouse 
retina when cultured adjacent to an explanted chick lens (Thut et al., 2001). The inductive power 
of the lens may in part involve BMP signaling, as transgenic expression of the BMP antagonist 
Noggin in the developing mouse lens abrogates expression of Bmp4 and Bmp7 in the 
presumptive CE at postnatal stages (Zhao et al., 2002). Without BMP signaling, the CE-specific 
genes Otx1 and Msx1 fail to be expressed, and neural retinal cells develop in place of the CB 
after birth (Zhao et al., 2002). 
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The appearance of the NR at the expense of the CE in the BMP-deficient ciliary margin 
suggests that progenitor cells at the boundary of the NR and CE remain competent to take on 
one fate or the other after these tissues have begun to be specified. Transcriptional control of 
this binary cell fate decision is mediated by SOX2 and PAX6 (Figure 1-4D). This relationship is 
discussed at length in Chapter III. Briefly, in the early optic cup, SOX2 and PAX6 exhibit inverse 
gradients of expression, with SOX2 high in the central OC but low in the periphery where PAX6 is 
maintained at a high level due in part to its retina-specific enhancer(Baumer et al., 2002; 
Matsushima et al., 2011). Specific ablation of SOX2 in OC progenitor cells results in elevated 
Pax6 expression and cell fate conversion from NR to CE, a phenotype described in detail in 
Chapter II. (Matsushima et al., 2011). This cell fate conversion can be partially rescued by 
reducing Pax6 (Matsushima et al., 2011). Indeed, several studies have demonstrated the 
importance of PAX6 to the development of the ciliary margin. Mice that are haplo-insufficient 
for Pax6 exhibit reduced ciliary margin size, and humans with mutations in PAX6 have aniridia 
(no iris) and small ciliary bodies (Davis-Silberman et al., 2005; Hanson et al., 1993; Okamoto et 
al., 2004). Further evidence suggests that Wnt signaling plays a role in specifying CE fate. 
Activated Wnt signaling in the peripheral NR induces expression of CE-specific genes (Liu et al., 
2007b). Moreover, the NR-to-CE cell fate conversion caused by the loss of SOX2 is associated 
with centrally expanded Wnt signaling prior to the ectopic expression of CE genes (Matsushima 
et al., 2011). Chapter IV focuses on the genetic relationship between SOX2 and Wnt signaling in 
OC patterning and CE fate specification.  
Retinal neurogenesis 
Retinal Progenitor Cells (RPCs) are established in the optic vesicle as early as E9.0, each 
giving rise to a clone of more than 1000 post-mitotic neural retina cells (Goldowitz et al., 1996). 
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Neurogenesis in the retina proceeds in an ordered and predictable fashion, beginning in the 
central optic cup and moving toward the periphery. Specification of RPC fate is coordinated with 
cell cycle exit to generate the correct numbers and types of neurons that make up the mature 
retina. Neuronal differentiation begins at E11.0 and cell types are generated in overlapping 
phases, beginning with retinal ganglion cells (RGCs), which are the projection neurons of the 
retina. The initiation of RGC production is followed in succession by horizontal interneurons, 
cone photoreceptors and amacrine interneurons in an early wave of neurogenesis (E11.0 – 
E18.0). A temporal switch in RPC competence then produces rod photoreceptors, bipolar 
interneurons and Muller glial cells in a late wave of neurogenesis (P0 – P7) (Young, 1985).  
The architecture of the mature retina is as follows: The cell bodies of rod and cone 
photoreceptors are localized to the apical side of the retina in a layer abutting the RPE known as 
the outer nuclear layer (ONL). Just basal to the ONL is the inner nuclear layer (INL), which 
contains the cell bodies of the retinal interneurons -- the bipolar, amacrine and horizontal cells – 
as well as the cell bodies of the Muller glia. The ganglion cells are located in the ganglion cell 
layer (GCL) on the basal side of the retina, nearest to the lens. Separating the ONL and the INL is 
the outer plexiform layer (OPL) where photoreceptors synapse onto horizontal cells and bipolar 
cells. The more elaborate inner plexiform layer (IPL) is located between the INL and the GCL and 
contains the dendrites of amacrine cells and RGCs (Figure 1-7). All together, this structure 
illustrates the first neurological steps of visual processing: the photoreceptors receive light input 
and transmit the signal through bipolar cells, whose axons terminate in the IPL, where RGCs 
then transmit the signal to visual processing centers in the brain. SOX2 expression remains only 
in a subset of amacrine cells and in the Muller glia (Surzenko et al., 2013) (Figure 1-7). 
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A number of transcription factors that regulate RPC fate decisions have been identified. 
These are members of the homeodomain family or bHLH family of transcription factors. (Figure 
1-7). The homeodomain transcription factors include those that are expressed in the forebrain 
and eye field (OTX2, RAX, SIX3, SIX6, PAX6 and LHX2) as well as those that are expressed early in 
the prospective retina (VSX2) or play a role in specifying retinal subtypes (PROX1, CRX, LHX1, 
DLX1 and BRN3). The bHLH factors include repressors of neuronal differentiation, HES1 and 
HES5, and activators of neuronal differentiation, including the Atonal homologs MATH5, MATH3 
and NEUROD and the Acheate-Schute homologs NGN2 and MASH1. RPCs that express one or a 
combination of these bHLH factors are biased toward a particular cell fate (Hatakeyama and 
Kageyama, 2004). Achaete-Schute homologs generally play dual roles in regulating the onset of 
differentiation and cell fate specification. Similarly, atonal homologs are expressed in RPCs at 
the onset of neuronal differentiation and often identify the fate of the progenitor cell. MATH5 
expression in early RPCs, for example, predicts RGC development, while NEUROD and MATH3 
each predict amacrine cell development. Late RPCs are competent to give rise to bipolar cells or 
Muller glia. Math3 or Mash1 expression in these cells predicts bipolar fate (Hatakeyama et al., 
2001). Homeodomain and bHLH factors can also act in combination to specify cell fate, with the 
former regulating layer specificity and the latter regulating subtype within the layer 
(Hatakeyama and Kageyama, 2004).   
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Neural Induction 
The development of the central nervous system (CNS) in vertebrates begins with neural 
induction, or the process in which an ectodermal cell is specified as neural (neural plate) or non-
neural (epidermis). The mechanisms directing this cell fate decision have come to be understood 
primarily through experiments using gastrulating frog and chick embryos. Nonetheless, certain 
neural induction paradigms hold true for mammals as well: secreted factors, namely BMPs and 
FGFs, specify whether an ectoderm progenitor cell maintains neural competence, becoming 
neural plate, or acquires epithelial identity, thus losing neurogenic capacity (Delaune et al., 
2005; Hemmati-Brivanlou and Melton, 1997; Kuroda et al., 2005; Linker and Stern, 2004; 
Reversade et al., 2005; Stern, 2006; Wawersik et al., 2005; Wills et al., 2010).  
Neural development in mice 
At E5, the mouse embryo consists of two layers, the primitive endoderm and the 
epiblast. The epiblast gives rise to all the cells of the adult mouse. The naïve state of the epiblast 
is ectoderm. Gastrulation begins at E6.5 when the ectoderm invaginates to produce the 
primitive streak, which moves anteriorly to produce the mesoderm and endoderm. The anterior 
end of the primitive streak is the organizing center or node, which secretes signals important for 
specifying neural progenitor cells, which arise from the anterior distal tip of the ectoderm 
(Zernicka-Goetz, 2002). Nodal signaling from the primitive streak stabilizes the epiblast state, 
while Nodal antagonists expressed from the anterior visceral endoderm (AVE), an 
extraembryonic tissue, disrupt Nodal signaling. The earliest derivative of the mouse epiblast is 
the anterior neural plate (ANP). It is thought that Nodal, a member of the TGFfamily, functions 
to specify the AVE, which in turn functions to specify anterior identity in the adjacent epiblast 
through secretion of the Nodal antagonists Lefty, Cerberus-like and Dickkopf1 (Brennan et al., 
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2001; Perea-Gomez et al., 2001). In the absence of Nodal, epiblasts ectopically express neural 
plate markers, including Sox1 and Hesx1, suggesting that Nodal antagonizes neural fate (Camus 
et al., 2006).  
The default model 
The classical model of neural induction predicts that neural is the default or ground 
state of the ectoderm (Hemmati-Brivanlou and Melton, 1997; Weinstein and Hemmati-
Brivanlou, 1999). Mouse embryonic stem (ES) cells develop into neural progenitor cells (NPCs) 
without the addition of exogenous factors (Ying and Smith, 2003). The anterior ectoderm of the 
mouse will express neural genes in the absence of Nodal (Camus et al., 2006). Similarly, cultured 
Xenopus ectodermal explants, which express BMP4, develop into epidermis when kept intact, 
but become neural when dissociated. Non-neural fate in these cells can be rescued with the 
addition of BMP4. Moreover, intact explants become neural with the addition of BMP inhibitors 
(Munoz-Sanjuan and Brivanlou, 2002). These experiments informed the idea that ectoderm 
becomes epidermis in response to BMP signals and neural plate -- “by default” -- when BMP 
signals are inhibited. 
According to this model, non-neural fate must thus be imposed upon the ectoderm. 
Nodal-deficient tissues exhibit little-to-no BMP and Wnt activity, suggesting that all three of 
these pathways are inhibited during anterior neural fate specification. In other words, Nodal, 
BMP and/or WNT must be active for non-neural fate to be specified (Camus et al., 2006). In 
Xenopus, BMP signaling through BMP receptor (BMPR)-mediated activation of the transcription 
factor SMAD1 promotes non-neural fate. The BMP antagonists Noggin, Chordin and Follistatin 
collectively prevent BMPR from phosphorylating SMAD1, thus allowing the ectoderm to 
generate neural plate. These extracellular signals are produced by Spemann’s organizer, a region 
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of the dorsal mesoderm that is thought to maintain neural fate in the ectoderm (Reviewed in 
(De Robertis and Kuroda, 2004)).  
However, numerous studies have suggested that the default model is an over-
simplification of neural induction. For one, it does not fully explain neural fate specification in 
avian embryos. In chicks, the organizer is sufficient for neural fate, but BMP inhibition is not; 
only cells at the border of neural and non-neural ectoderm are competent to respond to BMP 
inhibition, suggesting that these cells are exposed to additional neural-provoking cues (Streit et 
al., 1998; Streit and Stern, 1999). Similarly, BMP inhibition is sufficient to suppress epidermis but 
insufficient to induce neural fate in regions of the ectoderm distant from the endogenous neural 
plate (Delaune et al., 2005). Experiments in Xenopus suggest that FGF and IGF, which are potent 
inducers of neural fate, may be required for neural ectoderm specification and are potential 
candidates for “neural-inducing cues” (Hardcastle and Papalopulu, 2000; Pera et al., 2001; Streit 
et al., 2000; Wilson et al., 2000). These growth factors function through SMAD1 regulation as 
well: activation of MAPK by FGF or IGF phosphorylates SMAD1 in a highly conserved linker 
region, inhibiting its neural-antagonizing ability. Mutation of the target serines in this linker 
region results in a strongly ventralized embryo, indicating loss of neural fate. Conversely, BMPR 
phosphorylates the C-terminus of SMAD1. Mutating these C-terminus serine residues in addition 
to those in the linker region rescues ventralization, demonstrating that BMPR activity is required 
to antagonize neural fate (Pera et al., 2003). Therefore, a fine balance between FGF, IGF and 
BMP signaling regulates neural ectoderm development via SMAD1.  
The roles of BMP and FGF signaling differ between mammals and lower vertebrates. In 
Xenopus, as described above, neural induction requires both BMP inhibition by Chordin and the 
combined activity of FGF and IGF. Over-expression of Chordin, Fgf or Igf alone can expand the 
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neural plate, induce ectopic sensory neurons and suppress epidermal genes while inducing 
anterior neural genes. Moreover, constitutive activation of BMPR in a dorsal animal blastomere 
of Xenopus embryos suppresses neural fate, resulting in loss of Sox2 and Sox3, and induces 
epidermis, expressing cytokeratin81 (Delaune et al., 2005). Likewise, inhibition of FGF signaling 
by mutation of the SMAD1 linker region results in loss of neural fate (Pera et al., 2003). In mouse 
embryos, however, the role of SMAD1 is more complex. Mutation of the linker region does not 
abrogate neural fate. Rather, mice with targeted disruption of these SMAD1 sites exhibit defects 
of the gastric epithelium and actin cytoskeleton (Aubin et al., 2004). This relatively mild 
phenotype may be due to the compensatory function of SMADs 5 and 8. Nonetheless, the 
regulation of neural fate in mammals is exceedingly more complex than in lower vertebrates. 
And despite the evolutionary conservation of neural induction genes throughout all vertebrates, 
further investigation into the function of these genes in mammals is needed.  
WNT signaling and neural induction 
The studies described above demonstrate that BMP and FGF signaling converge at the 
regulation of SMAD1 activity and have opposing effects on neural fate. In chick embryos, 
however, activation of FGF alone or in combination with BMP antagonists is insufficient to 
induce neural fate. Indeed, even in Xenopus, complete removal of Smad1 only results in a mild 
ventralization phenotype, suggesting that additional pathways are required for neural induction. 
A third pathway implicated in neural induction is WNT/-Catenin signaling. WNTs are secreted 
glycoproteins that bind transmembrane Frizzled receptors, initiating a signaling cascade that 
culminates in the de-repression of -CATENIN, a transcription factor that complexes with 
members of the TCF/LEF family of transcription factors to regulate the expression of target 
genes (Nusse, 2012).  
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WNTs are generally thought to promote non-neural fate in the ectoderm or epiblast: 
WNT signaling must be inhibited for mouse ESCs to become neural, and antagonism of WNT and 
Nodal signaling increases generation of telencephalic (neural) precursors (Aubert et al., 2002; 
Watanabe et al., 2005). Conversely, WNT1 and lithium chloride, which stimulates WNT signaling, 
can inhibit neural fate in mouse ESCs. In the chick epiblast, Wnt signaling can block the ability of 
ectoderm cells to respond to FGF, and antagonism of Wnt signaling permits cells to respond to 
FGF, placing WNTs at the hinge of BMP and FGF antagonism (Wilson et al., 2001). In contrast to 
its role as an antagonist of anterior neural fate, WNT signaling has been demonstrated to 
regulate posterior neural plate development in mice through direct activation of the Sox2 
enhancer N-1 (Takemoto et al., 2006). This study provides a direct link between WNT signaling 
and SOXB1 factors in neural fate specification, and thus begins to piece together the relationship 
between cell-extrinsic signaling molecules and cell-intrinsic gene expression. 
The roles of SOXB1 factors in neural induction 
Little is known about the transcriptional regulation of neural induction. Members of the 
SOXB1 family of transcription factors are highly conserved early makers of neural fate in many 
species from Drosophila (Ma et al., 1998; Nambu and Nambu, 1996; Soriano and Russell, 1998) 
to fish (Vriz et al., 1996) and avians (Uwanogho et al., 1995) (Figure1-9). In chick embryos, SOX2 
is expressed in pre-gastrula cells that are competent to undergo neural induction upon node 
transplantation (Streit et al., 1997). Similarly, in Xenopus, SOX2 is a specific early readout of 
neural identity (Mizuseki et al., 1998). BMP antagonists, including Chordin, induce SOX2 
expression, and SOX2 synergizes with FGF signaling to initiate neural fate (Mizuseki et al., 1998). 
Moreover, inhibition of SOX2 function combined with expression of a dominant negative BMPR 
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in animal caps prevented neural induction, but SOX2 expression itself was unaffected (Kishi et 
al., 2000).  
These experiments prompted further investigation into the role of SOXB1 genes in 
neural induction and questioned the use of SOX genes as definitive neural markers. -Catenin-
depleted Xenopus embryos become ventralized and lack an organizer, thus de-repressing BMP 
signaling. Sox2 is still expressed around the blastopore lip of these embryos, but a neural plate 
never forms, and Sox2-positive cells never give rise to neurons, which are identified by the 
expression of -tubulin and neural cell adhesion marker (NCAM). Moreover, Sox2 expression 
disappears with the addition of an inhibitor of FGF receptor. Sox2 therefore appears to be 
regulated by FGF signaling, but the presence of Sox2 does not definitively mark neurogenic 
tissue, leading some investigators to think of SOX2 as “pre-neural.” Conversely, BMP antagonists 
induce SOX2 expression, even in the absence of FGF signaling, and these SOX2-positive cells do 
give rise to neurons. SOX2 expression is lost in the absence of BMP antagonists, and epidermis 
develops at the expense of neural plate. Together, these results support three conclusions: 1) 
Even with the activation of BMP signaling, Sox2 is still expressed, but these cells never form 
neural ectoderm, thus supporting the default model of neural induction. 2) SOX2 is induced by 
both FGF signaling and BMP antagonism independently. 3) Either a more specific marker of 
neural ectoderm exists downstream of the organizer, or additional pathways are necessary for 
SOX2-positive cells to give rise to neurons -- perhaps -Catenin in this instance -- a conclusion 
that would render the “default model” still questionable (Wills et al., 2010). Indeed, SOX2 may 
indicate neural fate, rather than “pre-neural” fate, while BMP signaling inhibits neurogenesis 
(Figure 1-8A vs. B). The controversy, then, would be the definition of neural fate: is “neural” 
solely the ability to generate neurons, or does “neural” designate the population of non-
epidermal cells? 
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Direct inhibition of SOX2 signaling in early neurula stage Xenopus embryos prevents 
expression of early pan-neural markers but does not affect expression of dorsal BMP 
antagonists, nor does it induce epidermal markers (Kishi et al., 2000). This result suggests that 
SOX2 is necessary for neurogenesis but does not repress non-neural fate. However, one caveat 
of this experiment is that the SOX2-ablated ectoderm peels off at tailbud stages, perhaps not 
allowing enough time for non-neural markers to become up-regulated, but nonetheless 
implicating loss of cell adhesion properties. The loss of neural fate in Sox2-mutant ectoderm, 
without manipulating FGF signaling, further supports the conclusion that FGFs do not act as 
neural inducers per se, but rather maintain ectoderm in a neural-competent state (Hongo et al., 
1999). Collectively, results from studies of neural induction in Xenopus suggest that SOX2 is 
necessary but not sufficient to induce neural fate. 
In mice, SOX1 is the earliest neural ectoderm-specific marker, becoming expressed in 
the neural plate at around E7.75, coincident with neural induction (Pevny and Placzek, 2005; 
Pevny et al., 1998; Rex et al., 1997; Takemoto et al., 2006; Wood and Episkopou, 1999) (Figure 
1-9E). SOX2 and SOX3 expression precede gastrulation: SOX2 is expressed in the oocyte and 
inner cell mass of the blastula, and SOX3 expression initiates in the egg cylinder (Avilion et al., 
2003; Kamachi et al., 1998; Pevny and Placzek, 2005). Although it is difficult to manipulate SOX 
gene expression in mouse epiblasts, experiments in mouse ESCs give insight into the roles of 
these genes in neural induction, suggesting that they function similarly in mammals and lower 
vertebrates. Indeed, SOX1 and SOX2 over-expression in mouse ESCs induces neuroectoderm at 
the expense of mesoderm (Zhao et al., 2004). 
In human embryos, it is not a SOX gene, but PAX6 that is the definitive marker of neural 
plate identity (Zhang et al., 2010). In human embryonic stem cells, PAX6 expression is induced 
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when FGF and TGFb signaling are inhibited. Conversely, the presence of FGF2 inhibits PAX6 
expression, suggesting that FGF may have an opposite role in human neural induction than in 
that of lower vertebrates, maintaining cells in a self-renewing state rather than inducing neural 
fate. Indeed, pharmacological inhibition of SMAD2 but maintenance of FGF2 results in 
decreased NANOG and OCT4 but increased SOX2, reminiscent of early neuroectoderm 
formation. Without PAX6, however, these cells are not able to produce neural tissue and instead 
continue to cycle. FGF signaling may antagonize PAX6 expression in part via OCT4 and NANOG, 
which are found to occupy the Pax6 promoter. Moreover, OTX2 positively regulates PAX6 
expression in hESCs, and Otx2 up-regulation correlates with FGF inhibition. Therefore, in human 
embryos, FGF signaling may antagonize neural fate by promoting self-renewal genes, while 
OTX2 promotes neural fate by activating PAX6 (Greber et al., 2011). 
The roles of SOXB1 factors in neural progenitor cell fate  
In addition to regulating the early stages of neural fate, SOXB1 genes are implicated in 
neural progenitor cell (NPC) maintenance in embryos and adults. In mouse embryos, SOX2 is 
expressed in neuroblasts of the neural retina (Taranova et al., 2006), olfactory epithelium (Ellis 
et al., 2004) and inner ear sensory epithelium (Uchikawa et al., 1999). In adult mice, SOX2 is 
found in persistent progenitor cells of the subventricular zone of the later ventricles, the rostral 
migratory stream, the subgranular zone of the hippocampus and the ependyma surrounding the 
central canal of the spinal cord (Ellis et al., 2004). Persistent Sox2 expression is also found in 
supporting cells of the retina (the Muller Glia) and the auditory sensory epithelium (the inner 
pillar cells) (Liu et al., 2012; Surzenko et al., 2013). 
Although SOXB1 genes are necessary for proper specification and maintenance of NPCs, 
they become down-regulated in newly generated neurons. SOX2, for example, is expressed in a 
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ventralHI-dorsalLO gradient in the mouse neural tube consistent with neuronal differentiation, 
eventually becoming restricted to the ventricular zone (Graham et al., 2003). SOX1 may play a 
direct role in inducing neuronal differentiation. Over-expression of SOX1, but not SOX2 or SOX3, 
in E14.0 mouse telencephalon NPCs promotes cell cycle exit and doubles the number of 
differentiated neurons via activation of Neurogenin1 and suppression of TCF/LEF signaling and 
Hes1 expression (Kan et al., 2004). 
However, in chicks, overexpression of SOX2 retains neural progenitor cells in an 
undifferentiated proliferative state and decreases the number of cells in M-phase of the cell 
cycle (Bylund et al., 2003; Graham et al., 2003). Conversely, expression of a dominant-negative 
SOX2 results in premature cell cycle exit and down-regulation of other SOXB1 genes and 
induction of early but not late neuronal markers (Bylund et al., 2003; Graham et al., 2003). 
These data suggest that SOXB1 factors must be gradually down-regulated in order for neurons 
to properly differentiate. SOX3 has also been implicated in cell cycle regulation in Xenopus 
embryos, where it has been shown to promote proliferation of neuroectoderm cells via 
repression of the cell cycle inhibitor p27KIP1 (Hardcastle and Papalopulu, 2000). 
The function of SOXB1 proteins in neural progenitor cells is highly conserved. There are 
two SOXB1 homologs in Drosophila, SoxNeuro (SoxB1) and Dichaete (SoxB2-1) (Cremazy et al., 
2001) (Figure 1-9A). These are expressed in the early central nervous system of fly embryos and 
play crucial roles in neural development. SoxNeuro-deficient embryos exhibit neural hypoplasia 
(Overton et al., 2002), and Dichaete-deficient embryos suffer loss of midline structures and 
disorganization of the CNS (Nambu and Nambu, 1996; Russell et al., 1996). Double-mutants 
show severe neural hypoplasia throughout the CNS and loss of Achaete-positive proneural 
clusters (Buescher et al., 2002; Ma et al., 1998; Overton et al., 2002; Soriano and Russell, 1998). 
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SOXB1 transcriptional targets in neural progenitor cells 
SOX proteins are a subgroup of the Class II family of high mobility group (HMG)-
containing transcription factors. HMG proteins were initially identified as a cluster of chromatin 
non-histone proteins exhibiting high mobility in gel electrophoresis (Grosschedl et al., 1994). 
SOX genes are grouped based on their greater than 50% amino acid sequence homology to Sex-
Determining Region Y (SRY) (Bowles et al., 2000). The SOXB group shares over 85% homology of 
the HMG domain and consists of SOX1-3 -- the SOXB1 transcriptional activators -- and SOX14 
and SO21 -- the SOXB2 transcriptional repressors. SOX genes loosely recognize the DNA 
sequence T/A T/A GTTT T/A with low affinity in vitro (Kamachi et al., 1999). However, in vivo, 
SOX genes appear to bind DNA with strong affinity always in complex with co-regulatory 
proteins. 
Analysis of the secondary and tertiary structures of SOXB1 proteins reveals why these 
factors are often found in complex with other transcription factors and gives insight into how 
SOX genes exhibit striking tissue specificity. The HMG box consists of 70-80 amino acids in three 
 helices stabilized in an L-shaped configuration by two hydrophobic cores. An unfolded 
(randomly coiled) C-terminus binds DNA in the major groove, inducing a bend toward the minor 
groove and perhaps inducing the assembly of complex nucleoprotein structures on the DNA. 
Indeed, SOX genes are known for their ability to quickly switch gene expression, perhaps 
through changing the local confirmation of DNA (Bianchi and Beltrame, 2000) The SOXB1 
homology region is just C-terminal to the HMG domain and participates in protein-protein 
interactions (Kamachi et al., 1999; Uchikawa et al., 1999). The Serine/Threonine-rich C-terminus 
is required for transcriptional activation and can function independently of the SOX N-terminus 
when linked to a heterologous DNA-binding domain (Kamachi et al., 1999; Kamachi et al., 1995; 
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Uchikawa et al., 1999). The structure of SOX2 bound to DNA in complex with a POU-domain 
containing transcription factor has been predicted using X-ray crystallography (Remenyi et al., 
2003) and NMR (Williams et al., 2004). Circular dichroism of full-length SOX2 confirms the alpha 
helical structure of the N-terminus and largely unfolded nature of the C-terminus (Figure 1-10).  
There have been few well-characterized transcriptional targets of SOXB1 proteins in 
NPCs: SOX2 in coordination with BRN2 (POU3F2) can bind an enhancer element in the second 
intron of Nestin, and SOX1 can repress Hes1 expression through direct binding to its promoter 
(Kan et al., 2004). In mouse retinal progenitor cells, SOX2 can bind an intronic regulatory 
element of Notch1, and reintroduction of the Notch intracellular domain in Sox2-ablated Muller 
Glia partially rescues the gliotic phenotype (Surzenko et al., 2013; Taranova et al., 2006). A 
chromatin immunoprecipitation screen in ESCs identified a number of targets of the 
pluripotency factors OCT4, SOX2 and NANOG. In complex, these proteins bind DNA regulatory 
elements of Oct4, Sox2, Nanog, Stat3, Zic3, TDGF1, Lefty2, Ebaf, Dkk1, Frat2 and Notch1, 
keeping these genes active. OCT4, SOX2 and NANOG also have a repressive function in ESCs, 
inhibiting the expression of Esx11, HoxB1, Meis1, Pax6, Lhx5, Lbx1, Myf5 and Onecut1 (Boyer et 
al., 2005). 
Humans with SOX2 mutations exhibit profound neural defects 
Heterozygous mutations in human SOX2 are most often associated with anophthalmia 
(absence of eye) and have been reported in 10-20% of cases of severe bilateral ocular 
malformation (Fantes et al., 2003; Ragge et al., 2005b). In cases in which the SOX2 mutation 
causes microphthalmia (small eye), the retina remains functional (Fitzpatrick and van 
Heyningen, 2005). Outside of the eye, there is functional redundancy among SOX1-3. 
Nonetheless, additional neural defects associated with SOX2 mutations include hippocampal 
   30 
abnormalities, epilepsy, pituitary malformation, hypothalamic hamartoma, impaired motor 
function, and deafness. Cleft palate has also been demonstrated in a hypomorphic mouse model 
of Sox2 (Langer et al., 2013). Thus, SOX2 is a key regulator of NPC development throughout the 
CNS and especially of optic cup progenitor cells, where SOX2 is expressed exclusively of SOX1 
and SOX3.   
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The Optic Cup as a Model of Neural Induction 
It has been suggested that SOX2 regulates changes in gene expression necessary to 
respond to neural-inducing signals (Rex et al., 1997), but its direct transcriptional targets and 
upstream regulators are as yet unclear. A lack of precise genetic tools to study its role in lower 
vertebrates and the difficulty of visualizing mouse epiblasts in vivo contribute to the challenge of 
identifying SOX2 target genes in neural ectoderm. A study using mouse epiblast stem cells 
(EpiSCs), which molecularly resemble the mouse epiblast at E6.5, sought to identify the 
transcriptional networks involved in neural fate specification (Iwafuchi-Doi et al., 2012). EpiSCs 
were maintained by Activin (to mimic Nodal) and FGF2, and removal of these exogenous factors 
resulted in NPC development as identified by expression of OTX2, SOX2, and POU3F1 and down-
regulation of POU5F1. The first stage of EpiSC -- NPC development (NP1) resembled the ANP as 
characterized by the ANP-specific transcription factors Hesx1, Otx1 and Pax6. Manipulation of 
SOX2 levels in this system revealed that SOX2 functions to maintain the epiblast state in 
cooperation with POU5F1 (OCT4). SOX2 promoted the expression of Nanog, Zic3 and Otx2, 
while ZIC2/3 and POU5F1 participated in a feedback loop to promote Sox2 expression. In 
addition, SOX2 was shown to promote ANP fate once POU5F1 was down-regulated, likely 
participating in the down-regulation of POU5F1 in coordination with OTX2.  Over-expression of 
SOX2 promoted the expression of the ANP transcription factors Pou3f1, Zic3 and Pax6, and, in 
an additional feedback loop, POU3F1 and ZIC3 in coordination with the ANP gene OTX2 
promoted Sox2 expression. SOX2 also promoted expression of the posterior NP marker Gbx2 
and inhibited the expression of the endoderm gene Sox17, consistent with a role for SOX2 in 
maintaining neural competence of progenitor cells throughout the CNS. Collectively, these data 
begin to piece together a transcriptional network that places SOX2 as a crucial regulator of 
   32 
epiblast multipotency in cooperation with POU5F1 and neural fate upon the down-regulation of 
POU5F1 (Iwafuchi-Doi et al., 2012). 
Despite the advantages of using EpiSCs to investigate mammalian neural induction, a 
simple and accessible model is needed to study SOX2’s function in neural progenitor cells in 
vivo. Results from this project demonstrate that the mouse retina provides just such a model: 
ablation of Sox2 in mouse optic cup progenitor cells (OCPCs) results in complete loss of neural 
fate and cell fate conversion to non-neural (non-neurogenic) ciliary epithelium. Chapter II 
describes this phenotype, and Chapters III and IV provide data supporting the notion that SOX2 
maintains neural retinal identity and suppresses non-neurogenic CE fate via transcriptional 
regulation of genes necessary to respond to neural versus non-neural signals.  
Neural ectoderm/neural retina is morphologically distinct from epidermis/ciliary epithelium 
The presumptive neural plate and epidermis exhibit clear morphological differences 
(Colas and Schoenwolf, 2001; Lawson et al., 2001). The initial distinction between presumptive 
neural ectoderm and epidermal ectoderm occurs when the neural plate first forms bilateral 
ridges at the neural-epidermal junction, and neural cells appear to thicken (Figure 1-11F, F’). 
Prospective neural cells elongate along the apical-basal axis, a process known as cell palisading, 
while prospective epidermal cells decrease in height such that the tissue appears to flatten and 
spread, becoming a single layer of cuboidal epithelium (Lawson et al., 2001). Similarly, the NR 
and CE can be distinguished morphologically as early as E14.5, when presumptive non-
neurogenic cells at the periphery of the eyecup adopt single-layered cuboidal morphology with 
attachments to both the inner and outer layers of the optic cup. As shown in the scanning and 
transmission electron micrographs in Figure 1-11A (box), A’, and E (box), the distal tips of the 
eyecup consist of cells attached at both the apical (outer) and basal (inner) surfaces. As optic 
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cup development proceeds, these prospective CE cells spread into a single-layered epithelial 
sheet reminiscent of the epidermis. Interestingly, upon SOX2 ablation, retinal tissue in the 
central part of the eyecup adopts a thin morphology characteristic of presumptive CE and in 
start contrast to SOX2-positive neural retina (Figure 1-11B, B’). SOX2-ablated cells also appear 
elongated in contrast to the rounded nature of neural retina progenitor cells (Figure 1-11D vs. 
C). Therefore, based on morphological characteristics, SOX2 appears to be necessary for neural 
fate in the optic cup, and loss of SOX2 leads to non-neural epithelial characteristics, making the 
optic cup an appropriate model to study the role of SOX2 in neural induction. 
Proliferation of neurogenic progenitor cells differs from that of non-neurogenic progenitor 
cells 
The neural plate and epidermis have distinct proliferative properties. The thickened 
morphology of the neural plate arises in part via greater proliferation of neurogenic progenitor 
cells. This intimate connection between cell proliferation and cell fate raises the question of how 
regulation of these two processes is linked. Any given tissue requires a certain number of cells of 
a particular type, so cell fate and cell cycle must be tightly coordinated. It is not surprising, then, 
that cell cycle regulators control levels of transcription factors, including SOX2, and these in turn 
control expression of cell cycle regulator genes (Li et al., 2012; Liu et al., 2012; Marques-
Torrejon et al., 2013).  
In the case of the neural plate, the neural fate-promoting transcription factor XBF1 
(FOXG1) controls expression of the cell cycle inhibitor p27Xic1. High levels of XBF1 inhibit p27 
expression and convert prospective epidermis into neural plate. This cell fate conversion occurs 
even when cell division is blocked, suggesting that XBF1 exerts its effect on cell fate 
independently of its cell cycle-promoting effect. Conversely, a low concentration of XBF1 
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promotes p27 expression. But even at low concentrations, XBF1 is pro-neurogenic, leading to 
ectopic neurons rather than ectopic neural progenitor cells. This “low-dose” effect can be 
altered to a “high-dose” effect when a low concentration of SOX3 is introduced, suggesting a 
synergistic relationship between XBF1 and SOX3. Expression of p27 alone is not sufficient to 
induce ectopic SOX3-positive neural plate progenitor cells or ectopic N-Tubulin-positive 
neurons, thus separating the mechanisms by which XBF1 promotes proliferation and imparts 
neural fate (Hardcastle and Papalopulu, 2000).     
The developing NR has a higher proliferation index than the presumptive CE at 
embryonic stages. The lower proliferation rate of the peripheral optic cup in comparison to the 
central optic cup is thought to contribute to the thin epithelial structure of the adult ciliary 
epithelium, thus making the optic cup a useful model for studying the link between cell 
proliferation and cell fate (Beebe, 1986; Cho and Cepko, 2006). Perhaps complicating the issue, 
however, is the fact that these two regions express positive and negative cell cycle regulators, 
albeit seemingly completely different sets in region (Trimarchi et al., 2009). Similar to the neural 
plate, p27 is expressed in the prospective NR and excluded from the CE. In neurogenic RPCs, p27 
promotes cell cycle exit and neuronal differentiation; however, its ectopic expression in the 
optic cup has not been tested. Therefore, its role in neural retinal fate specification is still 
unclear. Decreased SOX2 in the developing optic cup causes retinal hypoplasia/proliferation 
defects; therefore, the optic cup provides a model for addressing the mechanisms through 
which SOX2 regulates neural fate and cell proliferation. Moreover, given that p27 has been 
demonstrated to regulate Sox2 expression (Li et al., 2012), and SOX2 had been shown to 
regulate p27 (Liu et al., 2012), both of which are expressed in optic cup progenitor cells, this 
transcriptional/cell cycle network cell cycle can be worked out in the optic cup. 
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Neural retina and ciliary epithelium are specified by the same pathways that specify neural 
plate and epidermis 
FGF signaling 
As in the naïve ectoderm of mice and lower vertebrates, FGF signaling generally 
promotes neural/neural retina fate. FGFs expressed in the prospective lens activate Vsx2 in the 
distal OV, thereby specifying NR fate. Moreover, Vsx2 in turn represses Mitf, thereby 
suppressing non-neurogenic fate (Horsford et al., 2005; Nguyen and Arnheiter, 2000). FGF9 is 
also activated in the distal OV, and it promotes NR fate when ectopically expressed in the 
presumptive RPE. The RPE of mice mutant for Fgf9 is expanded into the putative NR domain 
(Zhao et al., 2001).  
However, the peripheral OC also expresses FGF ligands, supporting a possible role for 
FGF signaling in CE fate. To address this question and avoid the functional redundancy of the 
numerous FGFs and FGF receptors expressed in the OV, an experiment was conducted that 
ablated the protein phospatase Shp2, which mediates the FGF signaling cascade via sustained 
activation of Ras. This inactivation of all FGF signaling in the OC causes a cell fate conversion of 
the NR to RPE (Cai et al., 2010). It appears, then, that FGF signaling is necessary for neural retina 
fate, at least during early stages of eye development. However, it is still unclear what the role of 
sustained FGF signaling may be at later stages of OC development, and how induction of FGF 
signaling in the peripheral OC may affect cell fate.  
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BMP signaling 
BMP signaling in the OC is also consistent with its role in promoting non-neural fate. The 
function of BMP signaling in optic cup cell fate specification has been studied primarily from the 
perspective of the lens:  
Forced expression of FGF4 in the chick RPE causes a cell fate conversion of this tissue to 
NR, but at a distance from the FGF signal, ectopic CE tissue is observed. It was proposed that 
where FGF4 overlaps with endogenous BMP in the RPE, a secondary signal is induced that 
promotes CE fate. A potential candidate for this secondary non-neurogenic signaling pathway is 
WNT/-Catenin signaling. 
Canonical WNT signaling 
WNT signaling is the best-characterized pathway regulating peripheral optic cup cell 
fates. In chick and in mouse, forced activation of -Catenin in the optic cup suppresses neural 
retina fate and promotes ciliary epithelial fate, supporting a role for WNT signaling in the 
antagonism of neural identity (Cho and Cepko, 2006; Liu et al., 2007b). In the ectoderm, WNT 
signaling can block the competence of prospective neural cells to respond to FGF signaling, and 
Wnt down-regulation is necessary for mESCs to give rise to neural cells. However, a more direct 
look at the function of -Catenin itself paints a more complex of WNT signaling in mammalian 
embryonic stem cells. For example, -CATENIN appears to be inactive transcriptionally in mouse 
and human ESCs (Davidson et al., 2012; Lyashenko et al., 2011). In human ESCs, OCT4 keeps -
CATENIN inactive, and activation of -CATENIN inhibits self-renewal and promotes mesoderm 
formation (Davidson et al., 2012). Similarly, in mouse ESCs, -CATENIN appears to be important 
for mesendoderm development (Lyashenko et al., 2011). Mice that are hypomorphic for -
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catenin exhibit defective gastrulation and develop according to the neural default hypothesis 
(Rudloff and Kemler, 2012). Together, these studies suggest that canonical WNT signaling 
generally antagonizes neural fate in the ectoderm and in the optic cup. 
The role of WNT signaling in cell fate specification is often complicated by the additional 
function of -CATENIN in cadherin-mediated cell adhesion (Valenta et al., 2011). To address 
transcription separately from cell adhesion, it is possible to selectively inactivate and add back 
each functional component of -catenin. One group was able to introduce two mutatations to 
the -catenin locus -- an N-terminal amino acid substitution and a C-terminal truncation -- to 
abrogate its transcriptional response to WNTs but maintain its cell-adhesive properties (Valenta 
et al., 2011). In this manner, it is possible to assess the differences between the functions of the 
N- and C-termini in transcription and to assess the transcriptional function of the protein as a 
whole without compromising cell adhesion. It was thereby discovered that -Catenin 
transcription is crucial for maintaining neural progenitor identity and neuronal differentiation in 
the dorsal spinal cord of mice. In -CATENIN transcriptionally deficient mice, SOX2 expression 
was strongly reduced in spinal cord neural progenitors, and there was a reduction in the number 
of sensory neurons and dorsal interneurons as well as the complete absence of the neuronal 
marker Dcx (Valenta et al., 2011). Although these results suggest that -CATENIN promotes 
neural identity, it could be a cell-type and stage-specific phenomenon that does not parallel the 
function of canonical WNT signaling at earlier stages. Indeed, mouse ESCs lacking -CATENIN 
exhibit defective neuronal differentiation; however, adding back cell adhesion and not TCF/LEF 
rescues neuroepithelial formation, suggesting that adherens-junctions and not WNT-mediated 
transcription is important for neural development of mouse ESCs. Therefore, the majority of 
studies to date support a role for canonical WNT signaling in the suppression of anterior neural 
fate in gastrula-stage embryos and in mammalian ESCs. 
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Summary and scope 
Sox2 is specifically expressed in the neural ectoderm and plays a highly conserved role in 
neural fate specification. Despite its importance for neural progenitor multipotency, little is 
known of its transcriptional targets. The optic cup resembles the gastrula-stage ectoderm in its 
morphology and in the signaling pathways that regionalize its neurogenic – non-neurogenic 
boundary. Moreover, SOX2 is specifically maintained in neurogenic progenitor cells of the optic 
cup as in the neural ectoderm. Loss of SOX2 in either the ectoderm or the optic cup is associated 
with loss of neural characteristics. This project uses the mouse optic cup as a model of the 
gastrula-stage ectoderm to identify the mechanisms whereby SOX2 maintains neural fate. The 
optic cup thereby provides an accessible method of testing the genetic relationship between 
Sox2 and neural induction signaling pathways, thus bypassing the potential lethality of 
manipulating these pathways in the mouse epiblast and providing a means of confirming results 
in vivo using traditional molecular and developmental biology techniques.    
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Figure 1-1 Anatomy of embryonic mouse forebrain and eyes. (A) Frontal view of embryonic day 
(E) 8.5 forebrain, just before the eye field splits. The optic sulci are the large pits protruding from 
the ventral neural ectoderm. (B, D, E) Wide (B) and high magnification (D, E) views of frontal 
sections of the E 9.0 (D) to E 9.5 (D) optic vesicle. The coordinated invagination of the distal 
optic vesicle and the surface ectoderm, where the lens placode has thickened, begins at E 9.5 
(E). (C, F). Wide (C) and high magnification (F) views of frontal sections of the E 10.5 optic cup 
and lens vesicle. The retinal pigment epithelium is the thin layer of cells proximal to the neural 
retina, which is dorsal to the optic stalk. The optic stalk is continuous with the ventral forebrain. 
The lens vesicle is distal to the neural retina. Dorsal is to the top (A-F), and proximal is to the 
right (D-F). Scale bars: A, 50 um; B-C, 100um. (Photo Credit: Lee Langer) 
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Figure 1-2 Network of transcription factors that establish the eye field. The neural ectoderm 
transcription factors SOX2 and OTX2 activate Rax expression in the prospective eye field, which 
is located in the ventral forebrain. RAX is required for the upregulation of the EFTFs Lhx2, Pax6 
and Six3 in the eye field. The dashed arrows indicate that LHX2 may co-regulate the expression 
of Rax, Pax6 and Six3 in the eye field, as expression of these genes is delayed in Lhx2-/- embryos 
(Tetreault et al., 2009). The EFTFs then coordinate the cell-intrinsic and -extrinsic signaling 
pathways that regionalize the optic vesicle along its axes. 
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Figure 1-3 Signaling networks establish boundaries in the optic vesicle. Dorsal is to the top, and 
distal is to the left. The optic vesicle is regionalized into prospective RPE (red, dorsal), neural 
retina (green, central) and optic stalk (yellow, ventral). Extracellular signals organize the optic 
vesicle in part through the activation of transcription factors that specify the tissue type in which 
they are expressed. These transcription factors cell-intrinsically regulate optic vesicle 
organization through mutual repression of one another. The dotted arrow indicates that early 
Lhx2 expression may be required for Bmp7 expression in the optic vesicle (Yun et al., 2009), but 
Bmp7 expression is maintained when Lhx2 is ablated specifically in the eye field (Hagglund et al., 
2011). The lens placode, which expresses FGF ligands important for neural retinal specification, 
is shown in blue. (Electron microscopy by Dr. Lee Langer) 
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Figure 1-4 Regulation of Pax6 expression via its eye-specific enhancer during the early stages 
of eye development. (A) At E9.5, the OV is regionalized into three presumptive tissues: the 
retinal pigment epithelium (RPE, red), the central neural retina (NR, green) and the ventral optic 
stalk (vOS, yellow). PAX2 binds to antagonize Pax6 expression in the ventral OV. (B) At E10.5, 
the OV invaginates centrally, creating two nested cups -- the RPE and the NR. It also invaginates 
ventrally, creating the optic fissure. VAX1 and VAX2 suppress ventral Pax6 expression via . (C) 
At E11.5, the optic fissure has closed ventrally, leaving a small opening for RGC axons to exit 
through the optic nerve (ON, yellow). The RPE has completely surrounded the NR. (D) 
Transverse section through the optic cup at the dotted line in C. SOX2 (green) and PAX6 (red) 
exhibit inversely graded expression patterns, with SOX2 highest in the central OC and PAX6 
highest in the periphery. The peripheral part of the OC, the OCM, gives rise to the epithelia of 
the ciliary body and iris, while the central part gives rise to the NR. The OCM highly expresses 
Pax6 due in part to positive auto-regulation via . In the central OC, SOX2 antagonizes Pax6 via 
(see Chapters II and III). 
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Figure 1-5 Mechanics of lens placode formation. The optic vesicle (blue) contacts the surface 
ectoderm (orange with gray nuclei) prior to lens placode formation. Adhesion between the optic 
vesicle and the pre-lens ectoderm is mediated by extracellular matrix components (cross-hatch). 
The area of contact between the extracellular matrix and the surface ectoderm restricts 
expansion of the pre-lens domain. Continued cell division in this area leads to cell crowding and 
cell elongation resulting in placode formation. 
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Figure 1-6 Axes in the Optic Cup. The optic cup is regionalized along several axes: dorsal-ventral, 
anterior (cornea)-posterior (RPE), nasal-temporal and central (central neural retina)-peripheral 
(ciliary epithelium). 
 
  
Figure 1-7 Temporal progression of retinogenesis in the mouse. During development of the optic cup, the neural epithelium of the optic vesicle 
gives rise to pigmented and ciliary epithelia, as well as neural retinal progenitor cells. The wave of neurogenesis in the retina is characterized by 
production of early born retinal ganglion cells, horizontal interneurons, cone photoreceptors and amacrine interneurons. Postnatal neural 
progenitor cells predominantly give rise to rod photoreceptors, bipolar interneurons, and Müller glia. In the adult neural retina, neuronal and 
glial cell types are organized into three distinct cellular layers (GCL – ganglion cell layer, INL – inner nuclear layer, ONL – outer nuclear layer). 
(Adapted from figure by Dr. Natalia Surzenko) 
4
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Figure 1-8 Variations on SOX2, being regulated by neural inducing signals, as a marker of 
neural ectoderm in Xenopus. (A) SOX2 is often used as a specific marker of neural ectoderm in 
vertebrates; however, in the presence of BMP signaling, SOX2 is insufficient for neurogenesis. 
This raises the possibility that SOX2 actually designates “pre-neural” ectoderm, staying 
consistent with the neural default hypothesis. If neural ectoderm is defined by the ability to 
generate neurons, then there could be a more specific marker of neural ectoderm progenitor 
cells (“Factor X”), which is necessary and sufficient for neurogenesis and inhibited by BMPs. (B) 
An alternative possibility is that BMP signaling independently promotes non-neural fate and 
inhibits neurogenesis in neural ectoderm, such that SOX2 is a specific marker of neural 
ectoderm as defined by the absence of non-neural identity rather than neurogenesis. 
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Figure 1-9 SOX2 expression in neural progenitor cells is highly conserved. (A) SoxNeuro (green) 
and Dichaete (red) are co-expressed in the neuroectoderm of the gastrula stage Drosophila 
embryo. (B-E) Sox2/SOX2 is specifically expressed in the neural plate of Xenopus (B), chick (C), 
mouse (D) and human (E) embryos. Photos from Cremazy et al. (2000); Streit et al. (2000); Wills 
et al. (2009) and Zhang et al. (2010) and used with permission. 
 
   
Figure 1-10 Circular dichroism spectrum of purified full-length recombinant SOX2. The two minima around 205 and 225 nm indicate the alpha 
helical nature of SOX2. Concentration is 12uM SOX2 in 50mM NaPO4 and 200mM NaCl. The legend to the right is from http://www.ap-
lab.com/circular_dichroism.htm.  
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Figure 1-11 The morphology of OC progenitor cells is reminiscent of that of neural tube cells. 
(A-A’) SEM of an E14.5 OC of a wild-type embryo showing the difference between the laminar 
morphology of the central OC and the single-layered morphology of the distal tips (box and A’). 
(B-B’) SEM of an E14.5 OC of a Sox2-deleted embryo showing the thinning of the central OC (box 
and B’). (C-E) TEMs of E14.5 wild-type (C,E) and Sox2-ablated (D) OCs showing the rounded 
morphology of wild-type central progenitor cells (C “NR”,E above box) versus the elongated 
morphology of peripheral CE progenitor cells (E box) and central Sox2-ablated progenitor cells 
(D “NR”). (F-F’) SEM of a stage 7 chick neural tube showing the contrast in morphology between 
the neural ectoderm (between arrows) and the epidermal ectoderm (outside arrows), and the 
kinking of cells at the border of these two tissue types (F’ arrow). F and F’ from (Lawson et al., 
2001) 
  
CHAPTER II: SOX2 ANTAGONIZES PAX6 TO MAINTAIN NEURAL RETINAL FATE 
Overview 
In humans, heterozygosity of either SOX2 or PAX6 is associated with microphthalmia, 
anophthalmia, or aniridia.  In this study, through the genetic spatio-temporal specific ablation of 
SOX2 on both wild-type and Pax6-heterozygous backgrounds in the mouse, we have uncovered 
a transcriptionally distinct and developmentally transient stage of eye development.  We show 
that genetic ablation of SOX2 in the optic cup results in complete loss of neural competence and 
eventual cell fate conversion to non-neurogenic ciliary epithelium.  This cell fate conversion is 
associated with a striking increase in PAX6, and genetically ablating SOX2 on a Pax6-
heterozygous background partially rescues the Sox2-mutant phenotype.  Collectively, these 
results demonstrate that precise regulation of the ratio of SOX2 to PAX6 is necessary to ensure 
accurate progenitor cell specification and place SOX2 as a decisive factor of neural competence 
in the retina.  
Introduction 
The vertebrate eye, which is composed of neurogenic and non-neurogenic structures, 
arises from a single progenitor pool in the optic vesicle. The eye therefore provides a useful and 
accessible model for studying potential interactions of signaling pathways in specifying distinct 
cell fates. Around embryonic day (E) 10.5 of mouse development, the optic vesicle receives 
signals from the surface ectoderm telling it to invaginate, forming the bilayered optic cup. The 
inner layer of the optic cup gives rise to the neural retina (NR), while the outer layer becomes 
the retinal pigment epithelium (RPE). The interface of these two domains is the peripheral optic 
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cup margin, which gives rise to the non-pigmented ciliary body epithelium (CE) and the inner iris 
epithelium. Progenitor cells at the boundary between prospective NR and CE make a binary cell 
fate decision to become either neurogenic (NR) or non-neurogenic (CE) (Beebe, 1986). The 
molecular and cellular mechanisms regulating this cell fate decision are poorly understood in 
part because cells fated to become CE exhibit pervasive expression of the retinal progenitor 
transcription factors Rax, Chx10 and Pax6 (Cho and Cepko, 2006; Fuhrmann et al., 2000; 
Furukawa et al., 1997; Hodgkinson et al., 1993; Kubo and Nakagawa, 2008; Liu et al., 2006a; Liu 
et al., 2003b; Pittack et al., 1997; Rowan and Cepko, 2004). 
A number of cell-extrinsic signaling pathways have been implicated in CE fate 
specification. One report showed that CE markers are found at the edges of tissue that 
ectopically expresses FGF, suggesting that the ciliary body is specified in the optic vesicle where 
BMP and FGF signals overlap (citation). In addition, studies in multiple species have shown 
canonical Wnt signaling to be a potent regulator of peripheral eye structures (Cho and Cepko, 
2006; Liu et al., 2007b; Tomlinson, 2003). A role for Wnt signaling in specifying CE fate in the 
mouse comes from the observation that constitutive activation of -catenin in optic cup 
progenitor cells results in the ectopic expression of CE-specific genes at the expense of NR-
specific genes (Liu et al., 2007b). However, these ectopic CE-like cells fail to express Pax6 and 
Chx10, both of which are normally maintained in the prospective CE of control eyes at early 
stages. In the adult, Pax6 is maintained in the CE of the iris and ciliary body. 
The reduction of Pax6 expression upon activated Wnt signaling is surprising given that 
PAX6 is a positive regulator of peripheral eyecup development (Davis-Silberman et al., 2005). A 
member of the paired-box and homeobox-containing family of transcription factors, PAX6 has 
been shown to be required for iris specification, optic cup morphogenesis, lens formation, and 
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retinal neuronal differentiation (Baumer et al., 2002; Davis-Silberman and Ashery-Padan, 2008; 
Davis-Silberman et al., 2005; Grindley et al., 1997; Marquardt et al., 2001; Philips et al., 2005; 
Smith et al., 2009; Xu et al., 1999). These developmental processes require a critical threshold of 
PAX6 as demonstrated by the fact that heterozygous carriers of PAX6 deletions (Davis-Silberman 
et al., 2005; Hill et al., 1991; Hogan et al., 1986; Ton et al., 1991) and transgenic mice with 
increased levels of PAX6 (Ericson et al., 1997; Schedl et al., 1996) each display eye abnormalities 
(Favor et al., 2001; Hack et al., 2004; Heins et al., 2002; Kim and Lauderdale, 2008; Manuel et al., 
2007 08). Humans with mutations in PAX6 exhibit aniridia (no iris) and often have smaller ciliary 
bodies (reviewed by (Hanson and Van Heyningen, 1995; Hayashi et al., 2004; Okamoto et al., 
2004; Prosser and van Heyningen, 1998). Mice that are heterozygous for the Pax6Sey mutation 
exhibit reduced size of the optic cup margin, implicating a shift in the boundary between NR and 
CE (Davis-Silberman et al., 2005). 
Here we address the hypothesis that there is an antagonistic relationship between 
transcription factors restricted to the prospective NR and those that, like PAX6, span the 
boundary between prospective NR and CE. One of these potential regulators of NR specification 
is the high mobility group (HMG)-containing transcription factor SOX2. Conditional deletion of 
Sox2 in the developing mouse retina results in the loss of competence to undergo neuronal 
differentiation, and mice that are hypomorphic for Sox2 exhibit reduced eye size (Taranova et 
al., 2006). Moreover, ~10% of human individuals with anophthalmia (lack of eye) or severe 
microphthalmia (small eye) carry a SOX2 mutation (Fantes et al., 2003; Hagstrom et al., 2005; 
Hanson and Van Heyningen, 1995; Ragge et al., 2005a; Ragge et al., 2005b; Zenteno et al., 2005; 
Zenteno et al., 2006); reviewed by (Hever et al., 2006)). 
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While both SOX2 and PAX6 have been shown to be essential for the maintenance of 
multipotent retinal progenitor cells (RPCs) (Marquardt et al., 2001; Taranova et al., 2006; Xu et 
al., 1999), and studies in mouse illustrate that changes in SOX2 and PAX6 dosage result in 
developmental defects of the eye, no study has yet addressed their epistatic relationship in the 
developing optic cup. To examine the relationship between Sox2 and Pax6 in the optic cup, we 
performed genetic analysis in the mouse and uncovered a mechanism through which the 
eyecup is regionalized into NR and CE. We show that SOX2 and PAX6 are expressed in an inverse 
gradient in the developing optic cup and find that ablation of SOX2 in multipotent optic cup 
progenitor cells biases them towards a non-neurogenic CE fate. The immediate molecular 
readout of this cell fate conversion is the upregulation of PAX6. Accordingly, the deletion of Sox2 
on a Pax6-heterozygous background (Pax6Sey/+) significantly rescues the Sox2-mutant 
phenotype. Therefore, in the absence of SOX2, multipotent RPCs cannot maintain neuronal 
differentiation capacity (i.e. NR identity) and undergo cell fate conversion to CE. These results 
place SOX2 as a critical factor defining multipotent neural retinal progenitor identity (Taranova 
et al., 2006) and suggest a model of dosage-dependent transcriptional regulation of cell fate in 
the optic cup.  
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Materials and Methods 
Mouse Breeding 
Sox2cond/+ mice (Taranova et al., 2006) were crossbred to P0CREiresGFP (Dr. P. Gruss, Max-
Planck-Institute of Biophysical Chemistry, Germany (Marquardt et al., 2001)) or Chx10CREiresGFP, 
(Jackson Laboratories (JAX), Bar Harbor, ME (Rowan and Cepko, 2004)) to generate Sox2cond/+; 
P0CREiresGFP and Sox2cond/+; Chx10CREiresGFP mouse lines.  These lines were then backcrossed to the 
Sox2cond line to obtain homozygous mutant genotypes. Lineage tracing was carried out using 
Rosa26Reporter (R26R) mice (JAX (Soriano et al., 1987)). Pax6Sey/+ mice (Dr. A. LaMantia, The 
George Washington University (Hill et al., 1991)) were bred to Sox2cond/+; P0CREiresGFP mice to 
obtain Sox2cond/+; P0CREiresGFP; Pax6Sey/+ mice and then backcrossed to Sox2cond/+ mice to yield the 
Sox2cond/cond; Pax6Sey/+; P0CREiresGFPdouble mutant.  -cateninactivated mice (Dr. R. Wechsler-Reya, 
Duke University (Harada et al., 1999)) were crossed with the P0CREiresGFP to obtain the 
constitutively activated genotype -cateninactivated; P0CREiresGFP. Primer sequences for all of the 
alleles mentioned can be found in Table 2-1. It was necessary to genotype for the Sox2cond allele 
to eliminate animals in which germline recombination occurred. All animal work was carried out 
in accordance with University of North Carolina at Chapel Hill IACUC and DLAM approval. 
Tissue preparation, Immunohistochemistry, and in situ hybridization 
Mouse embryos were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS).  
Tissue was immersed sequentially in 10%, 20% and 30% sucrose/DEPC PBS overnight and then 
embedded and frozen in OCT medium (Tissue-Tek).  Horizontal 14m cryostat sections were 
blocked in 1% goat serum/0.1% Triton-X in PBS and incubated with primary antibodies at 4C 
overnight and secondary antibodies for one hour at room temperature.  The following 
antibodies were used in this study: rabbit anti-Cleaved Caspase 3 (1:300, Cell Signaling), chicken 
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anti-GFP (1:2000, Abcam), rabbit anti-Ki67 (1:1000, Abcam), mouse anti-PAX6 (1:100, 
Hybridoma), rabbit anti-SOX2 (1:3000, Millipore), mouse anti--tubulin III (1:1000, Covance), 
Alexa Fluor 488 anti-chicken (1:2000, Molecular Probes (MP)), Alexa Fluor 546 anti-mouse 
(1:2000, MP), and Alexa Fluor 546 anti-rabbit (1:2000, MP).  In situ hybridization was performed 
on 20m cryostat sections using DIG-labeled antisense probes, followed by enzymatic detection 
according to manufacture protocols (Roche).  The following in situ probes were employed in this 
study: Axin2 ((Dr. F. Costantini (Jho et al., 2002)),  Bmp4 (Dr. A LaMantia (Bhasin et al., 2003), 
Bmp7 (Dr. B. Hogan, (Lyons et al., 1995)), Chx10 (Dr. R. McInnes (Horsford et al., 2005)), Hes5 
(Dr. E. Anton (Chenn and Walsh, 2002)), Lef1 (Dr. R. Grosschedl (Galceran et al., 1999)), Msx1 
(Dr. Y. Liu (Liu et al., 2006a)), NeuroD1 (Dr. J. Lee (Lee et al., 1995)), Notch1 (Dr. U. Lendahl 
(Lardelli and Lendahl, 1993)), Rax (Dr. C. Cepko (Furukawa et al., 1997)), Sfrp2 (Dr. J. Nathans 
(Rattner et al., 1997)), Otx1 (Dr. J.P. Martinez, (Simeone et al., 1992)), Pax6 (Dr. A. LaMantia 
(Anchan et al., 1997)), and Zic1 (Dr. K. Millen (Aruga et al., 1994)).  For -galactosidase (-gal) 
staining, slides were washed with PBS and immersed in -gal staining solution (final 
concentrations: 5mM K3Fe(CN)6 (Sigma), 5mM K4Fe(CN)63 H2O (Sigma), 2mM MgCl2 
(Mallinckrodt), 0.02% Igepal CA-630 (Sigma), 0.01% Na-Deoxycholate (Sigma) and X-gal (1:50, 
Promega))  overnight at 37C.  Fluorescent and light microscopy images were taken on a Leica 
inverted microscope (Leica DMIRB) using a Q-imaging Retiga-4000RV digital CCD camera 
(Vashaw Scientific, Raleigh, NC, USA). 
BrdU labeling 
Pregnant mothers were weighed and injected 2 hours before dissection with 6l/g of 
15mg/ml BrdU (Sigma B5002) in PBS.  Embryos were sectioned and prepared for 
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immunohistochemistry as stated above and stained overnight with mouse anti-BrdU (1:500, 
BD). 
PAX6 immunofluoresence intensity analysis 
PAX6 immunofluorescence intensity was measured in tissue sections taken from the 
central-most portion of E14.5 eyes. To exclude intensity variations caused by the appearance of 
different cell sections (and correspondingly, different volumes) at the focus of the objective, 
optical sectioning to generate the maximum image projection of the resulting slices was 
performed. To capture the whole cell volume, initial optical sectioning was conducted to 
determine the objective position at which the fluorescence intensity in the selected ROI (at least 
20 cells per ROI) would be maximal. The ROI was selected at similar locations in each sample. 
The maximum intensity plane served as a reference point. For the final imaging for intensity 
calculations, a stack of 13µm (6.5 µm above and below the reference point) was collected. 
Twenty cells from each region of the eyecup (the lens epithelium, prospective CE, retinal 
ganglion cells, SOX2-positive neural progenitors and SOX2-ablated neural progenitors) were 
selected from the final 8-bit image for fluorescence intensity calculations, and the intensity was 
plotted using the Olympus Fluoview 2.1c. All intensity measurements were conducted on an 
Olympus Fluoview FV1000 confocal microscope with a 40× NA0.6 objective (Olympus Corp.). 
Statistics calculations were performed using Excel software (Microsoft Corp., Redmond, Wa). 
  
 57 
Results 
The central NR and the peripheral optic cup margin are defined by an inverse gradient of SOX2 
and PAX6 
To establish the functional interaction between SOX2 and PAX6 in the specification of 
optic cup progenitor cells, we first compared their expression patterns using 
immunohistochemistry. SOX2 and PAX6 are co-expressed in the anterior neural plate and 
throughout the optic vesicle prior to optic cup formation (Rex et al., 1997; Uchikawa et al., 2003; 
Uwanogho et al., 1995). However, in the early optic cup (E10.5), SOX2 and PAX6 begin to exhibit 
inverse expression gradients. While SOX2 is highly expressed in the prospective NR (Fig. 2-1A,B) 
in a graded centralhigh-to-distallow pattern, PAX6 is highly expressed in prospective CE and RPE 
(Fig. 2-1A,C) in a gradient from centrallow-to-distalhigh (Baumer et al., 2002; Grindley et al., 1997; 
Kamachi et al., 2001; Walther et al., 1991). These inverse expression patterns are maintained 
throughout early optic cup development (Fig. 2-1D,G,J). Consequently, in the adult, SOX2 
appears to be excluded from the non-neural CE and RPE (Fig. 2-2A,C), while PAX6 is maintained 
in the CE (Fig. 2-2B,C). 
To determine whether the SOX2-PAX6 gradient is concurrent with the early divergence 
of cell fate into central prospective NR and peripheral prospective CE, we examined a repertoire 
of established optic cup markers at E13.5, before the NR and CE become morphologically 
distinguishable. We found that in the prospective NR, SOX2 and PAX6 (Fig. 2-3A,B) are co-
expressed with the NR-specific genes Notch1 (Lardelli and Lendahl, 1993), Hes5 (Chenn and 
Walsh, 2002) and NeuroD1 (Lee et al., 1995) (Fig. 2-3D,E,F) and with the multipotent optic cup 
progenitor genes Rax and Chx10 (Fig. 2-3G,H). In contrast, SOX2 is downregulated in the 
prospective CE (Fig. 2-3A,C,box), where Msx1 (Liu et al., 2006a), Otx1 (Simeone et al., 1992), 
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Bmp4 (Zhao et al., 2002) (Fig. 2-3J,K,L) and Zic1 (data not shown) (Trimarchi et al., 2009) are 
preferentially expressed. PAX6 is highly maintained in the prospective CE (Fig. 2-3B,I,box).  
Ablation of SOX2 results in neurogenic to non-neurogenic cell fate conversion  
We have previously generated mice carrying a conditional floxed allele of Sox2 
(Sox2cond/+) (Taranova et al., 2006). To conditionally ablate SOX2 from multipotent cells 
throughout the peripheral optic cup, we used P0CREiresGFP transgenic mice, in which CRE 
expression is driven by the Pax6 retina-specific enhancer  and minimal promoter P0 beginning 
at E10.0 (Kammandel et al., 1999; Marquardt et al., 2001). This mouse line can be used as a 
transgenic reporter of  enhancer-driven Pax6 expression in the optic cup (Baumer et al., 2002). 
We previously crossed Sox2cond/+ mice with Sox2cond/+; P0CREiresGFP mice and showed that ablation 
of SOX2 results in severe ocular deformities, including extremely reduced eye size (Taranova et 
al., 2006). Here, we determine the fate of Sox2-mutant optic cup progenitor cells by comparing 
gene expression, proliferation and cell death in mutant (Sox2cond/cond; P0CREiresGFP) eyes with that 
of control (Sox2cond/+; P0CREiresGFP) eyes. 
We first examined Sox2 and Pax6 expression at E16.5, when the prospective NR and CE 
initially become morphologically distinguishable. In control eyes, the inverse SOX2-PAX6 
gradient is maintained throughout the optic cup, with PAX6 expression (Fig. 2-4B) highest in the 
distal tips and SOX2 expression (Fig. 2-4C) highest in the central optic cup. In contrast, SOX2-
ablated cells (Fig. 2-4I) throughout the prospective NR exhibit an increase in P0CREiresGFP 
reporter (Fig. 2-4G), PAX6 protein (Fig. 2-4H) and Pax6 mRNA expression (Fig. 2-4U). To confirm 
this increase in PAX6 protein, we quantified PAX6 immunofluorescence intensity in different 
regions of the eyecup of control and mutant embryos (Fig. 2-5). PAX6 is significantly upregulated 
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exclusively in CRE-positive, SOX2-ablated progenitor cells of the central optic cup when 
compared to wild-type, SOX2-positive central progenitor cells (p<0.0001). 
To determine the identity of these Sox2-mutant cells, we examined the expression of 
NR-specific genes. Sox2-mutant cells fail to express the NR markers Notch1 (Fig. 3D,J) and Hes5 
(Fig. 3E,K) and markers of postmitotic neurons, including NeuroD1 (Fig. 3F,L) and -tubulin III 
(data not shown).  
We next examined whether this loss of neural characteristics is specific to the deletion 
of Sox2 or is associated with decreased expression of other optic cup progenitor transcription 
factors, Rax and Chx10. In contrast to the upregulation of Pax6 upon SOX2 ablation (Fig. 3H,U) 
Rax (Fig. 3M,S) and Chx10 (Fig. 3N,T) remain unchanged between controls and mutants. Given 
that Rax and Chx10 are expressed in CE progenitors, we hypothesized that Sox2-mutant cells 
may gain CE characteristics, so we examined the expression of established CE markers. Our data 
indicate that some Sox2-mutant cells ectopically express a subset of genes normally restricted to 
the prospective CE, including Bmp7 (Fig. 3P,V) and Raldh2 (data not shown). Otx1 (Fig. 3Q,W), 
which is normally restricted to the distal tips of the optic cup, exhibits slight central expansion in 
Sox2-mutant eyes. However, most Sox2-mutant cells fail to express other prospective CE genes, 
including Msx1 (Fig. 3R,X) and Mitf (data not shown) at E16.5. 
The WNT/-catenin signaling pathway has been implicated in the specification of CE fate 
(Cho and Cepko, 2006; Liu et al., 2007a; Liu et al., 2003b). We examined components of this 
pathway to test the hypothesis that the WNT signaling domain is expanded upon Sox2 deletion. 
Axin2, an endogenous readout of WNT activity (Fuhrmann et al., 2009; Jho et al., 2002), is 
increased in Sox2-mutant cells compared with wild-type controls (Fig. S3F,M), but Lef-1 
expression appears to be unchanged (Fig. S3E,L). Sfrp2, a Wnt signaling antagonist expressed in 
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NR progenitors (Liu et al., 2003b), is centrally shifted (Fig. S3D,K). Taken together these data 
suggest that the active Wnt signaling domain is centrally expanded upon SOX2 ablation. 
Forced expression of a stabilized form of -Catenin in optic cup progenitors has been 
used previously to model the role of WNT signaling in CE induction (Liu et al., 2007b). We 
therefore compared expression of prospective NR and CE genes between Sox2-mutant embryos 
and embryos with constitutive activation of Wnt signaling. Consistent with the previous results 
of Liu et al., regions with stabilized -catenin (cateninactivated; P0CREiresGFP) exhibit upregulation 
of Lef1 and Axin2 (Fig.2-6S,T) and fail to express the NR markers Sox2, Hes5 and Sfrp2 (Fig. 2-
6O,P,Q,R). However, in contrast to Sox2-mutant eyes, which exhibit central expansion of CRE 
and increased Pax6 expression, regions that constitutively express -catenin do not show 
expansion of P0CREiresGFP and do not express Pax6 (Fig. 2-6I,N,P,U). Thus, the loss of SOX2 
parallels activation of -catenin at E16.5 in the expansion of the Axin2-positive domain and the 
loss of NR characteristics. 
Based on the central expansion of some genes known to be involved in specifying CE 
fate, we hypothesized that the loss of SOX2 induces a transient liminal or “in-between” state in 
which a maturation period is required for cells to fully adopt CE identity. To address this 
hypothesis, we examined the expression of NR- and CE-specific genes in control and Sox2-
mutant eyes at postnatal day (P) 0. In control eyes, the NR exhibits laminar morphology and 
P0CREiresGFP expression in the inner nuclear layer and retinal ganglion cell layer (Fig. 2-7A,A’). The 
CE contains a single-layer of cuboidal cells with high P0CREiresGFP expression (Fig. 2-7A box and A’ 
arrow). The NR-specific gene Hes5 is expressed throughout the laminar NR and marks an abrupt 
boundary between the neurogenic retina and non-neurogenic CE (Fig. 2-7C,C’). The neurogenic 
and non-neurogenic regions are also distinguishable by the edge of -tubulin III expression (Fig. 
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2-7B,B’). In stark contrast to control eyes, Sox2-mutant eyes show expanded P0CREiresGFP 
expression throughout the central eyecup (Fig. 2-7D,D’). Similar to what was observed in the 
eyes of mutant embryos, postnatal Sox2-mutant cells fail to express genes specific to the NR, 
including Hes5 (Fig. 2-7C,C’,F,F’), and lose neuronal differentiation capacity as demonstrated by 
the mutual exclusivity of -tubulin III and P0CREiresGFP expression (Fig. 2-7B,B’,E,E’). In addition to 
the upregulation of P0CREiresGFP, Sox2-mutant cells gain expression of genes that are 
preferentially expressed in the CE at P0, including Pax6, Msx1 and Zic1 (Fig. 2-7G-I’). These 
ectopic CE-like regions exhibit thin single-layered morphology characteristic of wild-type CE. In 
contrast, the SOX2-positive NR regions, which presumably developed from cells that did not 
undergo CRE-mediated recombination, exhibit proper thickness and laminar morphology when 
compared with the NR of control eyes. These results suggest that Sox2-mutant progenitors 
autonomously undergo cell fate conversion from neurogenic retina to non-neurogenic CE. 
Previous studies have shown that the development of the CE monolayer results from a 
decrease in cell division. Indeed, the optic cup margin exhibits a lower proliferation rate than 
does the prospective NR (Beebe, 1986; Cho and Cepko, 2006; Kubota et al., 2004). Examination 
for proliferation markers depicts that many SOX2-ablated cells, particularly in the peripheral 
region of the eyecup, do not incorporate BrdU (Fig. 2-8B,F) or express Ki67 (Fig. 2-8C,G). 
However, many SOX2-ablated cells in the central eyecup do. These results suggest that upon the 
deletion of Sox2 by P0CREiresGFP, there is decrease in the number of proliferating cells, 
particularly throughout the peripheral eyecup. In contrast, there is no significant change in 
apoptosis as indicated by Cleaved Caspase-3 expression (Fig. 2-8D,H). 
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Optic cup progenitor transcription factors PAX6, CHX10 and RAX are not sufficient to maintain 
neuronal differentiation capacity in the absence of SOX2 
The previous data suggest that ablation of SOX2 in multipotent peripheral progenitor 
cells that can give rise to both NR and CE results in their eventual restriction to CE fate. To 
further address the hypothesis that cells that are specified to become NR will convert to CE 
upon loss of SOX2, we used the Chx10CREiresGFP mouse line to ablate SOX2 in a mosaic pattern of 
progenitor cells throughout the whole optic cup beginning at E11.0. Thus, SOX2 is removed from 
alternating patches of cells that have been specified to become NR, and neighboring wild-type 
cells can serve as internal controls (Fig. 2-9B,C,H-I’) (Donovan and Dyer, 2004; Jadhav et al., 
2006; Oron-Karni et al., 2008; Rowan et al., 2004; Zhang et al., 2004). In Sox2cond/cond; 
Chx10CREiresGFP mutant eyes, SOX2 is specifically ablated in CRE-expressing cells marked by GFP 
(Fig. 2-9B,G,H,H’). As a consequence of SOX2 loss, mutant cells do not undergo neuronal 
differentiation, as evidenced by the mosaic expression of -tubulin III (Fig. 2-9C,I,I’) and 
NeuroD1 (Fig. 2-9F,L) in a pattern mutually exclusive of Chx10CREiresGFP expression (Fig. 2-9I, 
arrowhead). Moreover, SOX2-ablated cells fail to express the NR-specific genes Notch1, Hes5, 
and Sfrp2 (Fig. 2-9D,E,J,K,M,S). 
To determine if these Sox2-mutant progenitor cells undergo cell fate conversion to CE, 
we examined the localization of genes normally expressed in the prospective CE at E14.5. In 
regions of SOX2 ablation, Pax6 is upregulated (Fig. 2-9N,T) and Chx10 (Fig. 2-9O,U) and Rax (Fig. 
2-9P,V) are maintained. Moreover, Sox2-mutant cells express some prospective CE markers, 
including Bmp7 (Fig. 2-9Q,W,W’), but not others including Msx1 (Fig. 2-9R,X). This expression 
profile recapitulates that of early Sox2cond/cond; P0CREiresGFP mutant cells described above. 
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The upregulation of Pax6 and Bmp7 suggest that ablation of SOX2 by Chx10CREiresGFP 
induces a liminal state similar to what was observed in Sox2cond/cond; P0CREiresGFP mutants. At P0, 
mosaic regions of Chx10CREiresGFP expression/SOX2-ablation are clearly distinguishable from 
neighboring Chx10CREiresGFP-negative/SOX2-postive regions (Fig. 2-10A,A’,D,D’). In mutant eyes, 
SOX2-ablated regions lack expression of the NR gene Hes5 (Fig. 2-10C,C’,F,F’) and the post-
mitotic neuronal marker -tubulin III (Fig. 2-10B,B’,E,E’). Conversely, Sox2-mutant regions 
upregulate Pax6 (Fig. 2-10G,G’,J,J’) and cell-autonomously gain expression of the CE markers 
Msx1 and Zic1 (Fig. 2-10H-I’,K-L’). These data support our finding that loss of SOX2 in 
multipotent progenitor cells results in a temporary liminal state typifying their maturation to CE. 
In addition, at P0, Sox2-mutant regions exhibit thin, single-layered morphology that starkly 
contrasts with neighboring control regions, which exhibit proper NR laminar morphology. Sox2-
mutant progenitors fated to become NR lose neuronal differentiation capacity and undergo cell 
fate conversion to CE (Cho and Cepko, 2006; Liu et al., 2007b). 
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Fate mapping of Sox2 mutant cells depicts loss of neural progenitor capacity in the retina 
To directly establish if ablation of SOX2 results in an autonomous cell fate change from NR 
to CE, we genetically fate mapped Sox2-mutant cells using the P0CREiresGFP mouse line. Sox2cond/+; 
P0CREiresGFP mice were crossed with mice carrying the Rosa26R CRE reporter allele (Sox2cond/+; 
R26R/+), which expresses -galactosidase (-gal) following CRE-mediated excision of a 
translational stop cassette, permanently marking the progeny of CRE-expressing cells (Soriano et 
al., 1987). Therefore, cells that express CRE at the time of analysis can be detected using GFP 
fluorescence, while all the progeny of CRE-positive cells express -gal. In control Sox2cond/+; 
P0CREiresGFP; R26R/+ embryos, P0CREiresGFP is initially expressed throughout the peripheral optic 
cup (Fig. 2-11A). By E15.5, it becomes restricted to the distal tips (Fig. 2-11B), maintaining high 
expression in the CE by E17.5 (Fig. 2-11D). However, at E15.5 and E17.5, -gal is detected 
throughout both the laminar NR (P0CREiresGFP -negative) and the distal CE (Fig. 2-11C,E), leaving 
only a portion of central NR cells unmarked. This -gal expression pattern confirms that 
CREiresGFP-expressing progenitor cells can give rise to both NR and CE. In contrast, as previously 
shown, Sox2cond/cond; P0CREiresGFP; R26R/+ mutant eyes exhibit expanded P0CREiresGFP expression into 
the central optic cup (Fig. 2-11F,G,I), and all P0CREiresGFP-positive cells appear to express -gal (Fig. 
2-11H,J). By E17.5, these -gal-positive regions exhibit thin morphology when compared to the 
SOX2-postive/-gal-negative regions in the same eye (Fig. 2-11J). 
Sox2 and Pax6 genes interact to coordinate eye development 
Based on the increase in PAX6 expression upon SOX2 ablation, we hypothesized that 
proper regionalization of the optic cup depends on a fine balance of SOX2 and PAX6 dosage. To 
directly address this hypothesis, we performed genetic epistasis analysis of SOX2 and PAX6 in 
the developing optic cup. To modulate PAX6 dosage, we used the Pax6Sey/+ mouse line in which a 
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spontaneous mutation in the Pax6 gene produces a truncated protein that lacks a DNA-binding 
homeodomain and the C-terminal transactivation domain. This truncated PAX6 is considered 
functionally inactive and is widely used as Pax6-null allele (Hill et al., 1991; Hogan et al., 1986; 
Osumi et al., 2008). Compared to Sox2cond/+ or Sox2cond/cond mice, which display normal eye 
development (Taranova et al., 2006), Pax6Sey/+ mice exhibit reduced external eye size, iris 
hypoplasia and small lens (Hill et al., 1991).  
To specifically ablate SOX2 in peripheral progenitors on this Pax6-heterozygous 
background, we crossed Sox2cond/+; P0CREiresGFP mice with Sox2cond/+; Pax6Sey/+mice. We then 
compared resulting Sox2cond/cond; P0CREiresGFP; Pax6Sey/+ (Sox2/Pax6-double mutant) embryos with 
Sox2cond/cond; P0CREireGFP (Sox2-single mutant) embryos and Sox2cond/+; P0CREiresGFP; Pax6Sey/+ 
(Pax6-single mutant) control embryos. Sox2/Pax6-double mutant eyes, which have reduced 
levels of both SOX2 and PAX6, are significantly normalized compared to Sox2-single mutant 
eyes, which are wild-type for Pax6 but lose SOX2 upon CRE-mediated ablation (Fig. 2-12J-R,S-
AA). The central expansion of P0CREiresGFP seen in Sox2-single mutant eyes is significantly 
rescued in Sox2/Pax6-double mutant eyes (Fig. 2-12S-AA,J-R). Lineage tracing analysis using the 
Rosa26R CRE reporter shows that the domain of P0CREiresGFP activity, as marked by -gal 
expression, is peripherally restricted in Sox2/Pax6-double mutants compared to Sox2-single 
mutants. These data indicate that P0CREiresGFP expression in Sox2/Pax6 double mutants is 
restored to an expression pattern that more closely resembles that of controls (Fig. 2-12B,K). 
Nevertheless, P0CREiresGFP expression co-localizes with -gal activity in Sox2/Pax6-double 
mutants (Fig. 2-12B,C,K,L), which is consistent with the maintenance of P0CREiresGFP in SOX2 
ablated cells as described above (Fig. 2-11). The ablation of SOX2 in the Pax6-heterozygous 
background significantly rescues neuronal differentiation capacity, as illustrated by 
normalization of -tubulin III (Fig. 2-12D,M,V), Notch1 (Fig. 2-12E,N,W), Hes5 (Fig. 2-12F,O,X) 
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and NeuroD1 (Fig. 2-12G,P,Y). Modulating SOX2 or PAX6 levels do not affect Rax (Fig. 2-12H,Q,Z) 
or Chx10 (Fig. 2-12I,R,AA) expression.  
To determine whether this rescue phenotype is maintained postnatally, we examined 
Sox2/Pax6-double mutants at P0, and found a slightly expanded region of P0CREiresGFP-positive 
thin CE-like cells compared to Pax6-single mutant controls (Fig. 2-13A-H, brackets). This result 
contrasts with the single-layered morphology and CE gene expression present throughout the 
center of the eyecup in Sox2-single mutants (Fig. 2-13I-L). Moreover, the NR of Sox2/Pax6-
double mutants exhibits proper laminar morphology and neuronal differentiation capacity as 
indicated by -tubulin III and Hes5 expression, and Msx1 expression is restricted to the distal 
tips (Fig. 2-13F-H). Therefore, Sox2/Pax6-double mutants more closely resemble Pax6-single 
mutants than Sox2-single mutants. 
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Discussion 
SOX2 maintains neuorgenic fate of proliferating neuorepithelial progenitor cells 
Here we have demonstrated for the first time that the genetic ablation of SOX2 causes a 
neurogenic-to-non-neurogenic cell fate conversion. These results place SOX2 as the critical 
factor defining neurogenic identity in retinal neuroepithelium. In early stage mouse embryos, 
SOX2 expression marks the region fated to become neural ectoderm, and its appearance in 
chicken embryos coincides with the onset of neural fate specification (Wood and Episkopou, 
1999). Inhibition of SOX2 function in Xenopus embryos blocks neural differentiation, and SOX2 
signaling in chick has been shown to promote proliferation and inhibit neuronal differentiation 
(Bylund et al., 2003; Graham et al., 2003; Kishi et al., 2000). In the retina, unlike in other regions 
of the CNS, SOX2 is expressed exclusively of the highly related SOXB1 factors, SOX1 and SOX3. 
Thus, the optic cup, which retains the unique capacity to generate non-neurogenic structures, 
provides an excellent model for studying SOX2’s transcriptional role in maintaining neurogenic 
identity.  
SOX2 ablation initiates gradual cell fate conversion from NR to CE 
Secreted molecules known to affect neurogenic versus non-neurogenic optic cup cell 
fate include FGFs, BMPs and WNTs. A previous report showed that converging FGF and BMP 
signals may define the prospective NR/CE boundary at optic vesicle stages of the chick (citation). 
BMP signaling appears to be required for Otx1 and Msx1 expression in the prospective CE (Zhao 
et al., 2002), and Msx1 expression has been shown to be induced by activated Wnt signaling 
(Willert et al., 2002). Thus, overlapping FGF, BMP and Wnt signals may coordinate the cell-
intrinsic gene expression necessary for CE development. However, at least one study has shown 
induced ectopic CE marker expression without the onset of Wnt2b expression (citation). 
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Interestingly, it has been proposed that extrinsic signals that direct neurogenic versus non-
neurogenic fate converge at the regulation of SOX proteins (Wilson et al., 2001). Here we 
investigate the cell-intrinsic role of SOX2 and PAX6 in setting up the NR/CE boundary in the optic 
cup. 
Using genetic fate mapping, we have demonstrated that removal of a transcription 
factor, SOX2, converts prospective NR to CE. Our results are consistent with previous data 
showing that neural RPCs maintain multipotent differentiation capacity (i.e. the capacity to form 
CE) at a developmental time point (E11.0) subsequent to the division of NR and CE fate (Fekete 
et al., 1994; Turner and Cepko, 1987; Turner et al., 1990). The gradual cell fate conversion upon 
Sox2 deletion is characterized by 1) loss of the NR markers Notch1, Hes5, NeuroD1, and Sfrp2, 2) 
maintenance of the multipotent progenitor genes Chx10, Rax and Pax6, 3) expansion of WNT 
and BMP signals and 4) decreased proliferation with progressive thinning of the 
neuroepithelium. These characteristics define a liminal or in-between state that culminates in 
the expression of CE markers, including Otx1, Zic1 and Msx1 (markers are summarized in Table 
2-2). A similar delay in the consolidation of CE identity in response to ectopic Wnt signaling has 
been previously demonstrated (Cho and Cepko, 2006). In both instances, the delay may be due 
to the presence of competing signals in the eyecup: WNT signals promote non-neurogenic fate 
but multipotent progenitor genes and Wnt antagonists promote neurogenic fate. Intringuingly, 
activation of -Catenin in the eyecup was shown to produce a stronger and more rapid onset of 
CE characteristics than did Wnt2b overexpression, suggesting that stabilized -Catenin bypasses 
WNT antagonists in the prospective NR to cause a more immediate increase in CE gene 
expression (Cho and Cepko, 2006). Thus, the presence of WNT antagonists may explain why 
consolidation of CE fate is gradual upon SOX2 ablation but rapid upon -catenin activation (Liu 
et al., 2007a).  
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Sox2 and Pax6 interact to regionalize the optic cup  
A major difference between SOX2 loss-of-function and -Catenin gain-of-function in the 
prospective retina is the effect on Pax6. Ablation of SOX2 leads to an immediate increase in 
Pax6 expression, while activation of -catenin diminishes Pax6 expression. In humans, 
haploinsufficiency of PAX6 is associated with anterior eye formations, including defects of the 
iris and ciliary body (reviewed by (Hever et al., 2006; Hill et al., 1991)). In the mouse, deletion of 
one copy of Pax6 in the distal optic cup resulted in the loss of CE precursors and a distal shift in 
the boundary between prospective NR and CE (Davis-Silberman et al., 2005). Moreover, 
transgenic overexpression of Pax6 resulted in abnormalities of the ciliary body, the iris and the 
cornea (Schedl et al., 1996). These studies demonstrate the importance of regulating 
appropriate levels of PAX6 for the proper development of peripheral eye structures. Here, we 
have described increased Pax6 expression in the optic cup upon the removal of a potential 
repressor. 
Our genetic epistasis analyses provide evidence for a mechanism of PAX6 regulation in 
the developing eyecup. The dramatic increase in PAX6 upon Sox2 deletion and the subsequent 
NR-to-CE cell fate conversion suggest that SOX2 normally antagonizes PAX6 signaling to 
maintain NR identity. Moreover, the genetic rescue of eye development by lowering PAX6 levels 
while deleting Sox2 indicates a functional antagonism between the two genes. These data raise 
the possibility that neurogenic versus non-neurogenic fate in the optic cup is extremely sensitive 
to the ratio of PAX6 to SOX2.  
We propose a model (Fig. 2-14) in which SOX2 levels are high enough to antagonize 
Pax6 expression in central optic cup progenitor cells, thereby maintaining neurogenic capacity. 
Conversely, in the peripheral optic cup, SOX2 levels are low, perhaps allowing PAX6 to activate 
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its own expression via the  enhancer. In fact, previous studies have shown that PAX6 can 
directly bind a conserved site in , and lowering PAX6 levels decreases -driven CRE-GFP 
expression (Baumer et al., 2002; Schwarz et al., 2000). Further studies are needed to address 
whether SOX2 and PAX6 coordinate Pax6 expression through the enhancer. Indeed, SOX2 and 
PAX6 have been shown to co-regulate expression of the -crystallin gene in the lens, where they 
form a complex at the DC5 enhancer that is stabilized by both protein-protein and protein-DNA 
interactions (Kamachi et al., 2001). A similar co-regulation of  enhancer activity may control 
Pax6 expression in the optic cup given that the  enhancer has been suggested to mediate the 
proximallow-to-distalhigh PAX6 gradient (Baumer et al., 2002; Davis-Silberman et al., 2005). 
Whereas the role of secreted signaling molecules in positioning the boundary between 
prospective NR and CE has been studied extensively, little is known about the cell-intrinsic 
mechanisms responsible for setting up or maintaining this boundary. Our results suggest a 
tightly coordinated dosage-dependent transcriptional mechanism directing NR versus CE cell 
fate. We have shown that the functional antagonism between SOX2 and PAX6 is necessary for 
proper patterning of the eyecup, such that in the absence of SOX2, PAX6 is not sufficient to 
maintain NR identity, and cells originally fated to become retinal neurons instead take on a 
peripheral non-neurogenic cell fate. 
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Figure 2-1 The neural retina and optic cup margin are defined by an inverse gradient of SOX2 
and PAX6. (A) Schematic of an E12.5 eye indicating the boundaries of the mouse neural retina 
(NR), lens (L), prospective ciliary body epithelium (CE) and retinal pigment epithelium (RPE). (B-
D) Immunohistochemistry on horizontal sections of wild-type embryos shows high SOX2 
expression (red) in the central optic cup and high PAX6 expression (green) in the peripheral 
optic cup margin. (E-J) As the eye develops, the inverse gradients of SOX2 and PAX6 expression 
are maintained. Scale bar: 100 μm. 
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Figure 2-2 SOX2 is expressed in the adult mouse NR but is absent from the ciliary body. (A,B) 
Immunohistochemistry for SOX2 (A, red) in the wild-type adult eye shows expression in the 
neural retina (NR) but not in the ciliary body (CB), whereas PAX6 (B, green) shows high 
expression in the adult CB. (C) Merged image of SOX2 (red) and PAX6 (green) illustrates the 
inverse relationship between the two proteins, with SOX2 restricted to the NR and absent from 
the CB. PNR, peripheral neural retina. Scale bar: 100m 
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Figure 2-3 Expression profiles of the central NR and peripheral OCM at E13.5 reflect the 
inverse expression patterns of SOX2 and PAX6. (A-C) IHC for SOX2 (red) and PAX6 (green) on 
horizontal sections of wild-type mouse eyes illustrates inverse gradients of expression, with 
SOX2 highly expressed in the NR and PAX6 highly expressed in the OCM. (D-F) The NR-specific 
genes Notch1 (D), Hes5 (E) and NeuroD1 (F) are co-expressed with SOX2. (G-I) The OC progenitor 
transcription factors Rax (G), Chx10 (H) and Pax6 (I) are expressed in both NR and OCM. (J-L) 
Msx1 (J), Otx1 (K) and Bmp4 (L) are expressed in the OCM. Boxes delineate the OCM. Scale bar: 
200 μm. 
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Figure 2-4 Ablation of SOX2 in the peripheral OC results in loss of neural fate and central 
expansion of the OCM. (A-X) Horizontal sections through the eyes of E16.5 mouse embryos. 
(A,G) αP0CREiresGFP reporter expression as indicated by CRE-GFP (green) depicts central expansion 
in mutant OCs (G) compared with controls (A). (B,C,H,I) PAX6 is increased in SOX2-negative cells 
(H,I) when compared with SOX2-positive cells (B,C) of wild-type controls. (D-F,J-L) Expression of 
the NR-specific genes Notch1 (N,J), Hes5 (E,K) and NeuroD1 (F,L) is lost in SOX2-ablated regions 
(J-L). (M-O,S-U) Rax (S,M) and Chx10 (T,N) are unchanged, but Pax6 mRNA is increased (U,O) in 
Sox2-mutant eyes. (P,Q,V,W) Bmp7 (P,V) and Otx1 (Q,W) are expanded into the prospective NR 
of Sox2-mutant eyes. (R,X) Msx1 is unchanged between control (R) and mutant eyes (X). Scale 
bar: 200 μm.   
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Figure 2-5 PAX6 IF intensity per cell in different regions of the E14.5 OC is increased in central 
progenitors of mutants. (A,B) Squares delineate regions in which cells were chosen to quantify 
PAX6 IF intensity (clockwise from top): RGC layer, lens epithelium, distal-most OC and 
prospective NR. PAX6-expressing RGCs were identified by -tubulinIII expression (red) on 
adjacent sections (insets). Arrowheads in B indicate regions that do not express P0CREiresGFP 
(green, inset) and, therefore, maintain SOX2. (C) Average pixel intensity per cell is not 
significantly different between distal cells, RGCs and lens epithelial cells of wild-type and Sox2-
mutant eyes. By contrast, the average pixel intensity per cell is significantly increased in central 
OC cells of Sox2-mutants compared with that of controls (P<0.0001). For each region, n=20 cells. 
Error bars indicate s.e.m. 
  
Figure 2-6 WNT signaling is expanded in Sox2-mutant eyes at E16.5. (A,B,H,I,O,P) IHC for SOX2 (red) and αP0CREiresGFPreporter expression (green) 
in horizontal sections of control (αP0CREiresGFP/+), Sox2-mutant (Sox2cond/cond; αP0CREiresGFP) and stabilized β-Catenin (β-cateninactivated; αP0CREiresGFP) 
eyes. (C-G,J-N,Q-U) ISH for Hes5 (C,J,Q) and Sfrp2 (D,K,R) reveals no expression in αP0CREiresGFP-positive mutant cells. ISH for Lef1 (E,L,S) 
and Axin2 (F,M,T) indicates restriction to the prospective CE in control eyes. Axin2 but not Lef1 is up-regulated in Sox2-mutant cells, which are 
designated by αP0CREiresGFP expression (inset in M), and both are highly expressed in regions with stabilized β-Catenin (S,T). ISH for Pax6 (G,N,U) 
shows expression in the prospective CE as well as in the inner nuclear layer and retinal ganglion cell layer of control eyes, whereas Pax6 is 
upregulated in Sox2-mutant cells but absent from cells with constitutively activated β-catenin. Arrowheads indicate areas where stabilized β-
catenin is localized. Scale bar: 200 µm. 
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Figure 2-7 Ablation of SOX2 by αP0CREiresGFP results in cell fate conversion of the NR to CE. (A-L′) 
Low (A-L) and high magnification (A′-L′) images of sections through the eyes of P0 control and 
mutant pups. Boxes indicate magnified regions. P0CREiresGFP is expressed in the distal tips as well 
as in the INL and RGC layer of control eyes (A,A′). By contrast, αP0CREiresGFP expands into the 
putative NR of Sox2-mutant eyes (D,D′). β-tubulinIII (B,B′,E,E′) and Hes5 (C,C′,F,F′) are present 
only throughout the SOX2-positive NR of mutant eyes and not in SOX2-ablated regions. CE-
specific genes, including Pax6 (G,G′,J,J′), Msx1 (H,H′,K,K′) and Zic1 (I,I′,L,L′), are ectopically 
expressed in mutant eyes when compared with controls. CE, ciliary epithelium; RPE, retinal 
pigment epithelium. Scale bars: in L, 400 μm for A-L; in L′, 100 μm for A′-L′. 
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Figure 2-8 Sox2-mutant eyes contain fewer proliferating cells. (A,E) αP0CREiresGFP reporter 
expression (green) in horizontal sections of E14.5 eyes shows peripheral restriction in control 
(Sox2cond/+; αP0CREiresGFP) eyes compared with central expansion in mutant 
(Sox2cond/cond; αP0CREiresGFP) eyes. (B-D,F-H) IHC for the proliferation markers BrdU (B,F) and Ki67 
(C,G) reveals cycling cells in central regions and very few cycling cells in peripheral regions of 
mutant eyes. IHC for Cleaved Caspase-3 (D,H) does not depict increased apoptosis in Sox2-
mutant eyes. The dotted lines outline the eyecup. Scale bar: 200 µm. 
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Figure 2-9 Mosaic ablation of SOX2 in neural progenitors results in loss of neuronal fate and 
central expansion of the OCM. (A-X) Horizontal sections through the eyes of E14.5 control 
(Sox2cond/+; Chx10CreGFP) and mutant (Sox2cond/cond; Chx10CreGFP) mouse embryos. (A-C,G-I′) 
Chx10CreGFP reporter (B,C,H-I′; green) double labeled with SOX2 (A,B,G-H′; red) or β-tubulin 
III (C,I,I′; red) shows expression throughout the whole OC in control eyes. In mutant eyes, CRE-
GFP is mutually exclusive of SOX2 (H) and β-tubulin III (I). Arrowheads indicate regions in which 
SOX2 has been ablated. (D-F,J-X) Expression of Notch1 (D,J), Hes5 (E,K) and NeuroD1(F,L) is 
lost, Sfrp2 (M,S) expression is decreased, Pax6 (N,T) expression is increased, and Chx10 (O,U) 
and Rax (P,V) are maintained in regions where SOX2 has been ablated when compared with 
wild-type controls. Bmp7 (Q,W,W′) is ectopically expressed in the prospective NR of mutant 
embryos, whereas Msx1 (R,X) shows little difference in expression between the control and 
mutant eyes. Scale bar: 200 μm.  
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Figure 2-10 At P0, mosaic regions of SOX2 ablation indicate cell fate conversion of the NR to 
CE. (A-L′) Low (A-L) and high magnification (A′-L′) images of sections through the eyes of P0 
mouse pups. Boxes indicate magnified regions. IHC for SOX2 (A,A′,D,D′; red), β-tubulin III 
(B,B′,E,E′; red) and GFP (A-E′; green) in control and mutant eyes shows thinning of the retinal 
neuroepithelium to CE-like morphology (D-E′) and loss of neuronal differentiation capacity (E,E′) 
in SOX2-negative regions. Hes5 (F,F′) is lost, Pax6 (J,J′) is increased, and Msx1 and Zic1 (K-L′) are 
ectopically expressed in SOX2-ablated regions. CE, ciliary epithelium; RPE, retinal pigment 
epithelium. Scale bars: in L, 400 μm for A-L; in A′, 100 μm for A′-L′.
  
 
Figure 2-11 Fate mapping Sox2-mutant progenitor cells. (A, H) αP0CREiresGFP (green) is expressed in the CE and in peripheral progenitor cells in the 
control (Sox2cond/+; αP0CREiresGFP; R26R) eyes at E13.5, while αP0CREiresGFP reporter expression in the mutant embryo (Sox2cond/cond; αP0CREiresGFP; R26R) 
is expanded into the central prospective NR.  (B, I, D, K) As the wild-type eye develops, αP0CRE reporter expression (green) is further restricted to 
the peripheral retina and eventually serves as a marker of prospective CE by E17.5, while in the mutant eye αP0CRE reporter expression remains 
an indicator for all recombined cells throughout the NR and prospective CE.  (C, E, J, L) -galactosiadase (-gal) reporter assay on E15.5 as well 
as E17.5 eyes indicates that αP0CREiresGFP-positive progenitor cells are capable of giving rise to both NR and non-neurogenic cells in control eyes 
but are cell fate-restricted in Sox2-mutant eyes.  (D, K) By E17.5, αP0CRE reporter expression is only present in the distal tips of the retina as well 
as in some cells of the inner nuclear layer while αP0CRE reporter expression reflects all recombined cells in the mutant embryo. (F, M) 
Chx10CREiresGFP fluorescent expression (green) at E16.5 in Sox2cond/+; Chx10CREiresGFP; R26R and Sox2cond/cond; Chx10CREiresGFP; R26R eyes. (G, N) -gal 
reporter assay on E16.5 eyes shows restricted proliferation (expansion) of progenitor cells in the presumptive NR of the mutant Sox2cond/cond; 
Chx10CREiresGFP; R26R eye. Scale bar: 200m. 
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Figure 2-12 Pax6-heterozygosity significantly rescues the Sox2-mutant NR. (A,B,J,K,S,T) Comparison of SOX (red) with αP0CREiresGFP (green) 
in Pax6 single mutant, Sox2 Pax6 double mutant and Sox2 single mutant eyes indicating little to no SOX2 expression in the Sox2 single mutant 
compared with the other two genotypes. (C,L,U) β-gal activity illustrating the progeny of all αP0CREiresGFP-expressing cells indicates rescue of 
αP0CREiresGFP expression in Sox2 Pax6 double mutants. (D,M,V) β-tubulin III  staining (red) shows maintenance of neuronal differentiation capacity 
in Pax6 single mutants and Sox2 Pax6 double mutants but not in Sox2 single mutants. (E-I,N-R,W-AA) 
Notch1 (E,N,W), Hes5 (F,O,X), NeuroD1 (G,P,Y), Rax (H,Q,Z) and Chx10 (I,R,AA) are maintained in the central OC of Sox2 Pax6 double mutants. 
Scale bar: 200 μm. 
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Figure 2-13 The NR is rescued in Sox2 Pax6 double mutant eyes. (A-L) αP0CREiresGFP  (A,E,I; green) 
and (B,F,J) β-tubulin III expression (B,F,G; red) indicate rescued neuronal differentiation capacity 
in the NR of Sox2 Pax6 double mutants when compared with Sox2 single mutants 
and Pax6 single mutant controls. ISH of  Hes5 (C,G,K) and Msx1 (D,H,L) shows proper neurogenic 
versus non-neurogenic regionalization in Sox2 Pax6 double mutants, resembling that 
of Pax6 single mutants. The dotted lines outline the region converted to CE in the Sox2 single 
mutant. Scale bar: 200 µm 
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Figure 2-14 Model of how SOX2 expression in the central OC antagonizes Pax6 expression. In 
the central optic cup, SOX2 might function as an antagonist to PAX6 at the protein level by 
binding directly to PAX6 (A) or by cooperatively or competitively binding with PAX6 at its α 
enhancer (B). In the peripheral optic cup, where SOX2 expression is low and PAX6 expression is 
high, PAX6 is free to up-regulate its own expression (C). 
  
Allele  Primers (5' to 3')  Product size  Conditions  
Sox2cond Fwd: CAGAGGACTCGTGTTTGGGAAC   Sox2cond: 307 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: TCTTGGATACATAAGGGTGGATGG wt: 345 bp  57°C, 30 seconds at 72°C)335, 5 minutes at 72°C  
Sox2dcond Fwd: CTTCTTTCCGTTGATGCTTTCG  589 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: ATCTTGGTGGCTGAACAGTTATCC  
 
57°C, 30 seconds at 72°C)335, 5 minutes at 72°C  
Cre Fwd: GCTAAACATGCTTCATCGTCGG  750 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: GATCTCCGGTATTGAAACTCCAGC  
 
57°C, 30 seconds at 72°C)335, 5 minutes at 72°C  
Rosa26Rep Primer 1: AAAGTCGCTCTGAGTTGTTAT  transgene: 650 bp   4 minutes at 94°C, (30 seconds at 93°C, 30 seconds at  
 
Primer 2: GCGAAGAGTTTGTCCTCAACC  wt: 340 bp 58°C, 1 minute at 65°C)335, 10 minutes at 72°C  
 
Primer 3: GGAGCGGGAGAAATGGATATG  
  Pax6-Sey Fwd: AACTTTTTGGCTTGCTTTGTCATTC  188 bp  1 minute at 95°C, (20 seconds at 92°C, 20 seconds at  
 
Rev: CTGAGCTTCATCCGAGTCTTCTCA  
 
63.5°C, 50 seconds at 72°C)334, 4 minutes at 72°C  
Pax6-wt  Fwd: GAACACCAACTCCATCAGTTCTAACG   646 bp  1 minute at 95°C, (20 seconds at 92°C, 20 seconds at  
 
Rev: CTTTCCCGGGCAAACACATC 
 
63.5°C, 50 seconds at 72°C)334, 4 minutes at 72°C  
β-catenin-act  Fwd: AGAATCACGGTGACCTGGGTTAAA  transgene: 900 bp  90 seconds at 94°C, (30 seconds at 94°C, 1 minute at  
 
Rev: CATTCATAAAGGACTTGGGAGGTGT  wt: 600 bp  60°C, 1 minute at 72°C)335, 2 minutes at 72°C  
Table 2-1 PCR primers and protocols. 
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Marker 
E13.5 wildtype P0 wildtype 
NR OCM NR CE 
Neural Retina     
Sox2 + - + - 
Sfrp2 + - + - 
Notch1 + - + - 
Hes5 + - + - 
NeuroD1 + - + - 
Math5 + - + - 
OCPTF     
Chx10 + + + + 
Rax + + + + 
Pax6 + + + + 
CE     
Bmp4/7 - + - + 
Lef1 - + - + 
Raldh2 - + - + 
Otx1 - + - + 
Msx1 - + - + 
Mitf - + - + 
Zic1 - + - + 
Table 2-2 Expression profiles of the prospective NR and CE.  At E13.5 and P0, NR markers are 
restricted to the central eyecup, OC progenitor transcription factors are expressed in the central 
and peripheral eyecup and CE markers are restricted to the peripheral eyecup. 
 
  
CHAPTER III: SOX2 AND WNT SIGNALING COORDINATE THE NEUROGENIC BOUNDARY OF THE 
RETINA 
Overview 
Multipotent progenitor cells of the mammalian optic cup generate all the neurons of the 
mature retina as well as the epithelium of the circumjacent ciliary body and iris. Survival of 
retinal neurons depends on the proper function of the ciliary body epithelium in both 
development and adulthood. In this study, we show that precise coordination of SOX2 and 
canonical Wnt/-Catenin signaling regulates the boundary between the presumptive retina and 
ciliary epithelium. Using genetic epistasis analysis and whole-genome expression arrays, we 
demonstrate that response to Wnt signaling was expanded upon specific deletion of Sox2 in 
mouse optic cup progenitor cells. The region of ectopic Wnt signaling correlated with loss of 
neurogenic capacity, slowed proliferation and cell fate conversion of the neural retina to ciliary 
epithelium. Removal of -catenin rescued the cell fate conversion; however, the loss of neural 
competence and the proliferation defect were not restored. Moreover, Sox2-mutant optic cup 
progenitor cells exhibited Wnt-independent up-regulation of D-type cyclins and persistent 
expression of the progenitor transcription factors Pax6 and Chx10. Collectively, these data show 
that SOX2 antagonizes Wnt signaling to regulate the boundary of the neural retina, and removal 
of these two pathways reveals a primitive stem-like population of cells at the optic cup margin. 
Moreover, our genome-wide expression analysis of the Sox2-mutant optic cup provides a 
resource for understanding ciliary epithelial fate and function.   
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Introduction 
Proper vision relies on the correct specification of the diverse cell types that make up 
the complex eye. Human eye disease, both congenital and degenerative, can result from 
improper function of one or more of these cell types. Therefore, the eye is a valuable model to 
understand the role of developmental pathways in human disease pathogenesis. Moreover, 
evidence for potential regenerative capacity of mammalian retinal cells in vitro (Ahmad et al., 
2000; Tropepe et al., 2000), and more recently in vivo (Kiyama et al., 2012; Moshiri and Reh, 
2004), underscores the importance of investigating the mechanisms involved in retinal 
progenitor cell multipotency and fate.   
All of the cell types that make up the neural-derived components of the eye, including 
the neural retina (NR), ciliary body (CB) and retinal pigment epithelium (RPE), arise from a 
common progenitor population located in the eyefield of the ventral forebrain (Li et al., 1997; 
Zaghloul et al., 2005). In mammals, these pre-neurogenic progenitors give rise to the optic cup 
(OC), which becomes regionalized along the central-peripheral axis. The central OC consists of 
neurogenic progenitor cells that give rise to the six types of neurons and one glial cell that make 
up the mature retina, while the peripheral OC gives rise to the non-neurogenic epithelium of the 
iris and CB, herein referred to as ciliary epithelium (CE) (reviewed in (Beebe, 1986; Heavner and 
Pevny, 2012)). Little is known about the molecular mechanisms that specify peripheral OC 
development, and a number of screens have been performed to identify CE-specific genes 
(Diehn et al., 2005; Escribano and Coca-Prados, 2002; Ha et al., 2012; Kubota et al., 2004; Thut 
et al., 2001; Trimarchi et al., 2009). 
Canonical WNT signaling, which functions through its downstream transcriptional 
effector, -Catenin, has been shown to be crucial for CE fate specification in a number of species 
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(Agathocleous et al., 2009; Cho and Cepko, 2006; Ha et al., 2012; Kitamoto and Hyer, 2010; Liu 
et al., 2003a; Liu et al., 2007b; Matsushima et al., 2011; Trimarchi et al., 2009). While -Catenin 
is expressed throughout the whole OC, a genetic reporter under the control of -
Catenin/TCF/LEF response elements showed WNT activity to be concentrated in the non-
neurogenic peripheral OC (Liu et al., 2003a). Moreover, constitutive expression of Ctnnb1 in 
mouse optic cup progenitor cells induces ectopic expression of CE-specific genes at the expense 
of SOX2-positive NR (Liu et al., 2007b). However, these ectopic CE cells do not express Pax6 or 
Chx10, two known transcriptional regulators of peripheral OC fate, suggesting that at least two 
populations of progenitor cells exist in the peripheral OC (Liu et al., 2007b). Further evidence 
supporting a role for WNT signaling in CE development is that specific ablation of Ctnnb1 in the 
developing OC reduces the size of the CE progenitor cell pool, causing hypoplasia of the CE and 
lamination defects in the neural retina (Fu et al., 2006; Liu et al., 2007b). 
SOX genes are known regulators of WNT signaling in a number of developmental 
systems and disease states (reviewed in (Kormish et al., 2010)). SOX2, a member of the SOXB1 
family of transcription factors, is necessary for maintaining neural stem cell competence (Pevny 
and Placzek, 2005). Moreover, SOX2 is required for retinal progenitor cell multipotency in mice 
(Matsushima et al., 2011; Taranova et al., 2006). Heterozygous mutations in human SOX2 are 
most often associated with anophthalmia (absent eye) and account for 10%-20% of cases of 
severe bilateral ocular malformation, including microphthalmia (small eye) (Fantes et al., 2003; 
Fitzpatrick and van Heyningen, 2005; Ragge et al., 2005b).  In mammalian development, the 
presumptive NR maintains SOX2 expression and neurogenic capacity, while the presumptive CE 
loses both SOX2 expression and neurogenic capacity (Matsushima et al., 2011). A role for SOX2 
in specifying NR fate was demonstrated when the ablation of Sox2 in mouse OC progenitor cells 
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resulted in loss of neural competence, cell fate conversion of the presumptive NR to CE, and 
ectopic expression of WNT target genes (Matsushima et al., 2011).  
In addition to eye defects, human patients with SOX2 mutations often exhibit pituitary 
abnormalities. WNT signaling is known to be involved in hypothalamo-pituitary development, 
and human SOX2 protein can inhibit -Catenin-driven reporter expression in vitro, but SOX2 
proteins containing the human mutations cannot (Alatzoglou et al., 2011; Kelberman et al., 
2006). Therefore, it has been suggested that an inability to repress WNT/-Catenin signaling 
may be an underlying cause of defects associated with SOX2 loss-of-function mutations in 
human patients (Kelberman et al., 2006). Moreover, the complementary eye phenotypes 
associated with Sox2 or Ctnnb1 loss-of-function suggest a genetic interaction between these 
two pathways in mammalian OC development. In this study, we tested the hypothesis that SOX2 
antagonizes canonical WNT signaling to maintain neurogenic fate in the OC of the mouse. We 
show that loss of Sox2 in OC progenitor cells resulted in slowed proliferation and aberrant 
expression of cell cycle regulators and that these defects were independent of -Catenin. We 
also demonstrate that removal of Ctnnb1 from the Sox2-mutant OC partially rescued the Sox2-
mutant phenotype, providing evidence that WNT signaling is a major transcriptional mediator of 
CE fate, and SOX2 antagonizes CE fate via modulation of WNT signaling. Lastly, using whole-
genome expression arrays, we demonstrate that the Sox2-mutant OC provides a valuable 
resource for identifying genes involved in CE fate and function, which has direct relevance to 
understanding the pathogenesis of diseases associated with the anterior segment, such as 
glaucoma. 
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Materials and Methods 
Mouse Breeding 
 All animal work was carried out in accordance with the University of North Carolina 
IACUC and DLAM approval. Generation of the Sox2Cond/+ mouse line was described previously 
(Taranova et al., 2006). Sox2cond/+ and Sox2cond/+; P0CREiresGFP mice were maintained on a 
C57BL/6J background, and all others described in this study were maintained on a mixed 
background containing 129/Sv and C57Bl/6J. P0CREiresGFP mice were a gift from Dr. P. Gruss 
(Marquardt et al., 2001). Chx10CreGFP  (Rowan et al., 2004), Ctnnb1cond/+ (Brault et al., 2001) and 
Rosa26Reporter (Soriano, 1999) transgenic mice were obtained from Jackson Laboratories (Bar 
Harbor, ME). Pax6Sey/+ mice were a gift from  Dr. A. LaMantia (Hill et al., 1991). Genotyping 
primers are listed in Table 3-1.  
Tissue Preparation, immunohistochemistry and in situ hybridization 
Immunostaining was performed as described in Matsushima et al. (2011). Antigen 
retrieval was used for antibodies against pH3, BrdU, p27Kip1, CyclinD3 and LEF1 as described in 
Surzenko et al. (2013). Antibody concentrations are provided in Table 3-2 In situ hybridization 
was performed on 14 m frozen sections (embryo heads or enucleated postnatal eyes) as 
described in Matsushima et al. (2011). The following probes were used: Bmp4 (gift from Dr. A. 
LaMantia) Msx1 (Gift from Dr. Y. Liu) CyclinD1 3’UTR (gift from Dr. C. Cepko) Shh (gift from Dr. E. 
Tucker) Axin2 (gift from Dr. F. Costantini) Sfrp2 (gift from Dr. J. Nathans) Chx10 (gift from Dr. R. 
McInnes) and Hes5 (gift from Dr. E Anton). Images were obtained on a Leica inverted 
microscope (Leica DMIRB) equipped with a Retiga (SRV-1394) camera or on an Olympus laser 
scanning confocal microscope (Olympus Fluoview FV1000) and processed using Adobe 
Photoshop software.  
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BrdU and IdU labeling 
Pregnant dams (16.5 dpc) were injected intraperitoneally with 0.12 mg IdU per mg body 
weight at time (T) 0. After 1.5 hours (T = 1.5), dams were injected with .10 mg BrdU (Sigma 
B5002) per mg body weight. At T = 2 hours, dams were sacrificed and embryos were removed 
and fixed as usual (ref). In preparation for cell cycle dynamics analysis, consecutive 12 m 
transverse sections were taken through the whole eyecup, and sections through the center of 
the eyecup were chosen for further analysis. A mouse antibody to BrdU (BD) was used to detect 
both thymidine analogs, and a rat antibody specific to BrdU (Serotec) was used to detect BrdU 
alone.  
Cell Counting, S-phase and Cell Cycle Measurements 
For each eye, a section through the middle of the eyecup was imaged using an Olympus 
Fluoview FV1000 confocal microscope. The prospective NR was divided into radial degrees in 
30° increments from the center to the prospective CE using Olympus Fluoview 2.1c software. All 
cells in each increment were counted, and the prospective CE was counted as a single unit. 
Three samples of each genotype were used in the final calculations. The following formulae 
were used to calculate BrdU index and Ki-67 index: 
BrdU index = (BrdU+ cells/Hoechst+ cells) x 100 
Ki-67 index = (Ki-67+ cells/Hoechst+ cells) x 100 
S-phase and cell cycle times were calculated as described in (ref). The ratio of “S” cells 
(BrdU and IdU double-positive) to “L” cells (IdU-only) was measured, and the following formulae 
were used: 
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S-phase length (Ts) = 1.5 x (S cells/L cells) 
Cell Cycle length = TS x (Ki-67+cells/S cells)  
Whole-genome expression analysis 
Pairs of eyes were enucleated from six wild-type (Sox2cond/+; P0CREresGFP) and six mutant 
(Sox2cond/cond; P0CREresGFP) embryos on embryonic day (E) 16.5 for a total of six samples (twelve 
eyes) per genotype. The tissue was immediately placed in RNA-Later RNA stabilization solution 
and stored at 4˚C for no longer than thirty days. RNA was purified using an Ambion RNaqueous 
kit following the manufacturer’s instructions. 500ng of RNA from each pair of eyes (12 samples 
total) were amplified and biotin-labeled using an Ambion Illumina TotalPrep RNA Amplification 
kit. 1.5 micrograms of labeled cRNA were hybridized to Illumina mouse WG-6 expression bead 
chips. To detect significant changes in gene expression between the control group and the Sox2-
mutant experimental group, a permutation analysis for differential expression (PADE) was 
performed. This analysis uses repeated random reassignment of each sample to one of the two 
groups to determine if the calculated difference in levels of a transcript between groups is non-
random. PADE was also used to estimate the false discovery rate for sets of differentially 
expressed transcripts. A p-value for each transcript was calculated using a two-sample t-test. 
Transcripts with an accumulated FDR of less than 5%, a p-value of less than 0.05, and a fold 
change of greater than ± 1.6, totaling 2194 transcripts, were chosen for further analysis. 
Electrophoretic Mobility Shift Assay (EMSA) 
Full-length HIS-tagged SOX2 (pET28a-SOX2-HIS) was expressed in BL21 (DE3) Codon Plus 
cells (Invitrogen, Carlsbad, CA) grown in LB at 37°C until an OD600 of 0.6 and then induced. 
SOX2-HIS was purified on a Sephadex S100 size exclusion column (GE Healthcare). Purification 
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and folding were assessed by immunoblotting and circular dichroism. For EMSA, purified SOX2 
at a final concentration of 50 M was incubated with 30,000 cpm of end-radio-labeled double-
stranded oligonucleotide probe in 2X binding buffer (20 mM Hepes pH 7.9, 20% glycerol, 0.2 
mM EDTA, 1mM tetrasodium pyrophosphate, 0.5 mM PMSF) and 50 mM KCl for 30 min. at 
room temperature. For competition assays, 20-fold molar excess unlabeled probe was added to 
the reaction. Reactions were run on a 12% non-denaturing polyacrylamide gel. The gel was fixed 
and exposed to autoradiography film at -80°C. Probe sequences are as follows: Pax6  enhancer 
TOP (5’-GTG CAG TTC ATT CTC GTC TGA GTG ATC TAC AAA TAG GGA -3’) and Notch1 intron 3 
TOP (5’- CGC AGC ATT GTC AAG GTG GCA TTG TTC CAG TCT GGA ACC CT-3’). Bottom sequences 
are the reverse complements. 
Results 
Ablation of Sox2 in the optic cup causes proliferation defects 
Heterozygous mutations in human SOX2 are often associated with anophthalmia 
(absence of eye) or microphthalmia (small eye), which suggests a defect in proliferation or 
survival of optic cup progenitor cells (OCPCs) (Fantes et al., 2003; Fitzpatrick and van Heyningen, 
2005; Ragge et al., 2005b). We have shown that mice hypomorphic for Sox2 exhibit 
microphthalmia (Taranova et al., 2006). However, ablation of Sox2 specifically in OCPCs did not 
result in increased cell death, suggesting that SOX2 may play a role in OCPC proliferation 
(Matsushima et al., 2011).  
To address this question, we used a previously generated conditional floxed allele of 
Sox2 (Sox2cond) (Taranova et al., 2006). To delete Sox2 specifically in OCPCs, we used mice 
transgenic for P0CREiresGFP, in which Cre recombinase is driven by the OC-specific enhancer of 
Pax6, and minimal promoter, P0. This Cre is expressed from embryonic day E10.0 in 
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progenitor cells competent to give rise to both NR and CE (Kammandel et al., 1999; Marquardt 
et al., 2001). We have previously crossed Sox2cond/+ mice with Sox2cond/+; P0CREiresGFP mice to 
efficiently ablate Sox2 from most OCPCs and reported that Sox2-mutant eyes (Sox2cond/cond; 
P0CREiresGFP ) were significantly smaller than those of controls (Sox2cond/+; P0CREiresGFP ) 
(Matsushima et al., 2011; Taranova et al., 2006). Here we measure BrdU incorporation and cell 
cycle length to compare proliferation of mutant OCPCs with that of controls at E16.5. 
We first quantified the percentage of cells that incorporated BrdU over two hours 
following a single injection (Fig 3-1B,C vs. D, E). Given that the central OC is more proliferative 
than the periphery, we divided the OC into radial degrees from the center to the prospective CE 
and analyzed the prospective CE as a single unit. The prospective CE was identified by sudden 
thinning of the neuroepithelium and a sharp decrease in BrdU incorporation and phospho-
Histone H3 expression (Fig 3-1F,G). While central OCPCs of controls steadily incorporated BrdU 
at an average of 41.2% (range: 36.6 – 45.2%), Sox2-ablated central OCPCs showed overall 
decreased BrdU incorporation at an average of 35.7% (range: 25.9 – 46.5%), and BrdU 
incorporation decreased in a graded manner from the center to the periphery (Fig 3-1D,E,H). 
The overall decrease in BrdU incorporation trended towards significance (p = 0.10). Consistent 
with previous reports, the prospective CE of controls was less proliferative than the central OC, 
with approximately 18% of CE progenitor cells incorporating BrdU (Fig 1H). The prospective CE 
was expanded upon Sox2 ablation, as previously shown (Fig 3-1G vs. F) (Matsushima et al., 
2011). These “CE-like” progenitor cells incorporated BrdU at an average of 8.7%, and this 
difference was not significant when compared with controls (p = 0.12) (Fig 1H). 
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Sox2-ablated OCPCs gradually increase cell cycle time 
The above data raise the possibility that in the absence of SOX2, OCPCs prematurely exit 
the cell cycle and/or increase cell cycle length in a graded manner. To address this hypothesis, 
we quantified the percentage of cells expressing Ki67, a marker of cycling cells, throughout the 
central OC of controls and mutants. Contrary to our expectations, there were significantly more 
Ki67-positive cells in Sox2-ablated central OCs compared with controls (p = 0.02) (Fig 3-2M). 
Given that Sox2-null OC progenitor cells are not competent to differentiate into neurons 
(Matsushima et al., 2011), this result suggests that they remain in the cell cycle for a prolonged 
period of time. An increase in the length of the cell cycle upon loss of Sox2 could therefore 
underlie the microphthalmia phenotype (fewer cells in mutants).  
To address whether cell cycle dynamics were affected by Sox2 ablation, we quantified 
the length of the cell cycle of central OCPCs by co-injecting thymidine analogs (see methods and 
Fig 3-2A-J). Sox2-deficient OCPCs exhibited a subtle but graded increase in S-phase and cell cycle 
lengths from the center to the periphery, whereas control OCPCs maintained a steady rate 
throughout (Fig 3-2K,L). Prospective CE cells of both controls and mutants did not cycle fast 
enough to be reliably quantified using this protocol. Together, these results suggest that upon 
loss of Sox2, OCPCs exhibit prolonged proliferation but gradually increased cell cycle time.  
Given that the cell fate conversion of the Sox2-mutant NR to CE occurs gradually over 
time and space and does not reliably manifest until postnatal day (P) 0 (Matsushima et al., 
2011), we asked whether the increase in cell cycle time culminates in cell cycle exit, which would 
be consistent with the onset of CE gene expression. To determine whether mutant cells exit the 
cell cycle to become CE, we examined expression of Ki67 at P0. In control eyes, the most 
peripheral part of the CE did not express Ki67 (Fig 3-3A- C arrowheads), but some cells of the 
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more central region did (Fig S2A-C arrows). These cells likely identify the presumptive pars 
plana, a region that has been shown to retain some proliferative capacity into adulthood in mice 
(Kiyama et al., 2012). Similarly, in mutant eyes, the most peripheral “CE-like” cells did not 
express Ki67, and this region was expanded compared with controls (Fig 3-3D-F arrowheads). 
Moreover, the more central Sox2-mutant cells retained Ki67 expression (Fig 3-3D-F). Therefore, 
upon loss of Sox2, OCPCs continued to cycle for an extended period of time, gradually increasing 
cell cycle length before exiting to become CE. This gradual increase in cell cycle length occurred 
in a graded manner such that more peripheral OCPCs slowed down and exited first, followed by 
more central cells. 
CyclinD1 protein is up-regulated in SOX2-ablated cells 
D-type cyclins are expressed in OCPCs and regulate their proliferation (Das et al., 2009; 
Das et al., 2012; Tong and Pollard, 2001). A variety of post-transcriptional and post-translational 
mechanisms regulate Cyclin D expression (Card et al., 2008; Hu et al., 2002; Lin et al., 2000; 
Spinella et al., 1999). To further investigate the role of cyclins in the proliferation defect, we 
analyzed protein expression and localization of D-type cyclins in mutant OCPCs versus controls. 
Cyclin D1 was localized to the prospective NR and excluded from the prospective CE of control 
retinas, with higher levels appearing to be localized to the boundary of the NR and CE (Fig 3-4B 
arrowheads). Surprisingly, Cyclin D1 was up-regulated in Sox2-ablated OCPCs (Fig 3-4D,E 
arrowheads). However, Cyclin d1 mRNA, as analyzed by in situ hybridization, was not increased 
in mutant OCPCs compared with controls (Fig 3-4C vs. F). Moreover, Cyclin D3 protein was 
confined to the prospective CE of controls and expanded into the central OC of mutants (Fig 3-
4G,H vs. J,K). Co-labeling with Cyclin D1 and Cyclin D3 indicated that these two proteins, which 
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are normally confined to the prospective NR and CE, respectively, were co-expressed in many 
cells of the Sox2-mutant OC (Fig 3-4M-P, arrows) (Das et al., 2012; Sicinski et al., 1995).  
D-type cyclins are thought to drive cell cycle progression in part through sequestration of the 
Cip/Kip family cell cycle inhibitor p27Kip1 (Sherr and Roberts, 1999). Moreover, the hypoplastic 
retina phenotype observed in Cyclin D1-/- mice can be fully rescued by deletion of p27Kip1 (Geng 
et al., 2001). To determine whether the increase in Cyclin D1 was associated with a concomitant 
decrease in p27Kip1, we analyzed p27Kip1 mRNA and protein in wild-type and mutant OCPCs at 
E16.5 (Fig 3-5). In wild-type OCPCs, p27Kip1 was expressed in the developing NR but excluded 
from the prospective CE (Fig 3-5A, D) (Zhang et al., 1998). By contrast, in the mutant OC, p27Kip1 
mRNA was decreased 2.3-fold, and p27Kip1 protein was absent from CRE-positive cells in the 
central OC (Fig 3-5B,C,E,F). 
The increase in Cyclin D1 and decrease in p27Kip1 could indicate the mechanism through 
which Sox2-ablated cells persistently divide. Several pathways are known to regulate OCPC 
proliferation in part through Cyclin D1, including Sonic Hedgehog (SHH) signaling (Moshiri and 
Reh, 2004; Wall et al., 2009; Wang et al., 2005). To address whether an increase in Shh mRNA 
could explain the increase in Cyclin D1 protein, we analyzed Shh mRNA levels by microarray and 
ISH. Shh expression was decreased 4.5-fold in mutants compared with controls (p = 0.0014), and 
the decrease was confirmed by ISH (Fig 3-4I vs. L). Moreover, the primary source of SHH in the 
developing retina is thought to be retinal ganglion cells (RGCs); however, Sox2-ablated OCPCs 
completely lose neural competence and are not able to produce RGCs (Matsushima et al., 2011; 
Wang et al., 2002). These data suggest that the persistent proliferation of Sox2-mutant OCPCs is 
most likely driven by an additional mitogenic pathway.  
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Canonical WNT signaling is activated in Sox2-mutant optic cups 
The graded manner of decreased proliferation in the mutant OC suggests that a 
morphogenetic pathway may be activated upon Sox2 loss (Rogulja and Irvine, 2005). OC 
development is regulated by a number of morphogens (reviewed in (Heavner and Pevny, 2012)). 
To determine which of these is regulated by SOX2 signaling, we used Illumina mouse WG-6 
expression bead chips to perform a whole genome expression screen of control and mutant 
eyes from E16.5 embryos. We first performed gene ontology analysis to confirm that genes up-
regulated in Sox2-mutant OCs were consistent with known functions of the CE and down-
regulated genes were consistent with known functions of the NR (which would indicate 
expansion of the peripheral OC) (Fig 3-6A).  We used DAVID to categorize 880 significantly up-
regulated genes and 951 significantly down-regulated genes (Huang da et al., 2009a; Huang da 
et al., 2009b). 
Up-regulated genes were enriched for secreted signaling molecules, extracellular matrix 
and cell adhesion proteins, collagens, and genes involved in organogenesis and the defense 
response (Fig 3-6B). These categories are consistent with the function of the CE, a highly 
secretory structure that maintains the intraocular pressure (IOP) through the active transport of 
fluid via Na+-K+ exchange pumps and Cl- channels (Civan and Macknight, 2004). It is thought that 
the presumptive CE is functional before it is histologically distinct, and proper IOP during 
embryonic development is necessary for the normal growth of the eye. The CE produces many 
of the proteins of the inner limiting membrane and the vitreous body (Beebe, 1986; Coulombre, 
1957; Coulombre and Coulombre, 1957). Moreover, the enrichment of defense response genes 
may suggest a previously unknown role for the presumptive CE in the host immune response, 
which would begin as early as embryonic stages. Indeed, the most significantly changed gene in 
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our screen was the defensin Defb11 (+13.04-fold change in mutants compared with controls). 
BioGPS confirmed expression of this gene in the mouse ciliary body and iris (Lattin et al., 2008; 
Wu et al., 2009).  
By contrast, down-regulated genes were enriched for molecules involved in neuronal 
development and function (Fig 3-6B). These categories included axonogenesis, synaptic 
development and signaling, neuronal differentiation and microtubule cytoskeleton (Fig 3-6B). 
Collectively, these data confirm that our screen provides a reliable indication of pathways 
potentially disrupted by Sox2 ablation. 
We used Ingenuity Pathway Analysis of our significantly differentially expressed gene set 
to identify additional signaling pathways disrupted in Sox2-mutant eyes. The most significantly 
affected pathways included REST, Tgf and canonical WNT signaling (Fig 3-6D). The apparent 
activation of REST, a repressor of neuronal differentiation, is consistent with the loss of neural 
competence of Sox2 mutant eyes (Ballas et al., 2005; Schoenherr and Anderson, 1995). Tgf 
signaling and canonical WNT signaling are two morphogenetic pathways known to be involved 
in CE fate specification (Cho and Cepko, 2006; Dias da Silva et al., 2007; Flugel-Koch et al., 2002; 
Hung et al., 2002; Liu et al., 2003a; Liu et al., 2007b; Zhang et al., 2007; Zhao et al., 2002). A 
previous report demonstrated that SOX2 antagonizes WNT signaling in the Xenopus OC, and 
Cyclin D1 is a well-established target of canonical WNT signaling in neural progenitor cells 
(Agathocleous et al., 2009; Megason and McMahon, 2002). Therefore we chose to investigate 
whether SOX2 antagonizes canonical Wnt signaling to maintain neurogenic OC fate.  
We first scanned our set of significantly changed genes for known OC-specific targets of 
canonical Wnt signaling and found ten for which the expression was changed at least 1.47-fold 
consistent with activated-Catenin (Ha et al., 2012; Kubota et al., 2004; Thut et al., 2001; 
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Trimarchi et al., 2009) (Fig 3-6E). We have previously observed that Axin2, a well-characterized 
endogenous readout of WNT activity, is sometimes expanded towards the center of the Sox2-
mutant OC, but this expansion is often variable between embryos, perhaps implicating WNT 
antagonists (Matsushima et al., 2011). To examine the expression Axin2 in relation to Sfrp2, a 
WNT antagonist expressed in the peripheral NR, we analyzed the expression of these genes on 
serial sections of wild-type and mutant OCs at E16.5 (Liu et al., 2003a). Axin2 was expanded 
toward the central mutant OC, consistent with our previous report (Fig 3-7A,B vs. F,G, left of the 
line) (Matsushima et al., 2011). Where Axin2 staining ended, Sfrp2 staining began in both wild-
type and mutant OCs, consistent with a role for Sfrp2 in Wnt antagonism (Fig 3-7C,H, right of the 
line). Moreover, the central restriction of dark Sfrp2 staining further confirmed expansion of 
peripheral OC identity into the central OC (Fig 3-7C,H, arrows). Overall, the increase in WNT 
activity indicated a de-repression of WNT signaling in the absence of SOX2. 
We hypothesized that the presence of Sfrp2 throughout the central mutant OC at E16.5 
could inhibit full expansion of WNT signaling at early stages and thus explain the delay in the cell 
fate conversion. To confirm that WNT signaling targets were up-regulated in mutant cells by 
postnatal stages, when the cell fate conversion was manifest, we examined expression of the 
Wnt targets Axin2 and LEF1, at P1. Axin2 was expressed in Sox2-mutant cells at P1 (data not 
shown). Moreover, LEF1 was ectopically expressed in all Sox2-ablated cells as in the CE of 
controls (Fig 3-7D,E vs. I,J). Interestingly, LEF1 protein was increased in a gradient from the 
center (thicker area between the arrowheads) to the periphery (thinner area between the 
arrows) of Sox2-mutant regions (Fig 3-7I,J). Collectively, these data suggest that WNT targets are 
gradually up-regulated as the retinal neuroepithelium thins and attenuates proliferation 
associated with cell fate conversion from NR to CE. Moreover, WNT antagonists may contribute 
to the graded and delayed nature of CE development in mutant eyes.  
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Genetic ablation of canonical WNT signaling partially rescues the Sox2-mutant phenotype 
The expansion of WNT signaling activation upon ablation of Sox2 supports our 
hypothesis that SOX2 antagonizes the WNT pathway to maintain NR fate. Moreover, WNT 
signaling can promote or inhibit proliferation in different contexts. Therefore, active WNT 
signaling could explain the proliferation attenuation and/or the increase in Cyclin D1 observed in 
Sox2-mutant cells.  
SOX2 has been shown to directly interact with -Catenin, the main transcriptional 
mediator of canonical WNT signaling, in many biological systems and disease states (Chen et al., 
2008; Kormish et al., 2010; Mansukhani et al., 2005; Zorn et al., 1999). These data raise the 
possibility that SOX2 and WNT signaling intersect at the level of -Catenin in OC development. 
To address this hypothesis in vivo, we performed genetic epistasis analysis of Sox2 and -catenin 
in the developing OC. We used -catenincond/+mice, in which exons 2-6 of the -catenin locus are 
flanked by loxP sites (Brault et al., 2001), and transgenic mice carrying Chx10CreGFP, a BAC 
containing Cre recombinase expressed from E11.0 in progenitor cells throughout the whole OC 
(Rowan et al., 2004). We used Chx10CreGFP in order to avoid any potential regulation of 
P0CreiresGFP by PAX6 and -Catenin. -catenincond/+ mice were crossed with previously generated 
Sox2cond/+; Chx10CreGFP mice to generate Sox2/-catenin double mutant OCPCs. We then 
compared the eyes of Sox2 single-mutants (Sox2cond/cond; Chx10CreGFP) and-catenin single 
mutants (-catenincond/cond; Chx10CreGFP) with Sox2/-catenin double mutants (Sox2cond/cond; -
catenincond/cond; Chx10CreGFP) and age-matched controls (Sox2cond/+; -catenincond/+; Chx10CreGFP) at 
E14.5 and P0. 
We first determined whether Sox2 and -Catenin could be efficiently ablated with 
Chx10CreGFP by analyzing the localization of these proteins in control and double mutant OCs. In 
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controls, SOX2 is expressed in a gradient from high in central OC nuclei to low in peripheral OC 
nuclei as previously reported (Matsushima et al., 2011). -Catenin is localized to the surface of 
cells throughout the OC (Fig 3-8A,B). SOX2 and catenin were absent from Cre-positive cells 
localized in a mosaic pattern throughout the OC, demonstrating that Chx10CreGFP was able to 
recombine both loci in the same cells (Fig 3-8C,D). Moreover, deletion of both genes did not 
result in increased cell death as assessed by activated-Caspase3 staining (data not shown). 
The CE is expanded in Sox2-mutant eyes, and -Catenin is an essential positive regulator 
of CE fate; therefore, the removal of -catenin from Sox2-mutant cells should rescue ectopic CE 
formation. To test this hypothesis, we compared expression of CE and NR markers in the eyes of 
neonatal single mutants with that of double mutants and controls (Fig 3-9 and 3-10). We used 
two methods to identify mutant cells: 1) We stained sections with an antibody to-Catenin to 
identify -Catenin-positive and negative cells; and 2) we backcrossed all lines to Rosa26R Cre 
reporter mice which express-galactosidase from the Rosa26 locus following Cre-mediated 
excision of a translational stop cassette (Soriano, 1999), resulting in genetic lineage tracing of 
Cre-expressing cells. BMP4 and Msx1, two well-established CE markers, were expressed in the 
CE and excluded from the NR of wild-type eyes at P0 (Liu et al., 2007b; Monaghan et al., 1991) 
(Fig 3-9A-H). However, neither of these markers was expressed in the CE ofCtnnb1-ablated (Cre- 
and -Galactosidase–positive) regions, consistent with previous evidence that BMP4 and Msx1 
are targets of canonical Wnt signaling in the peripheral OC (Fig 3-9I-P) (Liu et al., 2007b). 
Conversely, BMP4 and Msx1 were ectopically expressed in Sox2-ablated regions, as previously 
reported (Fig 3-9Q-X) (Matsushima et al., 2011). In support of our hypothesis, the ectopic 
expression of CE genes was rescued in Sox2/Ctnnb1 double-mutant OC cells (Fig 3-9Y-FF).  
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We next sought to determine how early in development the rescue of the Sox2-mutant 
phenotype could be observed. Evidence of peripheral OC expansion in Sox2-mutants can be 
identified as early as E13.5 (Matsushima et al., 2011). At this stage, Zic1, which is highly 
expressed in the prospective CE, was expanded into central OCPCs in Sox2 single-mutant cells. In 
Sox2/Ctnnb1 double mutant cells, Zic1 expression was restricted back to the periphery (data not 
shown). Therefore, the expansion of peripheral OC identity observed upon ablation of Sox2 as 
early as E13.5 is a result of ectopic activation of Ctnnb1 in the central OC.    
Removal of -Catenin rescued ectopic CE development in Sox2-ablated cells, but 
double-mutant regions remained hypoplastic compared with controls, suggesting that the NR 
was not fully restored.We therefore examined expression of the NR marker Hes5 and the pan-
OCPC marker Chx10 to determine the identity of double-mutant cells (Fig 3-10). Hes5 was 
expressed in NR progenitor cells throughout the central OC of wild-type controls, but expression 
was lost in Sox2-ablated regions (Fig 3-10E,F vs. K, L). Deletion of Ctnnb1 in these Sox2-mutant 
regions did not restore expression of Hes5 (Fig 3-10Q-R). By contrast, Chx10 was expressed in 
the CE and NR of wild-type controls and maintained in both single and double-mutant cells of 
the central OC (Fig 3-10C,D vs. I,J vs. O,P). Interestingly, Chx10 expression was mosaic in double-
mutant eyes in accordance with Chx10CreGFP expression (Fig 3-10M-O). Collectively, these data 
show that ectopic CE development in Sox2-mutant eyes depends on WNT/-Catenin signaling; 
however, the loss of neural competence associated with Sox2 deletion is independent of WNT 
signaling, and Chx10 expression persists in the absence of both.   
Genetic ablation of canonical WNT signaling does not rescue Cyclin D1 upregulation   
Our genetic epistasis analysis uncovered the role of WNT signaling in directing the fate 
of Sox2-mutant cells, but its role in cell cycle regulation was unclear. At P0, Sox2/Ctnnb1 double-
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mutant eyes were generally larger than Sox2 single-mutant eyes but smaller than those of wild-
type and Ctnnb1 single-mutant controls (n = 4) (Fig 4). This partial restoration of tissue in 
double-mutant eyes suggested that -Catenin may have a negative effect on OCPC proliferation. 
However, in the Xenopus OC, Wnt signaling was shown to promote OCPC proliferation 
(Agathocleous et al., 2009). 
To address this discrepancy and define the role of -Catenin in mouse OCPC 
proliferation, we examined expression of D-cyclins and SHH signaling in double-mutant, single-
mutant and wild-type control eyes at E13.5 (Fig 3-12 and Fig3-13). As expected, Cyclin D1 
protein was expressed in the central OC of wild-type and Ctnnb1 single-mutant eyes and was up-
regulated in the center of Sox2 single-mutant OCs at E13.5 (Fig. 3-12A-C and G-I vs. M-O). 
Interestingly, Cyclin D1 remained up-regulated in Sox2/Ctnnb1 double-mutant eyes (Fig. 3-12S-
U). By contrast, Ccnd1 mRNA was not up-regulated in Sox2 single-mutant or double-mutant eyes 
compared with wild-type and Ctnnb1 single-mutant controls (Fig. 3-12V and P vs. D and J). 
Similarly, removal of Ctnnb1 from Sox2-mutant OCPCs did not restore neurogenesis or, thus, Shh 
expression, both of which were detectable in the central OC of controls (Fig 3-12Q,R and W,X vs. 
E,F and K,L, arrows). Residual Shh was expressed where the few RGCs developed from Cre-
negative cells in Sox2 single-mutants and Sox2/Ctnnb1 double-mutants (Fig. 3-12Q-R and W,X). 
This residual Shh signaling may account for the prolonged proliferation and Cyclin D1 expression 
observed upon Sox2 ablation; however, other reports suggest that the population of RGCs have 
been depleted too much to maintain the amount of Cyclin D1 expression observed in Sox2 
single-mutants and Sox2/Ctnnb1 double mutants (Kiyama et al., 2012). Nevertheless, removing 
Ctnnb1 from Sox2-mutant cells did not rescue Cyclin D1 up-regulation or loss of neural 
competence at E13.5. 
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It was still possible that a difference in cell cycle regulation between single and double 
mutants was delayed until postnatal stages. We therefore examined expression of D-cyclins at 
P0 (Fig 3-14). Cyclin D1 was expressed in Chx10CreGFP-positive NR progenitor cells in wild-type 
and Ctnnb1 single-mutant eyes (Fig 3-13A-B, E-F, I- J). Surprisingly, Cyclin D1 remained up-
regulated in the central OC of Sox2 single-mutants at P0 (Fig 3-13C,G,K). Moreover, deletion of 
Ctnnb1 in these cells did not restore Cyclin D1 to wild-type levels, again supporting the idea that 
the prolonged proliferation observed in Sox2-ablated OCPCs is independent of canonical WNT 
signaling (Fig 3-13D,H,L). In all four genotypes, Cyclin D1 was excluded from the CE (wild-type 
and Ctnnb1 single-mutants) and from the thin CE-like converted regions in the far peripheral OC 
(Sox2 single-mutants and double mutants) (Fig 3-13A-L). Conversely, Cyclin D3 protein was 
restricted to the CE of wild-type and Ctnnb1 single-mutant eyes and was ectopically expressed in 
Sox2-ablated and Sox2/Ctnnb1-ablated cells of the central OC (Fig 3-13M-T). Collectively, these 
results demonstrate that SOX2 antagonizes expression of D-type cyclins in the OC independently 
of WNT/-Catenin and SHH signaling. The finding that Cyclin D1 and Cyclin D3 were expressed in 
OCPCs independently of -Catenin is consistent with previous reports that -Catenin does not 
affect the proliferation of mouse OCPCs (Fu et al., 2006). 
SOX2 antagonizes Pax6 signaling independently of -catenin 
In addition to SOX2, WNT and SHH signaling, retinal progenitor cell proliferation is 
driven by a number of pathways and transcription factors (Burmeister et al., 1996; Ferda Percin 
et al., 2000; Humayun et al., 2000). We next sought to identify which of these may support the 
observed increase in Cyclin D1 protein levels in the absence of SOX2 and -Catenin. One 
candidate was the paired-like transcription factor PAX6, which is import for maintaining retinal 
progenitor cell proliferation and multipotency (Davis-Silberman et al., 2005; Marquardt et al., 
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2001). We have previously shown that SOX2 antagonizes Pax6 to maintain NR fate in the 
developing OC (Matsushima et al., 2011). Other reports have shown evidence that Pax6 
expression in the OC is suppressed by -Catenin (Liu et al., 2007b). We therefore asked whether 
SOX2 and WNT/-Catenin signaling coordinate Pax6 levels in the OC, and whether in the 
absence of these two pathways, PAX6 is responsible for the increased CyclinD1.  
 We first examined whether the up-regulation of Pax6 expression previously reported 
in Sox2-mutant OCPCs remained up-regulated in double-mutant cells. At E13.5, Pax6 mRNA 
remained up-regulated in double-mutant OCPCs as in Sox2 single-mutant OCPCs (data not 
shown). Likewise, at P0, high Pax6 expression, as assessed by P0CreiresGFP, was expanded into the 
central OC of both Sox2 single-mutant and double-mutant eyes when compared with that of 
wild-type controls (Fig 3-14I,M vs. A). Despite the maintenance of Pax6, the ectopic expression 
of CE markers Bmp4 and Msx1 observed in Sox2-mutant eyes was rescued in double mutant 
eyes, as described above (Fig 3-14K,L vs. O,P).  Moreover, loss of the NR marker Hes5 was not 
rescued in double-mutant eyes (Fig 3-14J vs. N). Interestingly, little P0CreiresGFP expression was 
detectable in the CE of Ctnnb1 single-mutants, reflecting a reduction of CE progenitors upon loss 
of WNT signaling (Fig 3-14E-H) (Liu et al., 2007b). Nonetheless, the increased Pax6 expression 
that resulted from Sox2 loss occurred independently of Ctnnb1, and Ctnnb1 mediated the 
transcription of the CE genes Bmp4 and Msx1 independently or downstream of PAX6. These 
data indicate that PAX6 cannot regulate the expression of CE marker genes without the 
presence of -Catenin. 
 We next tested whether SOX2 antagonism of Pax6 was direct. PAX6 can bind a 
conserved paired domain site in its OC-specific enhancer, , to positively regulate its own 
expression (Baumer et al., 2002; Schwarz et al., 2000). We identified an evolutionarily conserved 
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SOX2 binding site directly adjacent to this PAX6 site (Collignon et al., 1996) (Fig 3-14A). Using 
purified recombinant SOX2 protein and electrophoretic mobility shift assay (EMSA), we 
determined that SOX2 was able to bind to this regulatory element in vitro (Fig 3-14B). Purified 
SOX2 also bound a previously characterized Notch1 regulatory element, which was used as a 
positive control, but did not bind a random sequence (Fig 3-14 and data not shown) (Taranova 
et al., 2006). Moreover, binding to labeled probe was competed away with the addition of 
unlabeled probe (Fig 3-14B). Circular dichroism indicated that the secondary structure of SOX2 
changes, or becomes more alpha-helical, when bound to the enhancer but not when bound to 
random DNA (Fig 3-15A-B). 
Genetic reduction of Pax6 does not rescue Cyclin D1 upregulation 
The above evidence that SOX2 directly antagonizes Pax6 expression in the OC raised the 
possibility that PAX6 drives the increase in Cyclin D1 observed upon Sox2 ablation. To test this 
hypothesis, we genetically decreased Pax6 in Sox2-ablated OCPCs using Pax6Sey/+ (small eye) 
mice as previously described (Matsushima et al., 2011). Pax6Sey/+ mice contain a nonsense 
mutation in the Pax6 locus, resulting in a truncated protein widely used as a Pax6-null (Hill et al., 
1991; Hogan et al., 1988).  We compared Cyclin D1 expression in Sox2cond/cond; Chx10CreGFP single-
mutant OCs with Sox2cond/cond; Pax6Sey/+; Chx10CreGFPdouble-mutant OCs and Pax6Sey/+ single-
mutant and wild-type controls at E14.5 (Fig 3-14). As expected, Cyclin D1 was upregulated in 
Sox2 single-mutants when compared with wild-type and Pax6 single-mutant controls (Fig 3-
14G,H vs. C-F). However, reduction of Pax6 in the Sox2-mutant background did not restore 
Cyclin D1 to wild-type levels, suggesting that PAX6 does not drive Cyclin D1 up-regulation in the 
absence of Sox2.  
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Trophic pathways are activated in the Sox2-mutant OC  
In addition to PAX6, trophic factors have been implicated in OCPC proliferation. For 
instance, bFGF (FGF2) and EGF were shown to stimulate human fetal retinal progenitors to 
proliferate in vitro (Kelley et al., 1995). Intriguingly, Bdnf, a neurotrophin known to be important 
for neuronal differentiation and survival, is one of the ten most up-regulated genes in the Sox2-
ablated OC (+6.78-fold change relative to controls). In corroboration with our model, Bdnf is 
expressed in the peripheral OC of developing mouse embryos (Bennett et al., 1999). We 
therefore hypothesized that growth factors present in Sox2-ablated OCPCs may support their 
prolonged proliferation. We used IPA to identify potentially upregulated trophic pathways. 
Based on the increased expression of myriad targets known to be regulated by FGF2, IPA 
predicted that this pathway is activated in the Sox2-deficient OC (Fig 3-14K). We also confirmed 
increased BDNF receptor, TrkB, FGF receptor, Fgfr2 (Fig 3-14I). Like Bdnf, some of these have 
been shown to be expressed in the presumptive CE of mice (de Iongh and McAvoy, 1993; 
Reneker and Overbeek, 1996). These data suggest that the presence of BDNF and FGF in the 
optic cup margin (OCM) supports OCPC proliferation in the absence of SOX2 (Fig 3-14K). Given 
that Sox2-single-knockout and Sox2/Ctnnb1 -double-knockout cells retain stem-like properties, 
including maintenance of Cyclin D1, Cyclin D3 and the OC progenitor markers Chx10 and Pax6, 
we propose that removal of SOX2 and -Catenin reveals a primitive retinal progenitor cell that is 
capable of prolonged proliferation. However, without either SOX2 or -Catenin, these cells are 
not competent to differentiate into retinal neurons or CE. 
  
 110 
Discussion 
SOX2 and -Catenin co-regulate the neurogenic/non-neurogenic boundary of the retina  
In this study, we have used genetic epistasis analysis in the mouse to show that SOX2 
and canonical Wnt signaling coordinately regulate opposing cell fates in the OC: neurogenic 
neural retina (NR) and non-neurogenic ciliary epithelium (CE), respectively (Modeled in Fig. 3-
16). Sox2 loss-of-function, like Ctnnb1 gain-of-function, results in restriction of NR progenitor 
identity and expansion of CE progenitor identity (Fig. 3-16C vs. A). Conversely, Ctnnb1 loss-of-
function results in expansion of NR progenitor identity and restriction of CE progenitor identity 
(Fig. 3-16B vs. A). Loss of both Sox2 and Ctnnb1causes restriction of NR identity similar to the 
Sox2 single-mutant phenotype, but CE-specific genes fail to be up-regulated (Fig. 3-16D vs. C). 
Together, these data demonstrate that precise coordination of SOX2 and WNT signaling is 
necessary to ensure proper development of the neural retina and circumjacent ciliary body. 
An additional pathway that has been implicated in this cell fate decision is TGF 
signaling, although the specific sources of ocular TGF are currently unclear (Dias da Silva et al., 
2007; Flugel-Koch et al., 2002; Hung et al., 2002; Veien et al., 2008; Zhang et al., 2007; Zhao et 
al., 2002). Forced expression of Noggin, a TGF antagonist, in lens fiber cells, inhibited 
expression of Bmp4 and Bmp7 in the presumptive CE and caused a cell fate shift of these cells 
from CE to NR. This cell fate conversion was rescued by transgenic co-expression of Bmp7 (Zhao 
et al., 2002). Conversely, over-expression of Bmp7 in the developing lens inhibited neural retinal 
development, causing widespread apoptosis throughout the retina (Hung et al., 2002). These 
experiments suggest that the developing lens may provide a source of TGFthat instructs the 
peripheral optic cup margin to become CE. However, the CE is correctly specified in the absence 
of a lens, and there is recent evidence that the lens may be more important for maintaining CE 
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fate rather than instructing it (Kitamoto and Hyer, 2010; Zhang et al., 2007). Therefore, either 
another source of ocular TGFexists separate from the lens, or TGF signaling is downstream of 
a more potent regulator of CE fate (Zhang et al., 2007). Here we have shown that WNT signaling 
acts upstream of TGF in the regulation of CE fate such that expression of Bmp4/7 and the BMP 
target gene Msx1 is lost in Ctnnb1 mutant cells. 
SOX proteins, including SOX2, have been shown to physically interact with -Catenin to 
modulate the expression of WNT target genes (reviewed in (Kormish et al., 2010))(Chen et al., 
2008; Mansukhani et al., 2005; Zorn et al., 1999). Our data support a model in which SOX2 and 
WNT signaling in the OC intersect at the level of target gene expression; however, it is unclear 
how SOX2 antagonizes these genes (Fig. 3-16E). SOX2 is distantly related to the TCF/LEF family 
of transcription factors, which also bind DNA through an HMG domain, and thus could compete 
with TCF/LEF for direct DNA binding (Fig. 3-16E) (Haremaki et al., 2003). However, one report 
showed that the SOX2 HMG domain was not required to inhibit -Catenin-induced gene in 
expression in osteoblasts, suggesting that SOX2 antagonizes Wnt signaling through its C-
terminus, most likely via -Catenin sequestration (Mansukhani et al., 2005). Attenuation of WNT 
signaling in Sox2 mutant cells rescued the ectopic expression of CE-specific genes but did not 
rescue all of the hallmarks of the Sox2-mutant phenotype, including the thinning of the retinal 
neuroepithelium and the loss of NR identity. Therefore, the role of WNT signaling in the Sox2-
mutant OC is to affect the cell fate conversion by turning on a set of CE-specific genes. This 
appears to occur in a gradient in which the most peripheral cells exit the cell cycle first and 
convert to CE followed by a progressive slowing down of central OC cells. The delay in this 
conversion may be due to the time needed to recruit co-activators to de-repressed WNT target 
genes, to overcome WNT antagonists such as Sfrp2, or to exit the cell cycle.  
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The observation that OCPCs can proliferate and survive without both SOX2 and 
canonical WNT signaling is intriguing, given the necessity of these two pathways in specifying NR 
vs. CE fate. Double-mutant cells do not express NR or CE-specific markers, but maintain the pan-
OCPC markers Chx10 and Pax6 in addition to up-regulating Cyclin D1 and Cyclin D3. The increase 
in trophic factors upon Sox2 ablation, and the maintenance of D-type Cyclins in both Sox2 single-
mutant and Sox2/Ctnnb1 double-mutant cells, suggests that SOX2 maintains a primitive stem 
cell population in the mouse OC in a competent state. These “stem-like” cells are revealed and 
expanded upon SOX2 ablation, and they are maintained even in the absence of WNT signaling. 
In other words, primitive ciliary margin stem-like cells are expanded in the Sox2/Ctnnb1 double 
mutant eye, and although they can proliferate, they are not competent to become either NR 
(without SOX2) or CE (without -Catenin) (Fig. 3-16D). 
SOX2 and -Catenin maintain a primitive stem cell niche in the peripheral OC in the mouse 
The eyes of lower vertebrates grow throughout adulthood and can regenerate in 
response to injury. The major source of progenitor cells for regular growth and regeneration of 
injured retinal neurons is the ciliary marginal zone (CMZ) located at the periphery of the neural 
retina (reviewed in (Reh and Fischer, 2001). Lineage analysis of the CMZ in Xenopus has 
identified two types of progenitor cells in this population: a more primitive slower cycling stem 
cell located at the far periphery of the CMZ and a faster cycling more fate-restricted cell located 
adjacent to the peripheral neural retina (Wetts et al., 1989). It is generally accepted that 
mammalian eyes do not contain an active CMZ. However, prolonged proliferation of cells in the 
retinal margin and pars plana (proximal CE) can be stimulated in vivo (Kiyama et al., 2012; 
Moshiri and Reh, 2004), and pigmented CE cells from adult mammalian eyes exhibit properties 
of neural stem cells in vitro (Ahmad et al., 2000; Tropepe et al., 2000).  
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Here, we have provided further evidence for a limited ciliary margin-like region in the 
developing mouse OC periphery and implicate SOX2 in its maintenance.  We propose a model in 
which OCPCs give rise to either NR progenitor cells in the central OC, where they maintain SOX2, 
or CE progenitor cells in the far periphery, where they lose SOX2. In addition, a third progenitor 
cell type located at the boundary of NR and CE progenitors is capable of giving rise to both NR 
and CE and exhibits properties of central CMZ cells of lower vertebrates (Fig 6L). In mice, these 
cells highly express the WNT antagonist Sfrp2 and retain SOX2 expression in order to retain 
neural competence. This model is consistent with a role for SOX2 in simultaneously conferring 
neuronal potential and maintaining progenitor cells in a poised state; SOX2 is necessary for the 
competence of neural progenitor cells (NPCs) to differentiate into neurons but must be down-
regulated in order for NPCs to exit the cell cycle and differentiate (Agathocleous et al., 2009; 
Graham et al., 2003; Kishi et al., 2000; Taranova et al., 2006).  
SOX2 regulates Cyclin D1 independently of PAX6, SHH and canonical Wnt signaling 
We have shown for the first time that loss of Sox2 in a neural progenitor cell population 
leads to increased Cyclin D1 protein. Although this result is consistent with a role for SOX2 in 
maintaining stem cell quiescence, it is surprising for two reasons: first, SOX2 has been shown to 
promote proliferation through the up-regulation of Cyclin D1, particularly in breast cancer cell 
lines (Chen et al., 2008). Therefore, ablation of Sox2 would be expected to result in decreased 
Cyclin D1 protein. Secondly, Cyclin D1 is often used to differentiate the prospective NR from the 
prospective CE. Except for Cyclin D1, all pan-NR markers examined to date have been lost in 
Sox2-ablated cells. These data suggest that Cyclin D1 expression is regulated by additional 
pathways. 
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Given that Cyclin D1 is a well-characterized positive target of canonical WNT signaling in 
neural progenitor cells, we examined whether the increase in Cyclin D1 was mediated by -
Catenin. This scenario would fit well with the expansion of Wnt signaling observed in Sox2-
ablated OCPCs. However, deletion of -catenin in Sox2-mutant cells did not rescue Cyclin D1 up-
regulation at E16.5 or P0. Moreover, reduction of Pax6, a highly conserved regulator of OCPC 
proliferation, in the Sox2-mutant OC did not rescue Cyclin D1 up-regulation. A third regulator of 
OCPC proliferation is Sonic Hedgehog (SHH) (Moshiri and Reh, 2004; Sakagami et al., 2009; Wall 
et al., 2009; Wang et al., 2005). In our model, Shh was drastically reduced by the near complete 
elimination of RGC production (Kiyama et al., 2012; Wang et al., 2005). However, OCPCs were 
able to proliferate and maintain high Cyclin D1 in the near absence of Shh. 
These results led us to hypothesize additional pathways that could up-regulate Cyclin D1 
in the absence of the above-mentioned regulators. One example of SOX2 indirectly antagonizing 
Cyclin D1 levels occurs in human embryonic stem cells: SOX2 together with OCT4 promotes the 
expression of miR-302, a cluster of eight microRNAs expressed in pluripotent cells. Specifically, 
miR-302a was shown to repress Cyclin D1 post-transcriptionally via its 3’UTR (Card et al., 2008). 
Such a scenario could occur in OCPCs in which repression of Cyclin D1 translation becomes de-
repressed in the absence of SOX2. Indeed, ablation of Dicer1, a major mediator of microRNA 
biosynthesis, in mouse OCPCs led to expansion of the Cyclin D1 expression domain and a 
persistent “ciliary margin-like” region in the OC (Davis et al., 2011b). Conversely, degradation or 
sequestration of Cyclin D1 protein may become inhibited, especially given that only Cyclin D1 
protein, not Ccnd1 mRNA, was increased. The up-regulation of trophic factors observed upon 
Sox2 ablation may regulate Cyclin D1 protein post-translationally. In olfactory sensory neuron 
precursors for example, BDNF elicits a rapid increase in Cyclin D1 independently of both 
transcription and translation (Simpson et al., 2007).  
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Lastly, SOX2 could antagonize Cyclin D1 via direct regulation of p27Kip1 expression. A 
recent report demonstrated that SOX2 maintains the quiescent state of inner pillar cells of the 
postnatal mouse auditory sensory epithelium by activating p27Kip1 transcription (Liu et al., 2012). 
Likewise, SOX2 has been shown to be down-regulated in some human gastric carcinomas 
exhibiting increased Cyclin D1 protein and decreased p27Kip1 expression. Given the absence of 
p27Kip1 in Sox2-null OCPCs, SOX2 may also promote the transcription of p27Kip1 in these cells. 
Moreover, the loss of p27kip1 is consistent with the loss of neurogenic fate, which provides a 
possible link between cell cycle regulation and fate determination in neuroepithelial cells 
(Bonner et al., 2008; Godin et al., 2012; Hardcastle and Papalopulu, 2000; Liu et al., 2012). 
The Sox2-deficient OC provides a resource to identify genes important for CE development 
and glaucoma pathogenesis 
Many of the most significantly up-regulated genes following Sox2 ablation were 
associated with ion exchange and secretion (Fig. 3-6). These data are consistent with the 
function of the ciliary body to maintain the intraocular pressure (IOP) through the active 
transport of fluid via Na+-K+ exchange pumps and Cl- channels (Civan and Macknight, 2004). 
Elevated IOP is often associated with glaucoma, a blinding disease characterized by the loss of 
retinal ganglion cells and optic nerve degeneration. One approach to the treatment of glaucoma 
is to lower IOP through the reduction of aqueous humour inflow. How the ciliary body integrates 
multiple mechanisms to regulate inflow is still not well understood (Civan and Macknight, 2004). 
Given that the presumptive ciliary body epithelium significantly expands upon Sox2 ablation, our 
genome-wide screen of up-regulated transcripts in these mutants may reveal previously 
unidentified genes important for the development and function of the CE.  
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Figure 3-1 Sox2-ablated OCPCs gradually decrease proliferation from the center to the 
periphery at E16.5. (A) Diagram of a transverse section through the OC indicating the region of 
SOX2 expression (B-G) Staining for BrdU, phosphorylated histone H3 and CRE in control (B,C,F) 
and Sox2-mutant (D,E,G) OCs allowed to incorporate BrdU over two hours following a single 
injection. Mutant CRE-expressing cells in D and E gradually decrease BrdU incorporation, while 
central OCPCs of controls (B,C) steadily incorporate BrdU. The prospective CE is expanded in 
mutants (G) compared with controls (F). (H) Quantification of the percent of cells that 
incorporate BrdU over the total number of Hoechst-positive cells throughout the OC of controls 
(blue) and mutants (orange). Scale bars: G ( for F,G): 50 m; E ( for B-E): 100 m 
  
Figure 3-2 The Sox2-ablated OC shows a graded increase in the lengths of S-phase and cell cycle at E16.5. (A-J) Staining for GFP, BrdU and IdU 
designates cells that leave S-phase (green, arrows) and cells that remain in S-phase (red, arrowheads) in wild-type (A-G) and mutant (C-J) OCs. 
(K,L) Quantification of S-phase (K) and cell cycle (L) length in central OCPCs divided into degrees from the center to the periphery in wild-type 
(blue) and Sox2-mutant (orange) OCs. (M) Quantification of the percentage of Ki-67-positive cells over total Hoechst-positive cells indicates 
significantly increased percentage of cycling cells in mutants (orange) compared with controls (blue). Scale bars: D (for A-D) 100m; J (for E-J) 
50m 
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Figure 3-3 Many Sox2-deficient OCPCs prematurely exit the cell cycle by postnatal day 0. (A-F) 
Staining for GFP, Ki-67 and Hoechst in wild-type (A-C) and mutant (D-F) eyes at P0. Ki-67 is 
expressed in NR progenitor cells throughout the central OC (A, red) and in Cre-positive CE cells 
adjacent to the NR in controls (B,C, arrows) but not in peripheral CE cells (B,C , arrowheads). 
Similarly, Ki-67 is expressed in centrally located Cre-positive Sox2-ablated cells (E-F, arrows) but 
not in peripheral Sox2-ablated cells (E-F, arrowheads). 
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Figure 3-4 D-type Cyclins are aberrantly expressed in Sox2-ablated OCPCs at E16.5. (A, B, D, E) 
Cyclin D1 protein is up-regulated or stabilized in Cre-positive Sox2-ablated cells (D,E 
arrowheads) compared with controls (A,B). CyclinD1 protein appears elevated in the peripheral 
NR of controls (A,B arrowheads). (C,F) ISH of Ccnd1 indicates that mRNA is not increased in 
mutants compared with controls. (G,H,J,K) Cyclin D3 is ectopically expressed in central mutant 
OCPCs (J,K box) but is restricted to the peripheral OC of controls (G,H, arrowheads). (I,L) Shh is 
decreased in central OCPCs of mutants (L) compared with controls (I). (M-P) Magnification of 
the box in K showing that Cyclin D1 and Cyclin D3 are aberrantly co-expressed in some Sox2-
mutant central OCPCs (P arrows).  
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Figure 3-5 P27Kip1 is absent from Sox2-ablated OCPCs at E16.5. (A-F) Staining for GFP, p27Kip1 
and Hoechst in wild-type (A,D) and mutant (B,C,E,F) eyes shows high expression in the central 
OC of controls (A,D) but reduced or absent expression in the GFP-positive central OC of mutants 
(B,C,E,F).  
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Figure 3-6 Genome-wide expression analysis of SOX2-ablated OCs reveals functional 
characteristics of the peripheral and central OC and indicates increased WNT activity at E16.5. 
(A) Diagram of expansion of peripheral OCPCs (orange) in mutant OCs compared with controls. 
(B) Gene ontology categories of peripheral OCPCs/CE progenitor cells (orange) and central 
OCPCs/NR progenitor cells (blue). (C) Potential pathways activated in the developing OC in the 
absence of SOX2 include the peripheral OC regulators Tgf and canonical WNT signaling. 
  
Figure 3-7 WNT activity is expanded in the Sox2-ablated OC at E16.5 and P1. (A-F) Axin2 is specifically expressed in the prospective CE (left of 
the line) at E16.5 (A,B) and Sfrp2 is adjacent to the CE in the peripheral NR (right of the line) (C, arrows). LEF1 is restricted to the CE at P1 (D,E, 
arrows). (G-L) Axin2 is expanded into the central mutant OC (F,G left of the line) and Sfrp2 is just adjacent to this region (H, right of the line). The 
areas with highest Sfrp2 expression (arrows in H) correspond with high BrdU incorporation (inset in H). Axin2 is expressed in thin Sox2-ablated 
cells, and LEF1 is expressed in GFP-positive CE-like cells at P1 (H-J). Ectopic LEF1 gradually increases as the epithelium thins (K,L, area between 
arrowheads versus area between arrows). 
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Figure 3-8 SOX2 and -CATENIN can be efficiently ablated from the OC using Chx10CreGFP 
without causing increased cell death. (A,B,D,E) Staining for GFP, SOX2 and -CATENIN indicates 
efficient ablation of both of these proteins in double-mutants (C,D) compared with controls 
(A,B). (C,F) Staining for cleaved Caspase 3 indicates no significantly increased cell death upon 
ablation of SOX2 and -CATENIN.  .
   
 
Figure 3-9 Deletion of Ctnnb1 in Sox2-ablated OCPCs rescues the ectopic expression of CE genes (A,B,I,J,Q,R,Y,Z) -CATENIN is efficiently 
ablated in Ctnnb1 single-mutants (I-P) and Sox2/Ctnnb1 double-mutants (Y-FF) compared with Sox2 single-mutants (Q-X) and wild-type 
littermates (A-H). (C-H) Bmp4 (C-E) and Msx1 (F-H) are specifically expressed in GFP-positive (E) and -gal-positive (H) CE. (K-P) Bmp4 (K-M) and 
Msx1 (N-P) are not expressed in GFP-positive (M, arrow) and -gal-positive (P, arrow) CE of Ctnnb1 mutants. (Q-X) Bmp4 (S-U) and Msx1 (V-X) 
are not expressed in GFP-positive (U, arrowheads) and -gal-positive (X, arrowheads) central OCPCs of Sox2 mutants. (Y-FF) Ectopic expression 
of Bmp4 (AA-CC) and Msx1 (DD-FF) is rescued in GFP-positive (CC arrowheads) and -gal-positive (FF arrowheads) central OCPCs of Sox2/Ctnnb1 
double mutants. 
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Figure 3-10 Deletion of Ctnnb1 in Sox2-ablated OCPCs does not rescue NR identity. (A,B,G,H, M,N) HC for GFP, -CATENIN and Hoechst 
identifies -CATENIN-depleted regions in double mutants (M,N) compared with Sox2 single-mutants (G,H) and controls (A,B). (C-F) Chx10 is 
expressed throughout the whole OC (C,D), and Hes5 is restricted to NR progenitor cells (E,F) in wild-type controls. (I-L) Chx10 is maintained in 
Sox2-ablated cells (I,J) but Hes5 is not (K,L). (O-R) Likewise, Chx10 is maintained in Sox2/Ctnnb1 double-ablated cells (O,P) but Hes5 is not 
expressed in these cells (Q,R). 
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Figure 3-11 Deletion of Ctnnb1 in Sox2-ablated OCPCs does not rescue increased Cyclin D1 at E13.5. (A-D,G-J,M-P,S-V) Cyclin D1 protein is 
localized to the central OC of control (A-C) and Ctnnb1 single-mutants (G-H), and Ccnd1 mRNA is restricted to the prospective NR of both 
controls (D) and Ctnnb1 mutants (J). Cyclin D1 protein is up-regulated in the central GFP-positive OC of both Sox2 single mutants (M-O) and 
Sox2/Ctnnb1 double mutants (S-U). However, Ccnd1 mRNA expression is not up-regulated (P,V vs. D,J). (E,F,K,L,Q,R,W,X) Staining for -TubulinIII 
(E,K,Q,W) and Shh (F,L,R,X) indicate specific expression of Shh in the RGC layer of controls (E,F arrowheads) and Ctnnb1 single-mutants (K,L 
arrowheads) and residual expression in the few neuronal cells that differentiate in Sox2 single-mutants (Q,R) and double mutants (W,X).  
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Figure 3-12 Deletion of Ctnnb1 in Sox2-ablated OCPCs does not rescue the aberrant expression 
of in D Cyclins observed in Sox2-deficient cells at P0. (A-L) Staining for GFP, Cyclin D1 and 
Hoechst indicates Cyclin D1 expression restricted to NR progenitor cells in controls (A,E,I) and 
Ctnnb1-mutant eyes (B,F,J). Cyclin D1 is increased in GFP-positive cells in the central OC of Sox2-
mutant eyes (C,G,K,arrows) and in Sox2/Ctnnb1 double-mutant eyes (D,H,L, arrows). (M-T) 
Staining for GFP, Cyclin D3 and Hoechst indicates Cyclin D3 expression restricted to CE cells in 
controls (M,N, arrows) and Ctnnb1 single-mutant eyes (N,R, arrows) but ectopic expression in 
GFP-positive cells in the central OC of Sox2-mutant eyes (O,P, arrows) and Sox2/Ctnnb1 double-
mutant eyes (S,T, arrows).  
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Figure 3-13 Deletion of Ctnnb1 and Sox2 in peripheral OCPCs rescues the ectopic expression of 
CE genes at P0. (A,E,I,M) Staining for GFP, SOX2 and Hoechst identifies SOX2-ablated regions in 
Sox2 single-mutant (I) and double-mutant eyes (M) compared with Ctnnb1 single-mutant (E) and 
control eyes (A). (B-D) Hes5 is specifically expressed in the NR (B), and Bmp4 and Msx1 are 
specifically expressed in the CE (C,D) of control eyes. (F-H) ISH of NR and CE genes shows correct 
specification of these regions in Ctnnb1-mutant eyes. (J-L) Hes5-positive NR identity is lost (J), 
and Bmp4 (K) and Msx1 (L) are ectopically expressed in Sox2-mutant eyes. (N-P), ISH of NR and 
CE genes in double-mutant eyes shows loss of Hes5-positive NR identity (N) but rescue of the 
ectopic expression of Bmp4 (O) and Msx1 (P) observed in Sox2-mutant eyes.  
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Figure 3-14 SOX2 directly antagonizes Pax6, but reduction of Pax6 in Sox2-ablated OCPCs does 
not rescue increased Cyclin D1 at E14.5. (A) A conserved SOX2 consensus binding sequence 
(blue) was located directly adjacent to a previously characterized PAX6 binding site (red) in the 
Pax6 OC-specific enhancer . (B) Purified SOX2 binds this sequence (left arrow) and a previously 
characterized regulatory element of Notch1 (top right arrow). (C-J) Staining for GFP and Cyclin 
D1 shows expression in the central OC of control (C,D) and Pax6Sey/+ mutants (E,F) and increased 
protein in the central OC of Sox2-mutants (G,H) and Sox2/Pax6Sey/+double mutants (I,J). (K) Many 
FGF2 targets are increased more than 1.6-fold in the Sox2-mutant OC. These data support a 
novel model in which cells at the boundary of NR and CE proliferate and retain the capacity to 
become NR or CE for a prolonged period of time. (L) Illustration of the location of OCPC types: 
prospective CE cells at the periphery, neurogenic progenitor cells in the center and marginal 
progenitor cells at the boundary.   
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Figure 3-15 CD spectra of SOX2 with DNA versus and DNA. A The CD spectrum of SOX2 mixed 
with  enhancer DNA (green) shifts to the left when compared with the CD spectrum of SOX2 
separated from  enhancer DNA (blue). This shift indicates a gain of helical structure. B The 
CD spectrum of SOX2 mixed with random DNA (red) completely co-localizes with the CD 
spectrum of SOX2 separated from random DNA.  
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Figure 3-16 Model of how SOX2 and canonical WNT signaling regulate the neurogenic 
boundary of the OC. (A-D) The boundary between NR (green) and CE (red) is shifted peripherally 
in the Ctnnb1-mutant OC (B vs. A), supporting a role for canonical WNT signaling in CE 
specification. BMP signaling is also decreased in these cells. Conversely, the NR-CE boundary is 
shifted centrally in the Sox2 single mutant OC (C vs. A), supporting a role for SOX2 in NR 
specification. WNT and BMP signaling are expanded in SOX2-ablated cells. The NR-CE boundary 
remains centrally shifted in the Sox2/Ctnnb1 double-mutant OC (D vs. A). However, BMP 
signaling and other classical CE markers fail to be expressed in this expanded “CE-like” region. 
(E) Model of how SOX2 and -Catenin coordinately regulate the neurogenic boundary of the 
retina: In the peripheral OC, -Catenin (yellow) in complex with TCF/LEF (red) regulates the 
transcription of classical CE markers, including BMPs. In the central OC, SOX2 (green) may 
compete with TCF/LEF/-Catenin for binding regulatory elements of these genes.
 Allele  Primers (5' to 3')  Product size  Conditions  
Sox2cond Fwd: CAGAGGACTCGTGTTTGGGAAC   floxed: 307 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: TCTTGGATACATAAGGGTGGATGG wt: 345 bp  57°C, 30 seconds at 72°C) x35, 5 minutes at 72°C  
Sox2dcond Fwd: CTTCTTTCCGTTGATGCTTTCG  589 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: ATCTTGGTGGCTGAACAGTTATCC  
 
57°C, 30 seconds at 72°C) x35, 5 minutes at 72°C  
Cre Fwd: GCTAAACATGCTTCATCGTCGG  750 bp  4 minutes at 94°C, (15 seconds at 94°C, 30 seconds at  
 
Rev: GATCTCCGGTATTGAAACTCCAGC  
 
57°C, 30 seconds at 72°C) x35, 5 minutes at 72°C  
Rosa26Rep Primer 1: AAAGTCGCTCTGAGTTGTTAT  transgene: 650 bp   4 minutes at 94°C, (30 seconds at 93°C, 30 seconds at  
 
Primer 2: GCGAAGAGTTTGTCCTCAACC  wt: 340 bp 58°C, 1 minute at 65°C) x35, 10 minutes at 72°C  
 
Primer 3: GGAGCGGGAGAAATGGATATG  
  Pax6-Sey Fwd: AACTTTTTGGCTTGCTTTGTCATTC  188 bp  1 minute at 95°C, (20 seconds at 92°C, 20 seconds at  
 
Rev: CTGAGCTTCATCCGAGTCTTCTCA  
 
63.5°C, 50 seconds at 72°C) x34, 4 minutes at 72°C  
Pax6-wt  Fwd: GAACACCAACTCCATCAGTTCTAACG   646 bp  1 minute at 95°C, (20 seconds at 92°C, 20 seconds at  
 
Rev: CTTTCCCGGGCAAACACATC 
 
63.5°C, 50 seconds at 72°C) x34, 4 minutes at 72°C  
β-catenincond  Primer 1: AAGGGTAGAGTGATGAAAGTTGTT floxed: 324 bp  1 minute 30 seconds at 94°C, (30 seconds at 94°C, 
 
Primer 2: CACCATGTCCTCTGTCTATTC wt: 221 bp  1 minute at 60°C, 1 minute at 72°C) x35, 
 
Primer 3: TACACTATTGAATCACAGGGACTT floxdel: 500 2 minutes at 72°C 
Table 3-1 PCR primers and genotyping protocols. 
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 Primary Antibodies Source Dilution 
mouse anti-BrdU Becton Dickinson 1:500 
rat anti-BrdU AbD Serotec 1:500 
rabbit anti-cleaved caspase 3 Cell Signaling 1:250 
chick anti-GFP Abcam 1:2000 
rabbit anti-phospho-histone H3 Abcam 1:1000 
rabbit anti-CyclinD1 Thermo Scientific 1:400 
mouse anti-CyclinD3 Cell Signaling 1:100 
rabbit anti--Catenin Abcam 1:250 
rabbit anti-Galactosidase Molecular Probes 1:10000 
rabbit anti-Ki-67 Abcam 1:1000 
mouse anti-p27Kip1 Thermo Scientific 1:100 
rabbit anti-LEF1 Cell Signaling 1:100 
mouse anti-SOX2 R&D 1:100 
rabbit anti-SOX2 Millipore 1:3000 
Secondary Antibodies Source Dilution 
Goat anti-mouse IgG, IgG2a Alexa Flour 546, 633 Invitrogen 1:1000 
Goat anti-rabbit IgG 546, 633 Invitrogen 1:1000 
Goat anti-chicken IgG Alexa Fluor 488 Invitrogen 1:1000 
Goat anti-rat Alexa Fluor IgM 546 Invitrogen 1:1000 
Fluorescent Dyes Source Dilution 
Hoechst 33258 Invitrogen 1:10000 
Table 3-2 Working dilutions of antibodies for immunohistochemistry. 
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Chapter IV: DISCUSSION AND FUTURE DIRECTIONS 
Re-analysis of the default model of neural induction 
The default model of neural induction is based on the finding that Xenopus ectoderm 
will become neural plate in the absence of any inductive cues. However, as discussed in Chapter 
I, conflicting reports from studies in chick leave the default model up for debate. This thesis 
project approaches the default model of neural induction from the standpoint of the optic cup 
and finds that the ground state of OCPCs is neural retina, and NR identity is fully dependent on 
SOX2. SOX2 maintains neural fate in part via antagonism of PAX6 and canonical WNT signaling. 
The optic cup can serve as a model of SOX2 function in neural induction 
Given the difficulty of accessing and manipulating the mammalian epiblast, the 
molecular mechanisms that specify neural fate remain a mystery. The optic cup is an 
appropriate model to study neural fate specification and the role of SOX2 as a neural ectoderm 
determinant. Ablation of SOX2 in the OC results in complete loss of neural characteristics and 
conversion to non-neurogenic epithelium reminiscent of epidermis. This cell fate conversion is 
associated with classical non-neural features including the loss of the ability to generate 
neurons, reduced proliferation, differential expression of cell cycle regulators and activated 
WNT/-Catenin signaling. 
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Neurogenic versus Non-neurogenic 
Neural fate is defined by the competence to generate neurons (Wills et al., 2010). SOX2 
is expressed throughout the epiblast before neural plate and epidermis are specified. Therefore, 
SOX2 expression itself does not define neural fate in all instances and is not sufficient to bestow 
neural competence (Wills et al., 2010). The maintenance of SOX2 specifically in neural plate, 
however, does implicate SOX2 as being necessary for neural competence. Indeed, without SOX2, 
epiblast cells are not able to generate neurons (Kishi et al., 2000; Wills et al., 2010). Likewise, 
SOX2 is expressed throughout the optic vesicle prior to the specification of neural retina and 
ciliary epithelium. SOX2 is specifically maintained in the NR and is required for retinal 
neurogenesis; however, ectopic expression of SOX2 in the CE is not sufficient to induce 
neurogenesis (W Heavner unpublished data). Again, in this instance, SOX2 is implicated in neural 
competence but alone is insufficient to bestow it. The OC therefore, provides a system with 
which to address the mechanism whereby SOX2 maintains the ability of a progenitor cell to 
generate a neuron. Given that SOX2 alone cannot induce neural competence, it is crucial to 
identify its transcriptional co-activators and downstream targets in order to fully understand 
what it means to be “neural-competent.” 
Differential Cell Cycle Regulation  
A persistent question in developmental biology is how cell cycle and cell fate are linked. 
Neural fate is associated with the cell cycle inhibitor p27Kip1 (Hardcastle and Papalopulu, 2000), 
and a mechanism for p27 in neuronal differentiation was recently identified (Godin et al., 2012). 
The loss of neural retinal fate upon ablation of SOX2 is characterized by loss of p27Kip1 (Chapter 
III). In addition to p27Kip1, other cell cycle regulators exhibit differential expression between the 
central and peripheral OC (Barton and Levine, 2008; Schwank and Basler, 2010). In the SOX2-
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ablated OC, both positive and negative cell cycle regulators were present in the increased and 
decreased gene sets. Cyclin D2, Cyclin D3 and Cyclin E1 all showed increased expression in 
mutants compared with controls, and each of these positive cell cycle regulators have been 
shown to be expressed in the peripheral OC (Fig 4-1) (Trimarchi et al., 2009). Moreover, 
expression of the Cip/Kip family members, p21Cip1 (Cdkn1a) and p57Kip2 (Cdkn1c), was slightly 
increased, 1.5- and 1.4-fold, respectively (Fig 4-1). These two cell cycle inhibitors are normally 
excluded from the prospective NR, and their increase could indicate a cell fate shift from NR to 
CE (Zhang et al., 1998). Conversely, Cyclin D1, p27Kip1 (Cdkn1b) and p19Ink4d (Cdkn2d), which are 
associated with neural fate, were decreased in mutants compared with controls (Fig 2C) 
(Cunningham et al., 2002; Godin et al., 2012; Liu et al., 2007b). 
Together, these results demonstrate that overall changes in cell cycle gene expression 
most likely indicate a shift in cell fate rather than a functional mechanism of proliferation 
inhibition in the Sox2-mutant OC. Nonetheless, the stark contrast in expression profiles between 
NR and CE supports the notion that cell cycle and cell fate are linked. It remains unclear how 
much proliferation contributes to cell fate. Indeed, these data do not rule out the possibility that 
one or more of these cell cycle genes is instrumental in differential OCPC proliferation, and, 
therefore, cell fate. Experiments to test this question are proposed below. 
Extrinsic Signals 
The link between cell cycle and cell fate may be a morphogenetic cue (Schwank and 
Basler, 2010). The classical extracellular neural induction signals -- BMPs and FGFs -- are 
differentially expressed in the OC, and their expression is affected by the loss of Sox2 consistent 
with a loss of neural fate and gain of non-neural fate. The major FGF associated with NR identity, 
FGF9, is drastically reduced, and the major BMPs associated with CE identity, BMP4 and BMP7, 
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are ectopically expressed. It remains in question how these morphogenetic cues affect the 
expression of cell cycle regulators and if these, in turn, are instrumental in affecting cell fate 
decisions.  
Alternatively, the overall in change in the expression of cell cycle regulators could simply 
be a secondary consequence of cell fate conversion. The data presented in Chapter III uncouple 
the mitogenic role of WNT signaling from its role in cell fate specification, placing WNT/-
Catenin signaling as a major regulator of non-neurogenic cell fate in the OC. OCPCs continue to 
cycle and express D-type cyclins in the absence of WNT signaling, but they do not fully 
differentiate into CE. These data are consistent with the known role of canonical WNT signaling 
in mammalian neural induction (Aubert et al., 2002) (further discussed below).  
However, it is curious that SOX2-ablated cells are not able to fully differentiate into CE 
until they exit the cell cycle or dramatically reduce their proliferation. Two possibilities for the 
link between cell cycle and cell fate thus arise: 1) cell cycle regulators, such as Cyclin D3 and 
p27Kip1, are simply part of the cohort of genes that are expressed in response to a neural or non-
neural-inducing signal and function to ensure that the correct number of cells are generated for 
a specific cell type. Or 2) cell cycle regulators somehow control the competence of a cell to 
become neural or non-neural.  
One way to test this question is to prevent a CE progenitor cell from exiting the cell cycle 
or to force a neural progenitor cell to exit the cell cycle prematurely. Variations of these 
experiments have been performed: Decreasing SOXB1 factors in chick neural tube progenitor 
cells forces them to exit the cell cycle and aberrantly differentiate, but they remain neuronal 
(Bylund et al., 2003). In fact, SOXB1 factors must be down-regulated in order for a neuron to 
form in the chick neural tube. Conversely, forcing peripheral OC cells to proliferate does not 
 138 
necessarily make them become neural retina (Kiyama et al., 2012; Moshiri and Reh, 2004). 
However, these experiments may need to be performed much earlier in optic cup development 
(E11-E14) in order for the question to be adequately resolved. At any rate, these studies 
combined with the present thesis project suggest that cell cycle regulators do not directly 
control cell fate but are nonetheless instrumental in specifying the correct numbers and types of 
cells in already-specified tissues. 
Neural retina is the ground state of the optic vesicle 
The specific ablation of Sox2 in the OC leaves upstream regulators untouched. This 
method allows for the analysis of SOX2 function in neural fate without manipulating extrinsic 
pathways. “Artificial” ablation of SOX2 in a neural cell type also offers insight into the default 
nature of neural fate. The data presented in this project suggest that neural is the ground state 
of the optic vesicle: all OV progenitor cells initially express SOX2, but SOX2 must be down-
regulated in order for non-neurogenic CE to form. Therefore, SOX2 essentially represses CE fate. 
It must be that non-neural inducing cues repress SOX2; otherwise, neural retina will form by 
“default” mechanisms anywhere SOX2 is present (Figure 4-2). BMPS and WNTS, in addition to 
being downstream markers of CE, may also function upstream to down-regulate SOX2 (Figure 4-
2). 
Re-defining default 
The term “default” is mis-leading, because it suggests that a particular cell fate will arise 
in the absence of all inducing cues. “Ground state” may be a more appropriate term to describe 
the initial fate of a cell, or the identity upon which other cell fates are imposed, often by 
inhibitory means (as in the case of sex determination). Indeed, both neural and non-neural 
signals are required for cells to become NR or CE, respectively. The true default nature of the OV 
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--- the cell type that develops in the absence of both SOX2 and WNT/BMP activity -- appears to 
be a progenitor cell type that is neither NR nor CE (Chapter III).  
The role of WNT signaling in OC development is consistent with its putative role in non-neural 
fate specification in the mouse epiblast 
-Catenin-mediated WNT signaling in mouse ESCs has been studied from the 
perspective of the dual function of -Catenin in cell adhesion and transcriptional regulation. -
Catenin is required for mESC pluripotency, but its transcriptional function appears dispensable 
for pluripotency (Davidson et al., 2012; Faunes et al., 2013). Whereas -Catenin mediates 
pluripotency through regulating the levels of membrane-bound OCT4, it also transcriptionally 
promotes mesoderm formation (Davidson et al., 2012; Faunes et al., 2013; Lyashenko et al., 
2011; Valenta et al., 2011). Mouse ESCs hypomorphic for -Catenin follow a neural-default 
developmental pathway, but this could be due to a loss of pluripotency rather than the 
suppression of neural fate (Rudloff and Kemler, 2012). All together, these studies place 
canonical WNT signaling as a dual regulator of ESCs: membrane-bound -catenin promotes 
pluripotency while nuclear -catenin promotes mesoderm. Neither of these functions has been 
shown to operate through direct repression of neural fate or Sox2 expression in ESCs. 
Similarly, in the OC, the transcriptional function of -Catenin is to specify non-neural 
retina fate and appears dispensable for neural fate. In the absence of -Catenin, CE-specific 
genes are not expressed, but OCPCs still self-renew and are capable of becoming neural retina. 
Moreover, the presence of -Catenin does not normally suppress NR fate. Therefore, in the OC, 
canonical WNT signaling induces non-neural fate in regions where SOX2 is absent; however, it is 
still unclear whether WNT signaling could act upstream of SOX2 to antagonize NR fate (Figure 4-
2). In this scenario, SOX2 would work in a feedback loop to repress WNT targets in the 
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prospective NR. The delay in the up-regulation of Axin2 upon SOX2 ablation suggests that there 
is an additional mechanism that represses -Catenin target gene expression. It is possible that 
this occurs through WNT antagonists, like Sfrp2, which are expressed in the prospective NR. 
However, it would be most informative to use a reporter of WNT activity, such as the Axin2-LacZ 
transgene, as a more sensitive readout of WNT activity upon SOX2 ablation. Nonetheless, the 
results of this study are consistent with the known role of WNT signaling in mammalian neural 
induction: -Catenin transcriptional activity specifies non-neural plate/non-neural retina fates 
but does not directly repress neural fate. 
SOX2 is the neural determinant in the mouse optic cup 
In the human epiblast, PAX6 is the earliest known marker of neural plate, whereas in the 
mouse, the earliest known marker of neuroepithelium is SOX1 (Pevny et al., 1998; Zhang et al., 
2010). In the mouse OC, SOX2 becomes restricted to the prospective NR domain and is excluded 
from non-neuroegenic regions, including the CE and RPE, making it the earliest known specific 
marker of NR. In contrast, PAX6 is expressed in all three regions of the OC, and high PAX6, 
especially in the absence of SOX2, is associated with non-neurogenic fate (Chapter II). Therefore, 
SOX2, not PAX6, is the neural determining factor in the OC. Indeed, as in the epiblast, where 
SOX2 is initially expressed in all cells but later becomes restricted to neurogenic progenitors; so 
too in the OC, where SOX2 is initially expressed throughout the whole OV but later becomes 
restricted to the NR.  
Clinical Significance 
Is there a “Factor X” that rescues neurogenesis in a Sox2-deficient retina? 
Knocking out Sox2 in OCPCs and simultaneously re-expressing it from the Rosa locus 
rescues neurogenesis. However, sustained ectopic expression of Sox2 in CE progenitor cells is 
 141 
not sufficient to induce neurogenesis (W Heavner unpublished data). These data raise the 
possibility that SOX2-positive neural epithelium is competent to generate neurons because of 
the activation of SOX2 downstream targets and/or the absence of inhibitory factors, which are 
presumably present in the CE or epidermis. Such inhibitory factors could include inaccessible 
chromatin in the regulatory regions of neurogenic genes and/or the presence of repressive co-
factors. The identification of SOX2 targets that induce or inhibit neurogenesis would give insight 
into how SOX2 confers neural competence and offer clinical significance. 
Cell Cycle Inhibition 
OCPCs that lose SOX2 continue to cycle and harbor increased or stabilized Cyclin D1. By 
contrast, in the mouse neural tube, premature loss of SOXB1 factors induces cell cycle exit and 
aberrant neuronal differentiation. In fact, down-regulation of SOX2 is necessary for neural 
progenitor cells to exit the cell cycle and differentiate into neurons, and this is accomplished in 
part at the protein level (Bani-Yaghoub et al., 2006; Bylund et al., 2003). It would be interesting 
to test whether forcing Sox2-ablated cells to exit the cell cycle would induce them to become 
neurons. It is likely that this experiment would have to be performed early enough (E11-E14) 
that SOX2-negative cells have not yet begun to follow the CE lineage. Such an early window 
comprises when their neuronal genes are most likely accessible and capable of being expressed. 
The results of this experiment would tell whether SOX2-negative cells have a window of 
competence when they are still capable of generating neurons (and neural-inhibiting pathways 
have not taken over) and whether prolonged proliferation (inability to exit the cell cycle) 
contributes to their loss of neural competence. 
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Neurogenin1 and the inner ear sensory epithelium 
The developing ear sensory epithelium is remarkably similar to the developing NR, 
especially in regard to SOX2 (Neves et al., 2007). Sox2 is initially expressed in the neural sensory 
domain of the otic cup but expression is lost in neuroblasts and sensory hair cells. Over-
expression of SOX2 in the chick otic cup induces ectopic expression of Neurogenin1 without 
concomitant neurogenesis (Evsen et al., 2013). However, over-expression of Neurogenin1 alone, 
or NeuroD1 alone, is sufficient to induce ectopic neurogenesis. The difference in these two 
experiments is that Sox2 expression is sustained in the former but down-regulated in the latter. 
In fact, both Neurogenin1 and NeuroD1 can repress Sox2 expression via the Nop1 enhancer 
(Evsen et al., 2013). These data suggest that Neuogenin1 is a direct target of SOX2 and 
contributes to the competence of neuroepithelial cells to generate neurons. And Neurogenin1 
works in a feedback loop to down-regulate Sox2 and allow for cell cycle exit. However, it is still 
unknown whether ectopic expression of Neurogenin1 in a normally non-neurogenic (SOX2-
negative) cell type, such as the CE, would confer neural competence. 
Identification of SOX2-regulated genes in the OC 
Despite Neurogenin1 being such a potent inducer of neurogenesis in an already neural- 
competent cell type, it still remains to be discovered exactly how SOX2 confers neural identity. 
Over-expression of Neurogenin1 in the SOX2-depleted OC would reveal whether neural 
competence can be defined by Neurogenin1. To identity other potential direct targets of SOX2 
in the OC, we scanned the regulatory regions of 1030 significantly changed genes in the 
Sox2cond/cond; P0CreiresGFP OC for SOX2/POU binding sites. Given that SOX2 is always found in 
complex with transcriptional co-factors, the best characterized being members of the POU 
family of transcription factors, we searched for the 13-bp SOX2/POU cassette 5000 bp upstream 
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and downstream of the transcription start sites of genes changed at least 2-fold with an FDR of 
0.04 or less (Chakravarthy et al., 2008) (Tables 4-1 and 4-2). These gene lists provide a starting 
point from which to test putative master regulators of neural fate downstream of SOX2. 
Is one of these a “magic bullet” for neural fate or does neural competence require a 
slew of neuronal genes? Two recent reports suggest that SOX2 regulates a larger network of 
genes than previously thought, primarily binding to distal enhancers in coordination with POU 
factors – POU5F1 (OCT4) in mouse ESCs and BRN2 (POU3F2) in mouse NPCs (Wenger et al., 
2013) (Lodato et al., 2013). This transition of POU binding partners between ESCs and NPCs 
contributes to SOX2 tissue specificity and may be a mechanism through which SOX2 keeps 
neuronal genes poised for expression. In fact, SOX2-bound poised enhancers in NPCs include 
those for genes involved in neuronal differentiation, such Atoh1, Lhx8, Id2 and Id4; whereas 
SOX2-bound active enhancers in NPCs are linked to genes involved in the negative regulation of 
neurogenesis and WNT receptor signaling (Lodato et al., 2013). 
A resource for identifying glaucoma-associated genes 
The two most enriched gene ontology categories of transcripts up-regulated following 
Sox2 ablation are secretion and extracellular matrix. These functional categories are consistent 
with the role of the ciliary body in maintaining IOP via Na+-K+ exchange pumps and Cl- channels 
(Civan and Macknight, 2004). Elevated IOP is a hallmark of glaucoma, and lowering IOP through 
the reduction of aqueous humour inflow is often used to treat this disease. However, it is still 
unclear how the ciliary body integrates multiple mechanisms to regulate inflow (Civan and 
Macknight, 2004). Given that ciliary body epithelial cells expand exponentially upon Sox2 
ablation, our genome-wide screen of up-regulated transcripts in these mutants may reveal 
previously unidentified genes important for the development and function of the CE. In fact, the 
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presumptive CE is considered to be functional before it is histologically distinct, because IOP is 
necessary for the normal growth of the embryonic eye, and the CE produces proteins of the 
inner limiting membrane and vitreous body (Beebe, 1986; Coulombre, 1957; Coulombre and 
Coulombre, 1957).  
Abnormal development of the anterior segment is often associated with elevated IOP 
and congenital glaucoma (Gould et al., 2004). Genes that are known to contribute to anterior 
segment dysgenesis are often linked to elevated IOP in humans and mice (Chang et al., 2001; 
Davis et al., 2011a; Gould et al., 2004; Mears et al., 1998; Nair et al., 2011; Nishimura et al., 
2001; Nishimura et al., 1998; Semina et al., 2001). Our screen of differentially expressed genes 
in Sox2-ablated eyes reveals up-regulation of genes that have been associated with anterior 
segment dysgenesis and juvenile-onset and age-related glaucoma (Table 4-3). The significance 
of these data is two-fold: 1) the Sox2-mutant OC provides a valuable resource for identifying 
previously unknown CE genes, and 2) disruption of the function of many of these genes may 
contribute to glaucoma. 
The current state of using gene therapy to treat eye disease 
The mature eye provides a valuable model for cellular replacement and regenerative 
therapies. It is surgically accessible and non-essential for life, and failed tissue grafts can be 
ablated or removed with relative ease. Moreover, advanced imaging technologies for evaluating 
the structure and function of the adult eye, and the wealth of basic knowledge of eye field and 
retinal development, together have enhanced the field of regenerative medicine for the 
treatment of currently incurable eye disease.  
At present, the only viable option for treating loss of retinal cells in the adult eye is 
cellular replacement therapy. Emerging technologies have shown promise for improving the 
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vision of patients suffering from diseases affecting the pigmented (RPE) and photoreceptor 
layers of the retina. The RPE serves as a barrier between the outer retina, where the 
photoreceptors reside, and the choriocapillaris, the network of capillaries that provides 
nutrients to the retina. Because the RPE actively maintains the homeostasis of the outer retina, 
diseases of the RPE can lead to secondary photoreceptor cell loss. The apposition of the RPE and 
photoreceptor layers creates the surgically accessible subretinal space where cells can be readily 
transplanted to treat retinal cell loss. Two diseases that affect these layers and may benefit from 
transplants to the subretinal space include age-related macular degeneration (AMD) and 
retinitis pigmentosa (RP).  
Retinal transplants have been studied for their therapeutic potential since the 1950s 
when it was demonstrated that fetal rat retina is viable for months after being transplanted to 
the anterior chamber of the maternal eye (Royo and Quay, 1959). Subsequent studies have 
shown that full thickness sheets of fetal retina transplanted intraocularly into the adult rodent 
eye survive, differentiate into retinal cell types, form synapses with host tissue and perhaps 
improve vision (del Cerro et al., 1991). The first indication that similar results could be obtained 
in humans was the temporary visual improvement of patients with RP after microaggregate 
suspensions of human fetal neural retina were injected into the subretinal space (Humayun et 
al., 2000). It was subsequently shown that injections of intact human fetal retinal sheets with 
attached RPE could survive and improve the vision of patients with RP or AMD (Radtke et al., 
2008; Radtke et al., 2002). 
Immune reactivity, insufficient donor material and persistent difficulty establishing 
graft-host connectivity present challenges to the use of fetal retinal transplants as a common 
treatment for degenerative eye disease. An alternative to fetal tissue is the use of healthy 
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autologous RPE transplanted from the peripheral retina to the damaged central retina of 
patients with AMD (Binder et al., 2004; Binder et al., 2002; Falkner-Radler et al., 2011). 
However, the surgical morbidity associated with this therapy, the volume of patients in need of 
RPE transplants and the genetic defects of autologous RPE cells isolated from patients with AMD 
highlight a need for alternative therapies to treat degenerative eye disease (MacLaren et al., 
2007). 
Stem cell biology has rapidly advanced the regenerative medicine field. The ability to 
generate large quantities of multipotent cells, which can then be directed to become any retinal 
cell type in culture, greatly expands the potential for new cell replacement therapeutics. Retinal 
progenitor cells (RPCs) are considered to be the active regenerating component of fetal retinal 
transplants. In 2004, Young and colleagues demonstrated that RPCs from mouse neonates can 
self-renew culture, develop into photoreceptors and improve the visual light response after 
being injected into the subretinal space of adult mice suffering from retinal degeneration 
(Klassen et al., 2004). Another study suggested that immature rod precursor cells, as opposed to 
multipotent RPCs, preferentially integrate into the host retina, form synaptic connections and 
improve visual function in mouse models of retinal degeneration (MacLaren et al., 2006).  
This landmark finding that donor cells must be differentiated in order to incorporate 
into the host retina anticipated future studies that used embryonic stem cells to generate 
photoreceptor precursors for transplantation. Indeed, both mouse and human embryonic stem 
cells (ESCs) can be directed to form retinal neurons or RPE in culture, and these differentiated 
cells improve vision when injected into mouse models of retinal degeneration (Haruta et al., 
2004; Ikeda et al., 2005; Kawasaki et al., 2002; Lamba et al., 2009; Lu et al., 2009; Osakada et al., 
2008). However, as with fetal retinal transplants, issues of donor-host compatibility and ethics 
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of tissue isolation have spurred investigation into the utility of adult stem cells and induced 
pluripotent stem cells for cellular replacement therapy.  
Potential adult stem cells have been identified in the ciliary margin of humans and mice, 
but their ability to self-renew and give rise to all of the retinal cell types remains unclear (Cicero 
et al., 2009; Coles et al., 2004; Tropepe et al., 2000). An alternative is the reprogramming of 
adult somatic cells to pluripotency using retroviral transfection of four embryonic transcription 
factors, Oct4, Sox2, KLF4 and c-Myc (Takahashi and Yamanaka, 2006). Like ESCs, these induced 
pluripotent stem (iPS) cells can be directed to produce RPE, RPCs, and retinal neurons in culture, 
and have demonstrated therapeutic potential in mouse models of retinal degeneration 
(Buchholz et al., 2009; Carr et al., 2009; Lamba et al., 2010; Meyer et al., 2009; Tucker et al., 
2011). One barrier to stem cell therapy for humans is the potential for cells to de-differentiate in 
the subretinal space, giving rise to teratomas. However, successive rounds of depletion of 
undifferentiated cells pre-transplantation have been shown to greatly decrease this risk (Tucker 
et al., 2011). Another challenge is the potential need to replace the damaged Bruch’s 
membrane, the basement membrane of the RPE, to provide a scaffold for injected cells (Lee and 
Maclaren, 2011).    
In addition to cellular replacement therapy, viral delivery of genes to the subretinal 
space has demonstrated therapeutic potential for a number of diseases. Leber congenital 
amourosis (LCA) is a group of rare hereditary retinal dystrophies caused by a mutation in one of 
more than fourteen genes. Gene therapy has been used to treat human patients with a specific 
form of LCA caused by a mutation in RPE65. After receiving subretinal injections of AAV carrying 
the human RPE65 gene, LCA patients reported improvements in visual sensitivity (Hauswirth et 
al., 2008). Similarly, viral delivery of the light-activated chloride pump halorhodopsin to cone 
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photoreceptor cell bodies can restore light sensitivity was restored in mouse models of RP 
(Busskamp et al., 2010).  
Advances in cellular replacement therapy for the treatment of degenerative eye disease 
have depended on a deep understanding of the basic science of eye field and retinal 
development. Indeed, protocols for generating retinal neurons and RPE from pluripotent cells 
have taken into account what is known about the signaling pathways involved in establishing the 
eye field -- BMP and WNT signaling inhibition and IGF-1 signaling -- and generating specific 
retinal cell types -- Notch pathway inhibition for photoreceptors, for example (Jadhav et al., 
2006; Tucker et al., 2011). Knowledge of the timing and location of tissue-specific gene 
expression in vivo has allowed for the identification and enrichment of specific cell types 
differentiated from human embryonic stem cells (hESCs) and induced pluripotent stem cells 
(iPSCs) (Vaajasaari et al., 2011). The intersection of basic and clinical science recently 
materialized in the use of hESC-derived RPE to treat dry AMD and Stargardt’s macular dystrophy 
in humans. The preliminary results of this Phase I/II clinical trial established the safety and 
tolerability of transplantation of hESC-RPE into the subretinal space (Schwartz et al., 2012). 
These cells did not appear to hyperproliferate, grow abnormally or cause intraocular 
inflammation. Moreover, no vision was lost, and there was even some evidence to suggest that 
vision was slightly improved (Schwartz et al., 2012). The ability to characterize differentiated 
RPE based on basic science principles, including morphology, gene expression and functional 
assays, was critical to this therapeutic use of hESC-RPE. 
The developing optic cup is an accessible model for understanding SOX2 and disease 
The eye has served as an invaluable model for understanding the mechanisms that 
coordinate human embryogenesis. Developmental genes can be identified readily through 
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ocular phenotypes, since the eye is not essential for the survival of the organism. Moreover, 
given that vision is so important for survival, the eye is particularly sensitive to selective 
pressure and therefore offers insight into the evolution of developmental genes. 
Continued characterization of eye development genes and persistent dialogue between 
basic scientists and clinicians serves as a paradigm for treating degenerative disease. The holy 
grail of developmental biology today is tissue regeneration. As an absolutely necessary 
component of neurogenesis and a marker of adult neural stem cells, SOX2 offers a springboard 
from which to investigate mechanisms that could stimulate neurogenesis in a diseased state. 
The data presented here confirm that the OC is an appropriate model for studying the role of 
SOX2 in neural ectoderm determination and investigates two mechanisms whereby SOX2 
confers neural competence or specifies neural fate: antagonism of Pax6 and repression of 
canonical WNT signaling. The natural next step of this project would be to identify the specific 
genes necessary for retina neural competence with the long-term goal of using these to treat 
degenerative diseases.  
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Figure 4-1 Expression of positive and negative cell cycle regulators are changed consistent 
with a cell fate conversion from NR to CE. The negative cell cycle regulators Cdkn1b (p27Kip1) 
and Cdkn2d (p19Ink4d) as well as the positive cell cycle regulator Ccnd1 are expressed in the 
prospective NR. These decrease upon SOX2 ablation. The negative cell cycle regulators Cdkn1a 
(p21Cip1) and Cdkn1c (p57Kip2) as well as the positive cell cycle regulators Ccnd3, Ccnd2 and Ccne1 
are expressed in the prospective CE. These increase upon SOX2 ablation.   
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Figure 4-2 Proposal that “neural retina” is the ground state of the OC. Morphogenetic 
pathways that regionalize the OV converge on the regulation of SOX2. SOX2 is initially expressed 
throughout the entire OV and may be maintained in the prospective NR by FGF signaling, where 
it antagonizes non-neurogenic fate. SOX2 must be down-regulated in the prospective CE and 
RPE in order for these regions to develop as non-NR. WNT and BMP signaling may act upstream 
of SOX2 to repress this repressor, thus allowing non-NR cell types to be specified. 
 Gene window chromosome sequence_Start TSS strand regulation evalue 
Evi2a 3 chr11 79341011 79344111 - up 1.8 
Elmo1 5 chr13 20181364 20182464 + up 1.8 
Cpne8 1 chr15 90504819 90509819 - up 2.8 
Smim6 11 chr11 1.16E+08 1.16E+08 + up 2.8 
Frrs1 11 chr3 1.17E+08 1.17E+08 + up 2.8 
Aldh1a1 5 chr19 20675371 20676471 + up 2.8 
Elmo1 1 chr13 20177464 20182464 + up 4.3 
Lgi1 10 chr19 38342921 38339271 + up 4.3 
Olfr1232 3 chr2 89163235 89166335 - up 4.3 
Cldn1 9 chr16 26374625 26371925 - up 4.3 
Cysltr1 9 chrX 1.04E+08 1.04E+08 - up 4.3 
Clcf1 10 chr19 4218041 4214391 + up 7 
Zmym1 11 chr4 1.27E+08 1.27E+08 - up 7 
Lingo2 3 chr4 36895677 36898777 - up 7 
Syngr1 3 chr15 79918663 79921763 + up 7 
Pxmp2 6 chr5 1.11E+08 1.11E+08 - up 7 
Il17d 7 chr14 58144465 58143665 + up 7 
Defb11 8 chr8 23018654 23016904 - up 7 
Table 4-1 Up-regulated transcripts in the Sox2-ablated OC that contain a consensus SOX2/POU binding site(s) in the proximal regulatory 
region. 
1
5
2
 
 Gene window chromosome sequence_Start TSS strand regulation evalue 
Nr2e1 1 chr10 42298394 42303394 - less_down 0.055 
Ttyh1 11 chr7 4075734 4071134 + less_down 0.055 
Pcsk2 3 chr2 1.43E+08 1.43E+08 + down 0.23 
Rbp3 11 chr14 34771807 34767207 + down 0.36 
Sox2 10 chr3 34552576 34548926 + down 0.9 
Itgbl1 11 chr14 1.24E+08 1.24E+08 + down 0.9 
Ptpro 2 chr6 1.37E+08 1.37E+08 + down 0.9 
Igfbpl1 7 chr4 45840499 45839699 - less_down 0.9 
Nrxn3 7 chr12 89962119 89961319 + down 0.9 
Zfp114 1 chr7 24955063 24960063 + down 1.8 
Stk32b 2 chr5 38104342 38108392 - less_down 1.8 
Pacsin1 3 chr17 27789526 27792626 + down 1.8 
Chrna4 1 chr2 1.81E+08 1.81E+08 - less_down 2.8 
St6galnac5 1 chr3 1.53E+08 1.53E+08 - down 2.8 
AI593442 10 chr9 52491184 52487534 - down 2.8 
Gnat2 10 chr3 1.08E+08 1.08E+08 + down 2.8 
Otx2 10 chr14 49290831 49287181 - less_down 2.8 
Adcy1 11 chr11 6968091 6963491 + less_down 2.8 
Fmn2 11 chr1 1.76E+08 1.76E+08 + down 2.8 
Nr2e1 11 chr10 42307994 42303394 - less_down 2.8 
Pkib 2 chr10 57347736 57351786 + down 2.8 
Gng3 3 chr19 8910636 8913736 - down 2.8 
Kcnrg 5 chr14 62225193 62226293 + down 2.8 
Dnaic1 7 chr4 41517626 41516826 + less_down 2.8 
Glra2 8 chrX 1.62E+08 1.62E+08 - down 2.8 
Ascl1 1 chr10 86951405 86956405 - down 4.3 
Rtn1 11 chr12 73514526 73509926 - down 4.3 
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Robo2 3 chr16 74408057 74411157 - less_down 4.3 
Cplx2 4 chr13 54470562 54472712 + down 4.3 
Nap1l3 4 chrX 1.2E+08 1.2E+08 - less_down 4.3 
Itgbl1 5 chr14 1.24E+08 1.24E+08 + down 4.3 
Slc1a2 5 chr2 1.02E+08 1.02E+08 + down 4.3 
Sox4 9 chr13 29048251 29045551 - less_down 4.3 
9330159F19Rik 1 chr10 28926448 28931448 + less_down 7 
Celsr3 1 chr9 1.09E+08 1.09E+08 + less_down 7 
Psmf1 10 chr2 1.52E+08 1.52E+08 - down 7 
Ptf1a 10 chr2 19370939 19367289 + down 7 
AA792892 11 chr5 94773373 94768773 + down 7 
Fgf15 11 chr7 1.52E+08 1.52E+08 + less_down 7 
Ing3 11 chr6 21904214 21899614 + down 7 
Tubb2b 11 chr13 34226823 34222223 - less_down 7 
9330159F19Rik 2 chr10 28927398 28931448 + less_down 7 
Glra2 2 chrX 1.62E+08 1.62E+08 - down 7 
Lmtk3 3 chr7 53036216 53039316 + less_down 7 
Dcx 4 chrX 1.4E+08 1.4E+08 - less_down 7 
Gadd45a 7 chr6 66988201 66987401 - less_down 7 
Pnma2 8 chr14 67531794 67530044 + less_down 7 
Cntn1 9 chr15 91782670 91779970 + less_down 7 
Cxcr4 9 chr1 1.3E+08 1.3E+08 - less_down 7 
Table 4-2 Down-regulated transcripts in the Sox2-ablated OC that contain a SOX2/POU consensus binding site(s) in the proximal regulatory 
region. 
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 Gene 
Symbol 
Fold Change Glaucoma Association 
Foxe3 2.92 Loss-of-function causes anterior segment dysgenesis 
PRSS56 2.39 Mutated in posterior microphthalmia in humans; causes angle-closure glaucoma in mice 
Foxc2 2.09 Loss of function causes anterior segment dysgenesis 
Cyp1b1 1.53 Loss-of-function associated with congenital glaucoma 
Rassf3 1.52 Duplicated in primary open angle glaucoma 
Sparc 1.50 Increased expression in PACG iris 
Foxc1 1.37 Loss of function causes anterior segment dysgenesis 
Nphp1 1.36 Duplicated in primary open angle glaucoma 
Bmp4 1.31 Heterozygosity causes anterior segment dysgenesis and elevated IOP 
Table 4-3 Genes up-regulated upon SOX2 ablation that have been linked to glaucoma, a disease often associated with malformation of the 
anterior segment. 
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